Premium Deep Dive NeuBase Therapeutics Deep Dive: August 2021 Aug 1, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for August 2021 7investing Lead Advisor Maxx Chatsko's Top Stock for August 2021 is building one of the most versatile technology platforms in genetic medicines. He thinks this under-the-radar stock has the best 10X... Aug 1, 2021 - By Maxx Chatsko Article The Mother of All Binary Events Might End in an… Deciphera Pharmaceuticals is nearing the most important data readout in its history. Jul 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update 7investing Biotech Recs: The Next De-Risking Events Jul 15, 2021 - By Maxx Chatsko Biotechnology Podcast How Do You Value Biotech Stocks? Pre-commercial drug developers don't have traditional fundamentals to analyze, but investors can estimate the likelihood of clinical development. 7investing Lead Advisors Simon Erickson checks in... Jul 6, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Relay Therapeutics Deep Dive: July 2021 Jul 1, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for July 2021 7investing Lead Advisor Maxx Chatsko's Top Stock to buy in July 2021 is incorporating machine learning and artificial intelligence to enable true precision medicine. Jul 1, 2021 - By Maxx Chatsko Article RNAi is Setting a High Bar for Gene Editing In the second quarter, three different RNAi drug candidates or drug products demonstrated the ability to reverse three different diseases. Jun 23, 2021 - By Maxx Chatsko Biotechnology Article What Makes a Biotech 10-Bagger? You don't necessarily have to sift through microcaps. You do need to focus on the right metrics. Maxx Chatsko offers his perspective. Jun 21, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Can Better Antibodies Challenge Cell Therapy? Jun 14, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Invitae Deep Dive: June 2021 Jun 1, 2021 - By Maxx Chatsko Healthcare Technology Video Maxx’s Top Stock for June 2021 7investing Lead Advisor Maxx Chatsko's Top Stock for June 2021 is well positioned to build solutions for some of the biggest obstacles facing the genetic testing markets. Jun 1, 2021 - By Maxx Chatsko Healthcare Technology Article Thermodynamics and Long-Term Investing There is a game. You have to play the game. May 22, 2021 - By Maxx Chatsko General Premium Advisor Update Investing Success Isn’t Measured in Months May 15, 2021 - By Maxx Chatsko General Premium Deep Dive Xcel Energy Deep Dive: May 2021 May 1, 2021 - By Maxx Chatsko Energy Video Maxx’s Top Stock for May 2021 7investing Lead Advisor Maxx Chatsko's Top Stock for May 2021 is leading the energy transition to zero-carbon power sources and the electrification of transportation. May 1, 2021 - By Maxx Chatsko Energy Article Can the Bioeconomy Transform Argentina into a Regional Superpower? Maxx Chatsko notes that while all eyes are on Brazil, the geographic strengths of its southern neighbor cannot be overlooked. Apr 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Running with Scissors: Will CRISPR be Humbled in the Clinic? Apr 13, 2021 - By Maxx Chatsko Biotechnology Podcast AACR Annual Meeting 2021: What’s the Frontier of Cancer Research? The American Association for Cancer Research (AACR) Annual Meeting 2021 begins this weekend. 7investing Lead Advisors Maxx Chatsko and Dan Kline discuss why the scientific meeting matters to... Apr 8, 2021 - By Daniel Kline Biotechnology Video Maxx’s Top Stock for April 2021 7investing Lead Advisor Maxx Chatsko's Top Stock to buy in April 2021 is developing a genetic medicine platform with several key advantages over peers. Apr 1, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Dicerna Pharmaceuticals Deep Dive: April 2021 Apr 1, 2021 - By Maxx Chatsko Biotechnology Article The Many Paths to Portfolio Allocation Investing is personal, but Maxx Chatsko points out the many ways you can handle portfolio allocation. Mar 22, 2021 - By Maxx Chatsko Premium Advisor Update My Long-Term Strategy in a Volatile Market Mar 15, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Certara Deep Dive: March 2021 Mar 1, 2021 - By Maxx Chatsko Enterprise Software Video Maxx’s Top Stock for March 2021 Maxx's Top Stock for March 2021 is an enterprise software company driving the digital transformation of a massive global industry and saving customers billions of dollars. Mar 1, 2021 - By Maxx Chatsko Enterprise Software Podcast What FinTwit Isn’t Telling You About These Biotech Stocks When biotech stocks rise on stories alone, and those stories become detached from reality, then you might be subjecting your portfolio to unnecessary risk. 7investing Lead Advisors Manisha Samy and... Feb 23, 2021 - By Manisha Samy Biotechnology Article A Mission Statement is Easy. Execution is Difficult A mission statement is nice to have, but it too often becomes a marketing pitch. Progress, including within a company's mission, is more important for investors. Feb 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Most Investors Neglect One of Their Biggest Advantages Feb 14, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for February 2021 7investing Lead Advisor Maxx Chatsko's Top Stock for February is an early-stage biopharma attempting to fundamentally change drug discovery and drug development. Feb 1, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Relay Therapeutics Deep Dive: February 2021 Feb 1, 2021 - By Maxx Chatsko Biotechnology Article Genomics Isn’t the Only Omics Maxx discusses misconceptions surrounding one of the market's oft-used buzzwords. Jan 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Will Renewable Energy Soar During the Biden Administration? Jan 15, 2021 - By Maxx Chatsko Energy Podcast JPM 39th Annual Healthcare Conference: What We’re Watching The JPM 39th Annual Healthcare Conference is next week. 7investing Lead Advisors Simon Erickson, Manisha Samy, and Maxx Chatsko discuss what they're watching as investors (and science nerds) ahead of... Jan 7, 2021 - By Manisha Samy Biotechnology Premium Deep Dive Selecta Biosciences Deep Dive: January 2021 Jan 1, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for January 7investing Lead Advisor Maxx Chatsko's top stock to buy in January 2021 is a small-cap biopharma developing an important technology platform that could increase the value of gene therapies, genetic... Jan 1, 2021 - By Maxx Chatsko Biotechnology Article Does the “B” Word Apply? It’s Complicated Maxx Chatsko offers a glimpse into how he values development-stage biopharma stocks. Dec 22, 2020 - By Maxx Chatsko Biotechnology Premium Advisor Update The 7investing Recommendation That Wasn’t Dec 15, 2020 - By Maxx Chatsko Pharmaceuticals Podcast ASH Conference Preview: What We’re Watching 7investing lead advisors Manisha Samy and Maxx Chatsko share what they're watching at the upcoming American Society of Hematology annual conference. Dec 3, 2020 - By Manisha Samy Biotechnology Podcast Synthetic Biology’s “Window of Opportunity” with ConVergInce Advisers’ Joel Stone Can synthetic biology break the chemical industry's reliance on fossil fuels? Industry veteran Joel Stone shares how industrial biotech is changing consumer brands, energy, agriculture, and more. Dec 1, 2020 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for December 7investing lead advisor Maxx Chatsko's Top Stock for December is leading the energy transition, today and tomorrow. Dec 1, 2020 - By Maxx Chatsko Energy Premium Deep Dive Xcel Energy Deep Dive: December 2020 Dec 1, 2020 - By Maxx Chatsko Energy Article Lesson Learned: Great Technology Doesn’t Guarantee a Great Business Maxx explains the importance of separating promising technology from great business. Nov 22, 2020 - By Maxx Chatsko Premium Advisor Update Vaccines Are On the Way, but Winter is Coming Nov 15, 2020 - By Maxx Chatsko Healthcare Technology Premium Deep Dive Dicerna Pharmaceuticals Deep Dive: November 2020 Nov 1, 2020 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for November 7investing lead advisor Maxx Chatsko's November 2020 recommendation is an under-the-radar, small-cap living technologies company at the very beginning of its growth trajectory. Nov 1, 2020 - By Maxx Chatsko Biotechnology Podcast Will the Cannabis Industry Give Way to Biotech? 7investing Lead Advisor Maxx Chatsko talks with Kevin Chen, co-founder and CEO of Hyasynth Bio, about the cannabis industry and how industrial biotech could transform the production of cannabinoid... Oct 22, 2020 - By Maxx Chatsko Biotechnology Article Not Another Political Discussion Maxx argues why investors today would do well to zoom out for a bigger-picture view of the world. Oct 22, 2020 - By Maxx Chatsko Premium Advisor Update “Cell Therapy’s First-Mover Disadvantage” Oct 15, 2020 - By Maxx Chatsko Biotechnology Premium Deep Dive Avita Therapeutics Deep Dive: October 2020 Oct 8, 2020 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for October 7investing lead advisor Maxx Chatsko's October 2020 recommendation is an under-the-radar, small-cap living technologies company at the very beginning of its growth trajectory. Oct 1, 2020 - By Maxx Chatsko Biotechnology Join Now! Why 7investing? Why Should I Invest? Why 7investing? Our Team Our 7 Principles Our Mission Testimonials How It Works What to Expect Our Report Format Membership Details Frequently Asked Questions Recommendations Research Articles Advisor Updates Company Updates Videos Special Reports Podcast Livestream Contact Us General Inquiries Submit a Testimonial Interested in Chatting With 7investing? My Account Log In
Video Maxx’s Top Stock for August 2021 7investing Lead Advisor Maxx Chatsko's Top Stock for August 2021 is building one of the most versatile technology platforms in genetic medicines. He thinks this under-the-radar stock has the best 10X... Aug 1, 2021 - By Maxx Chatsko Article The Mother of All Binary Events Might End in an… Deciphera Pharmaceuticals is nearing the most important data readout in its history. Jul 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update 7investing Biotech Recs: The Next De-Risking Events Jul 15, 2021 - By Maxx Chatsko Biotechnology Podcast How Do You Value Biotech Stocks? Pre-commercial drug developers don't have traditional fundamentals to analyze, but investors can estimate the likelihood of clinical development. 7investing Lead Advisors Simon Erickson checks in... Jul 6, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Relay Therapeutics Deep Dive: July 2021 Jul 1, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for July 2021 7investing Lead Advisor Maxx Chatsko's Top Stock to buy in July 2021 is incorporating machine learning and artificial intelligence to enable true precision medicine. Jul 1, 2021 - By Maxx Chatsko Article RNAi is Setting a High Bar for Gene Editing In the second quarter, three different RNAi drug candidates or drug products demonstrated the ability to reverse three different diseases. Jun 23, 2021 - By Maxx Chatsko Biotechnology Article What Makes a Biotech 10-Bagger? You don't necessarily have to sift through microcaps. You do need to focus on the right metrics. Maxx Chatsko offers his perspective. Jun 21, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Can Better Antibodies Challenge Cell Therapy? Jun 14, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Invitae Deep Dive: June 2021 Jun 1, 2021 - By Maxx Chatsko Healthcare Technology Video Maxx’s Top Stock for June 2021 7investing Lead Advisor Maxx Chatsko's Top Stock for June 2021 is well positioned to build solutions for some of the biggest obstacles facing the genetic testing markets. Jun 1, 2021 - By Maxx Chatsko Healthcare Technology Article Thermodynamics and Long-Term Investing There is a game. You have to play the game. May 22, 2021 - By Maxx Chatsko General Premium Advisor Update Investing Success Isn’t Measured in Months May 15, 2021 - By Maxx Chatsko General Premium Deep Dive Xcel Energy Deep Dive: May 2021 May 1, 2021 - By Maxx Chatsko Energy Video Maxx’s Top Stock for May 2021 7investing Lead Advisor Maxx Chatsko's Top Stock for May 2021 is leading the energy transition to zero-carbon power sources and the electrification of transportation. May 1, 2021 - By Maxx Chatsko Energy Article Can the Bioeconomy Transform Argentina into a Regional Superpower? Maxx Chatsko notes that while all eyes are on Brazil, the geographic strengths of its southern neighbor cannot be overlooked. Apr 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Running with Scissors: Will CRISPR be Humbled in the Clinic? Apr 13, 2021 - By Maxx Chatsko Biotechnology Podcast AACR Annual Meeting 2021: What’s the Frontier of Cancer Research? The American Association for Cancer Research (AACR) Annual Meeting 2021 begins this weekend. 7investing Lead Advisors Maxx Chatsko and Dan Kline discuss why the scientific meeting matters to... Apr 8, 2021 - By Daniel Kline Biotechnology Video Maxx’s Top Stock for April 2021 7investing Lead Advisor Maxx Chatsko's Top Stock to buy in April 2021 is developing a genetic medicine platform with several key advantages over peers. Apr 1, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Dicerna Pharmaceuticals Deep Dive: April 2021 Apr 1, 2021 - By Maxx Chatsko Biotechnology Article The Many Paths to Portfolio Allocation Investing is personal, but Maxx Chatsko points out the many ways you can handle portfolio allocation. Mar 22, 2021 - By Maxx Chatsko Premium Advisor Update My Long-Term Strategy in a Volatile Market Mar 15, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Certara Deep Dive: March 2021 Mar 1, 2021 - By Maxx Chatsko Enterprise Software Video Maxx’s Top Stock for March 2021 Maxx's Top Stock for March 2021 is an enterprise software company driving the digital transformation of a massive global industry and saving customers billions of dollars. Mar 1, 2021 - By Maxx Chatsko Enterprise Software Podcast What FinTwit Isn’t Telling You About These Biotech Stocks When biotech stocks rise on stories alone, and those stories become detached from reality, then you might be subjecting your portfolio to unnecessary risk. 7investing Lead Advisors Manisha Samy and... Feb 23, 2021 - By Manisha Samy Biotechnology Article A Mission Statement is Easy. Execution is Difficult A mission statement is nice to have, but it too often becomes a marketing pitch. Progress, including within a company's mission, is more important for investors. Feb 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Most Investors Neglect One of Their Biggest Advantages Feb 14, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for February 2021 7investing Lead Advisor Maxx Chatsko's Top Stock for February is an early-stage biopharma attempting to fundamentally change drug discovery and drug development. Feb 1, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Relay Therapeutics Deep Dive: February 2021 Feb 1, 2021 - By Maxx Chatsko Biotechnology Article Genomics Isn’t the Only Omics Maxx discusses misconceptions surrounding one of the market's oft-used buzzwords. Jan 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Will Renewable Energy Soar During the Biden Administration? Jan 15, 2021 - By Maxx Chatsko Energy Podcast JPM 39th Annual Healthcare Conference: What We’re Watching The JPM 39th Annual Healthcare Conference is next week. 7investing Lead Advisors Simon Erickson, Manisha Samy, and Maxx Chatsko discuss what they're watching as investors (and science nerds) ahead of... Jan 7, 2021 - By Manisha Samy Biotechnology Premium Deep Dive Selecta Biosciences Deep Dive: January 2021 Jan 1, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for January 7investing Lead Advisor Maxx Chatsko's top stock to buy in January 2021 is a small-cap biopharma developing an important technology platform that could increase the value of gene therapies, genetic... Jan 1, 2021 - By Maxx Chatsko Biotechnology Article Does the “B” Word Apply? It’s Complicated Maxx Chatsko offers a glimpse into how he values development-stage biopharma stocks. Dec 22, 2020 - By Maxx Chatsko Biotechnology Premium Advisor Update The 7investing Recommendation That Wasn’t Dec 15, 2020 - By Maxx Chatsko Pharmaceuticals Podcast ASH Conference Preview: What We’re Watching 7investing lead advisors Manisha Samy and Maxx Chatsko share what they're watching at the upcoming American Society of Hematology annual conference. Dec 3, 2020 - By Manisha Samy Biotechnology Podcast Synthetic Biology’s “Window of Opportunity” with ConVergInce Advisers’ Joel Stone Can synthetic biology break the chemical industry's reliance on fossil fuels? Industry veteran Joel Stone shares how industrial biotech is changing consumer brands, energy, agriculture, and more. Dec 1, 2020 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for December 7investing lead advisor Maxx Chatsko's Top Stock for December is leading the energy transition, today and tomorrow. Dec 1, 2020 - By Maxx Chatsko Energy Premium Deep Dive Xcel Energy Deep Dive: December 2020 Dec 1, 2020 - By Maxx Chatsko Energy Article Lesson Learned: Great Technology Doesn’t Guarantee a Great Business Maxx explains the importance of separating promising technology from great business. Nov 22, 2020 - By Maxx Chatsko Premium Advisor Update Vaccines Are On the Way, but Winter is Coming Nov 15, 2020 - By Maxx Chatsko Healthcare Technology Premium Deep Dive Dicerna Pharmaceuticals Deep Dive: November 2020 Nov 1, 2020 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for November 7investing lead advisor Maxx Chatsko's November 2020 recommendation is an under-the-radar, small-cap living technologies company at the very beginning of its growth trajectory. Nov 1, 2020 - By Maxx Chatsko Biotechnology Podcast Will the Cannabis Industry Give Way to Biotech? 7investing Lead Advisor Maxx Chatsko talks with Kevin Chen, co-founder and CEO of Hyasynth Bio, about the cannabis industry and how industrial biotech could transform the production of cannabinoid... Oct 22, 2020 - By Maxx Chatsko Biotechnology Article Not Another Political Discussion Maxx argues why investors today would do well to zoom out for a bigger-picture view of the world. Oct 22, 2020 - By Maxx Chatsko Premium Advisor Update “Cell Therapy’s First-Mover Disadvantage” Oct 15, 2020 - By Maxx Chatsko Biotechnology Premium Deep Dive Avita Therapeutics Deep Dive: October 2020 Oct 8, 2020 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for October 7investing lead advisor Maxx Chatsko's October 2020 recommendation is an under-the-radar, small-cap living technologies company at the very beginning of its growth trajectory. Oct 1, 2020 - By Maxx Chatsko Biotechnology Join Now! Why 7investing? Why Should I Invest? Why 7investing? Our Team Our 7 Principles Our Mission Testimonials How It Works What to Expect Our Report Format Membership Details Frequently Asked Questions Recommendations Research Articles Advisor Updates Company Updates Videos Special Reports Podcast Livestream Contact Us General Inquiries Submit a Testimonial Interested in Chatting With 7investing? My Account Log In
Article The Mother of All Binary Events Might End in an… Deciphera Pharmaceuticals is nearing the most important data readout in its history. Jul 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update 7investing Biotech Recs: The Next De-Risking Events Jul 15, 2021 - By Maxx Chatsko Biotechnology Podcast How Do You Value Biotech Stocks? Pre-commercial drug developers don't have traditional fundamentals to analyze, but investors can estimate the likelihood of clinical development. 7investing Lead Advisors Simon Erickson checks in... Jul 6, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Relay Therapeutics Deep Dive: July 2021 Jul 1, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for July 2021 7investing Lead Advisor Maxx Chatsko's Top Stock to buy in July 2021 is incorporating machine learning and artificial intelligence to enable true precision medicine. Jul 1, 2021 - By Maxx Chatsko Article RNAi is Setting a High Bar for Gene Editing In the second quarter, three different RNAi drug candidates or drug products demonstrated the ability to reverse three different diseases. Jun 23, 2021 - By Maxx Chatsko Biotechnology Article What Makes a Biotech 10-Bagger? You don't necessarily have to sift through microcaps. You do need to focus on the right metrics. Maxx Chatsko offers his perspective. Jun 21, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Can Better Antibodies Challenge Cell Therapy? Jun 14, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Invitae Deep Dive: June 2021 Jun 1, 2021 - By Maxx Chatsko Healthcare Technology Video Maxx’s Top Stock for June 2021 7investing Lead Advisor Maxx Chatsko's Top Stock for June 2021 is well positioned to build solutions for some of the biggest obstacles facing the genetic testing markets. Jun 1, 2021 - By Maxx Chatsko Healthcare Technology Article Thermodynamics and Long-Term Investing There is a game. You have to play the game. May 22, 2021 - By Maxx Chatsko General Premium Advisor Update Investing Success Isn’t Measured in Months May 15, 2021 - By Maxx Chatsko General Premium Deep Dive Xcel Energy Deep Dive: May 2021 May 1, 2021 - By Maxx Chatsko Energy Video Maxx’s Top Stock for May 2021 7investing Lead Advisor Maxx Chatsko's Top Stock for May 2021 is leading the energy transition to zero-carbon power sources and the electrification of transportation. May 1, 2021 - By Maxx Chatsko Energy Article Can the Bioeconomy Transform Argentina into a Regional Superpower? Maxx Chatsko notes that while all eyes are on Brazil, the geographic strengths of its southern neighbor cannot be overlooked. Apr 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Running with Scissors: Will CRISPR be Humbled in the Clinic? Apr 13, 2021 - By Maxx Chatsko Biotechnology Podcast AACR Annual Meeting 2021: What’s the Frontier of Cancer Research? The American Association for Cancer Research (AACR) Annual Meeting 2021 begins this weekend. 7investing Lead Advisors Maxx Chatsko and Dan Kline discuss why the scientific meeting matters to... Apr 8, 2021 - By Daniel Kline Biotechnology Video Maxx’s Top Stock for April 2021 7investing Lead Advisor Maxx Chatsko's Top Stock to buy in April 2021 is developing a genetic medicine platform with several key advantages over peers. Apr 1, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Dicerna Pharmaceuticals Deep Dive: April 2021 Apr 1, 2021 - By Maxx Chatsko Biotechnology Article The Many Paths to Portfolio Allocation Investing is personal, but Maxx Chatsko points out the many ways you can handle portfolio allocation. Mar 22, 2021 - By Maxx Chatsko Premium Advisor Update My Long-Term Strategy in a Volatile Market Mar 15, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Certara Deep Dive: March 2021 Mar 1, 2021 - By Maxx Chatsko Enterprise Software Video Maxx’s Top Stock for March 2021 Maxx's Top Stock for March 2021 is an enterprise software company driving the digital transformation of a massive global industry and saving customers billions of dollars. Mar 1, 2021 - By Maxx Chatsko Enterprise Software Podcast What FinTwit Isn’t Telling You About These Biotech Stocks When biotech stocks rise on stories alone, and those stories become detached from reality, then you might be subjecting your portfolio to unnecessary risk. 7investing Lead Advisors Manisha Samy and... Feb 23, 2021 - By Manisha Samy Biotechnology Article A Mission Statement is Easy. Execution is Difficult A mission statement is nice to have, but it too often becomes a marketing pitch. Progress, including within a company's mission, is more important for investors. Feb 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Most Investors Neglect One of Their Biggest Advantages Feb 14, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for February 2021 7investing Lead Advisor Maxx Chatsko's Top Stock for February is an early-stage biopharma attempting to fundamentally change drug discovery and drug development. Feb 1, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Relay Therapeutics Deep Dive: February 2021 Feb 1, 2021 - By Maxx Chatsko Biotechnology Article Genomics Isn’t the Only Omics Maxx discusses misconceptions surrounding one of the market's oft-used buzzwords. Jan 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Will Renewable Energy Soar During the Biden Administration? Jan 15, 2021 - By Maxx Chatsko Energy Podcast JPM 39th Annual Healthcare Conference: What We’re Watching The JPM 39th Annual Healthcare Conference is next week. 7investing Lead Advisors Simon Erickson, Manisha Samy, and Maxx Chatsko discuss what they're watching as investors (and science nerds) ahead of... Jan 7, 2021 - By Manisha Samy Biotechnology Premium Deep Dive Selecta Biosciences Deep Dive: January 2021 Jan 1, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for January 7investing Lead Advisor Maxx Chatsko's top stock to buy in January 2021 is a small-cap biopharma developing an important technology platform that could increase the value of gene therapies, genetic... Jan 1, 2021 - By Maxx Chatsko Biotechnology Article Does the “B” Word Apply? It’s Complicated Maxx Chatsko offers a glimpse into how he values development-stage biopharma stocks. Dec 22, 2020 - By Maxx Chatsko Biotechnology Premium Advisor Update The 7investing Recommendation That Wasn’t Dec 15, 2020 - By Maxx Chatsko Pharmaceuticals Podcast ASH Conference Preview: What We’re Watching 7investing lead advisors Manisha Samy and Maxx Chatsko share what they're watching at the upcoming American Society of Hematology annual conference. Dec 3, 2020 - By Manisha Samy Biotechnology Podcast Synthetic Biology’s “Window of Opportunity” with ConVergInce Advisers’ Joel Stone Can synthetic biology break the chemical industry's reliance on fossil fuels? Industry veteran Joel Stone shares how industrial biotech is changing consumer brands, energy, agriculture, and more. Dec 1, 2020 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for December 7investing lead advisor Maxx Chatsko's Top Stock for December is leading the energy transition, today and tomorrow. Dec 1, 2020 - By Maxx Chatsko Energy Premium Deep Dive Xcel Energy Deep Dive: December 2020 Dec 1, 2020 - By Maxx Chatsko Energy Article Lesson Learned: Great Technology Doesn’t Guarantee a Great Business Maxx explains the importance of separating promising technology from great business. Nov 22, 2020 - By Maxx Chatsko Premium Advisor Update Vaccines Are On the Way, but Winter is Coming Nov 15, 2020 - By Maxx Chatsko Healthcare Technology Premium Deep Dive Dicerna Pharmaceuticals Deep Dive: November 2020 Nov 1, 2020 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for November 7investing lead advisor Maxx Chatsko's November 2020 recommendation is an under-the-radar, small-cap living technologies company at the very beginning of its growth trajectory. Nov 1, 2020 - By Maxx Chatsko Biotechnology Podcast Will the Cannabis Industry Give Way to Biotech? 7investing Lead Advisor Maxx Chatsko talks with Kevin Chen, co-founder and CEO of Hyasynth Bio, about the cannabis industry and how industrial biotech could transform the production of cannabinoid... Oct 22, 2020 - By Maxx Chatsko Biotechnology Article Not Another Political Discussion Maxx argues why investors today would do well to zoom out for a bigger-picture view of the world. Oct 22, 2020 - By Maxx Chatsko Premium Advisor Update “Cell Therapy’s First-Mover Disadvantage” Oct 15, 2020 - By Maxx Chatsko Biotechnology Premium Deep Dive Avita Therapeutics Deep Dive: October 2020 Oct 8, 2020 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for October 7investing lead advisor Maxx Chatsko's October 2020 recommendation is an under-the-radar, small-cap living technologies company at the very beginning of its growth trajectory. Oct 1, 2020 - By Maxx Chatsko Biotechnology Join Now! Why 7investing? Why Should I Invest? Why 7investing? Our Team Our 7 Principles Our Mission Testimonials How It Works What to Expect Our Report Format Membership Details Frequently Asked Questions Recommendations Research Articles Advisor Updates Company Updates Videos Special Reports Podcast Livestream Contact Us General Inquiries Submit a Testimonial Interested in Chatting With 7investing? My Account Log In
Premium Advisor Update 7investing Biotech Recs: The Next De-Risking Events Jul 15, 2021 - By Maxx Chatsko Biotechnology Podcast How Do You Value Biotech Stocks? Pre-commercial drug developers don't have traditional fundamentals to analyze, but investors can estimate the likelihood of clinical development. 7investing Lead Advisors Simon Erickson checks in... Jul 6, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Relay Therapeutics Deep Dive: July 2021 Jul 1, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for July 2021 7investing Lead Advisor Maxx Chatsko's Top Stock to buy in July 2021 is incorporating machine learning and artificial intelligence to enable true precision medicine. Jul 1, 2021 - By Maxx Chatsko Article RNAi is Setting a High Bar for Gene Editing In the second quarter, three different RNAi drug candidates or drug products demonstrated the ability to reverse three different diseases. Jun 23, 2021 - By Maxx Chatsko Biotechnology Article What Makes a Biotech 10-Bagger? You don't necessarily have to sift through microcaps. You do need to focus on the right metrics. Maxx Chatsko offers his perspective. Jun 21, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Can Better Antibodies Challenge Cell Therapy? Jun 14, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Invitae Deep Dive: June 2021 Jun 1, 2021 - By Maxx Chatsko Healthcare Technology Video Maxx’s Top Stock for June 2021 7investing Lead Advisor Maxx Chatsko's Top Stock for June 2021 is well positioned to build solutions for some of the biggest obstacles facing the genetic testing markets. Jun 1, 2021 - By Maxx Chatsko Healthcare Technology Article Thermodynamics and Long-Term Investing There is a game. You have to play the game. May 22, 2021 - By Maxx Chatsko General Premium Advisor Update Investing Success Isn’t Measured in Months May 15, 2021 - By Maxx Chatsko General Premium Deep Dive Xcel Energy Deep Dive: May 2021 May 1, 2021 - By Maxx Chatsko Energy Video Maxx’s Top Stock for May 2021 7investing Lead Advisor Maxx Chatsko's Top Stock for May 2021 is leading the energy transition to zero-carbon power sources and the electrification of transportation. May 1, 2021 - By Maxx Chatsko Energy Article Can the Bioeconomy Transform Argentina into a Regional Superpower? Maxx Chatsko notes that while all eyes are on Brazil, the geographic strengths of its southern neighbor cannot be overlooked. Apr 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Running with Scissors: Will CRISPR be Humbled in the Clinic? Apr 13, 2021 - By Maxx Chatsko Biotechnology Podcast AACR Annual Meeting 2021: What’s the Frontier of Cancer Research? The American Association for Cancer Research (AACR) Annual Meeting 2021 begins this weekend. 7investing Lead Advisors Maxx Chatsko and Dan Kline discuss why the scientific meeting matters to... Apr 8, 2021 - By Daniel Kline Biotechnology Video Maxx’s Top Stock for April 2021 7investing Lead Advisor Maxx Chatsko's Top Stock to buy in April 2021 is developing a genetic medicine platform with several key advantages over peers. Apr 1, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Dicerna Pharmaceuticals Deep Dive: April 2021 Apr 1, 2021 - By Maxx Chatsko Biotechnology Article The Many Paths to Portfolio Allocation Investing is personal, but Maxx Chatsko points out the many ways you can handle portfolio allocation. Mar 22, 2021 - By Maxx Chatsko Premium Advisor Update My Long-Term Strategy in a Volatile Market Mar 15, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Certara Deep Dive: March 2021 Mar 1, 2021 - By Maxx Chatsko Enterprise Software Video Maxx’s Top Stock for March 2021 Maxx's Top Stock for March 2021 is an enterprise software company driving the digital transformation of a massive global industry and saving customers billions of dollars. Mar 1, 2021 - By Maxx Chatsko Enterprise Software Podcast What FinTwit Isn’t Telling You About These Biotech Stocks When biotech stocks rise on stories alone, and those stories become detached from reality, then you might be subjecting your portfolio to unnecessary risk. 7investing Lead Advisors Manisha Samy and... Feb 23, 2021 - By Manisha Samy Biotechnology Article A Mission Statement is Easy. Execution is Difficult A mission statement is nice to have, but it too often becomes a marketing pitch. Progress, including within a company's mission, is more important for investors. Feb 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Most Investors Neglect One of Their Biggest Advantages Feb 14, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for February 2021 7investing Lead Advisor Maxx Chatsko's Top Stock for February is an early-stage biopharma attempting to fundamentally change drug discovery and drug development. Feb 1, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Relay Therapeutics Deep Dive: February 2021 Feb 1, 2021 - By Maxx Chatsko Biotechnology Article Genomics Isn’t the Only Omics Maxx discusses misconceptions surrounding one of the market's oft-used buzzwords. Jan 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Will Renewable Energy Soar During the Biden Administration? Jan 15, 2021 - By Maxx Chatsko Energy Podcast JPM 39th Annual Healthcare Conference: What We’re Watching The JPM 39th Annual Healthcare Conference is next week. 7investing Lead Advisors Simon Erickson, Manisha Samy, and Maxx Chatsko discuss what they're watching as investors (and science nerds) ahead of... Jan 7, 2021 - By Manisha Samy Biotechnology Premium Deep Dive Selecta Biosciences Deep Dive: January 2021 Jan 1, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for January 7investing Lead Advisor Maxx Chatsko's top stock to buy in January 2021 is a small-cap biopharma developing an important technology platform that could increase the value of gene therapies, genetic... Jan 1, 2021 - By Maxx Chatsko Biotechnology Article Does the “B” Word Apply? It’s Complicated Maxx Chatsko offers a glimpse into how he values development-stage biopharma stocks. Dec 22, 2020 - By Maxx Chatsko Biotechnology Premium Advisor Update The 7investing Recommendation That Wasn’t Dec 15, 2020 - By Maxx Chatsko Pharmaceuticals Podcast ASH Conference Preview: What We’re Watching 7investing lead advisors Manisha Samy and Maxx Chatsko share what they're watching at the upcoming American Society of Hematology annual conference. Dec 3, 2020 - By Manisha Samy Biotechnology Podcast Synthetic Biology’s “Window of Opportunity” with ConVergInce Advisers’ Joel Stone Can synthetic biology break the chemical industry's reliance on fossil fuels? Industry veteran Joel Stone shares how industrial biotech is changing consumer brands, energy, agriculture, and more. Dec 1, 2020 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for December 7investing lead advisor Maxx Chatsko's Top Stock for December is leading the energy transition, today and tomorrow. Dec 1, 2020 - By Maxx Chatsko Energy Premium Deep Dive Xcel Energy Deep Dive: December 2020 Dec 1, 2020 - By Maxx Chatsko Energy Article Lesson Learned: Great Technology Doesn’t Guarantee a Great Business Maxx explains the importance of separating promising technology from great business. Nov 22, 2020 - By Maxx Chatsko Premium Advisor Update Vaccines Are On the Way, but Winter is Coming Nov 15, 2020 - By Maxx Chatsko Healthcare Technology Premium Deep Dive Dicerna Pharmaceuticals Deep Dive: November 2020 Nov 1, 2020 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for November 7investing lead advisor Maxx Chatsko's November 2020 recommendation is an under-the-radar, small-cap living technologies company at the very beginning of its growth trajectory. Nov 1, 2020 - By Maxx Chatsko Biotechnology Podcast Will the Cannabis Industry Give Way to Biotech? 7investing Lead Advisor Maxx Chatsko talks with Kevin Chen, co-founder and CEO of Hyasynth Bio, about the cannabis industry and how industrial biotech could transform the production of cannabinoid... Oct 22, 2020 - By Maxx Chatsko Biotechnology Article Not Another Political Discussion Maxx argues why investors today would do well to zoom out for a bigger-picture view of the world. Oct 22, 2020 - By Maxx Chatsko Premium Advisor Update “Cell Therapy’s First-Mover Disadvantage” Oct 15, 2020 - By Maxx Chatsko Biotechnology Premium Deep Dive Avita Therapeutics Deep Dive: October 2020 Oct 8, 2020 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for October 7investing lead advisor Maxx Chatsko's October 2020 recommendation is an under-the-radar, small-cap living technologies company at the very beginning of its growth trajectory. Oct 1, 2020 - By Maxx Chatsko Biotechnology Join Now! Why 7investing? Why Should I Invest? Why 7investing? Our Team Our 7 Principles Our Mission Testimonials How It Works What to Expect Our Report Format Membership Details Frequently Asked Questions Recommendations Research Articles Advisor Updates Company Updates Videos Special Reports Podcast Livestream Contact Us General Inquiries Submit a Testimonial Interested in Chatting With 7investing? My Account Log In
Podcast How Do You Value Biotech Stocks? Pre-commercial drug developers don't have traditional fundamentals to analyze, but investors can estimate the likelihood of clinical development. 7investing Lead Advisors Simon Erickson checks in... Jul 6, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Relay Therapeutics Deep Dive: July 2021 Jul 1, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for July 2021 7investing Lead Advisor Maxx Chatsko's Top Stock to buy in July 2021 is incorporating machine learning and artificial intelligence to enable true precision medicine. Jul 1, 2021 - By Maxx Chatsko Article RNAi is Setting a High Bar for Gene Editing In the second quarter, three different RNAi drug candidates or drug products demonstrated the ability to reverse three different diseases. Jun 23, 2021 - By Maxx Chatsko Biotechnology Article What Makes a Biotech 10-Bagger? You don't necessarily have to sift through microcaps. You do need to focus on the right metrics. Maxx Chatsko offers his perspective. Jun 21, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Can Better Antibodies Challenge Cell Therapy? Jun 14, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Invitae Deep Dive: June 2021 Jun 1, 2021 - By Maxx Chatsko Healthcare Technology Video Maxx’s Top Stock for June 2021 7investing Lead Advisor Maxx Chatsko's Top Stock for June 2021 is well positioned to build solutions for some of the biggest obstacles facing the genetic testing markets. Jun 1, 2021 - By Maxx Chatsko Healthcare Technology Article Thermodynamics and Long-Term Investing There is a game. You have to play the game. May 22, 2021 - By Maxx Chatsko General Premium Advisor Update Investing Success Isn’t Measured in Months May 15, 2021 - By Maxx Chatsko General Premium Deep Dive Xcel Energy Deep Dive: May 2021 May 1, 2021 - By Maxx Chatsko Energy Video Maxx’s Top Stock for May 2021 7investing Lead Advisor Maxx Chatsko's Top Stock for May 2021 is leading the energy transition to zero-carbon power sources and the electrification of transportation. May 1, 2021 - By Maxx Chatsko Energy Article Can the Bioeconomy Transform Argentina into a Regional Superpower? Maxx Chatsko notes that while all eyes are on Brazil, the geographic strengths of its southern neighbor cannot be overlooked. Apr 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Running with Scissors: Will CRISPR be Humbled in the Clinic? Apr 13, 2021 - By Maxx Chatsko Biotechnology Podcast AACR Annual Meeting 2021: What’s the Frontier of Cancer Research? The American Association for Cancer Research (AACR) Annual Meeting 2021 begins this weekend. 7investing Lead Advisors Maxx Chatsko and Dan Kline discuss why the scientific meeting matters to... Apr 8, 2021 - By Daniel Kline Biotechnology Video Maxx’s Top Stock for April 2021 7investing Lead Advisor Maxx Chatsko's Top Stock to buy in April 2021 is developing a genetic medicine platform with several key advantages over peers. Apr 1, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Dicerna Pharmaceuticals Deep Dive: April 2021 Apr 1, 2021 - By Maxx Chatsko Biotechnology Article The Many Paths to Portfolio Allocation Investing is personal, but Maxx Chatsko points out the many ways you can handle portfolio allocation. Mar 22, 2021 - By Maxx Chatsko Premium Advisor Update My Long-Term Strategy in a Volatile Market Mar 15, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Certara Deep Dive: March 2021 Mar 1, 2021 - By Maxx Chatsko Enterprise Software Video Maxx’s Top Stock for March 2021 Maxx's Top Stock for March 2021 is an enterprise software company driving the digital transformation of a massive global industry and saving customers billions of dollars. Mar 1, 2021 - By Maxx Chatsko Enterprise Software Podcast What FinTwit Isn’t Telling You About These Biotech Stocks When biotech stocks rise on stories alone, and those stories become detached from reality, then you might be subjecting your portfolio to unnecessary risk. 7investing Lead Advisors Manisha Samy and... Feb 23, 2021 - By Manisha Samy Biotechnology Article A Mission Statement is Easy. Execution is Difficult A mission statement is nice to have, but it too often becomes a marketing pitch. Progress, including within a company's mission, is more important for investors. Feb 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Most Investors Neglect One of Their Biggest Advantages Feb 14, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for February 2021 7investing Lead Advisor Maxx Chatsko's Top Stock for February is an early-stage biopharma attempting to fundamentally change drug discovery and drug development. Feb 1, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Relay Therapeutics Deep Dive: February 2021 Feb 1, 2021 - By Maxx Chatsko Biotechnology Article Genomics Isn’t the Only Omics Maxx discusses misconceptions surrounding one of the market's oft-used buzzwords. Jan 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Will Renewable Energy Soar During the Biden Administration? Jan 15, 2021 - By Maxx Chatsko Energy Podcast JPM 39th Annual Healthcare Conference: What We’re Watching The JPM 39th Annual Healthcare Conference is next week. 7investing Lead Advisors Simon Erickson, Manisha Samy, and Maxx Chatsko discuss what they're watching as investors (and science nerds) ahead of... Jan 7, 2021 - By Manisha Samy Biotechnology Premium Deep Dive Selecta Biosciences Deep Dive: January 2021 Jan 1, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for January 7investing Lead Advisor Maxx Chatsko's top stock to buy in January 2021 is a small-cap biopharma developing an important technology platform that could increase the value of gene therapies, genetic... Jan 1, 2021 - By Maxx Chatsko Biotechnology Article Does the “B” Word Apply? It’s Complicated Maxx Chatsko offers a glimpse into how he values development-stage biopharma stocks. Dec 22, 2020 - By Maxx Chatsko Biotechnology Premium Advisor Update The 7investing Recommendation That Wasn’t Dec 15, 2020 - By Maxx Chatsko Pharmaceuticals Podcast ASH Conference Preview: What We’re Watching 7investing lead advisors Manisha Samy and Maxx Chatsko share what they're watching at the upcoming American Society of Hematology annual conference. Dec 3, 2020 - By Manisha Samy Biotechnology Podcast Synthetic Biology’s “Window of Opportunity” with ConVergInce Advisers’ Joel Stone Can synthetic biology break the chemical industry's reliance on fossil fuels? Industry veteran Joel Stone shares how industrial biotech is changing consumer brands, energy, agriculture, and more. Dec 1, 2020 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for December 7investing lead advisor Maxx Chatsko's Top Stock for December is leading the energy transition, today and tomorrow. Dec 1, 2020 - By Maxx Chatsko Energy Premium Deep Dive Xcel Energy Deep Dive: December 2020 Dec 1, 2020 - By Maxx Chatsko Energy Article Lesson Learned: Great Technology Doesn’t Guarantee a Great Business Maxx explains the importance of separating promising technology from great business. Nov 22, 2020 - By Maxx Chatsko Premium Advisor Update Vaccines Are On the Way, but Winter is Coming Nov 15, 2020 - By Maxx Chatsko Healthcare Technology Premium Deep Dive Dicerna Pharmaceuticals Deep Dive: November 2020 Nov 1, 2020 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for November 7investing lead advisor Maxx Chatsko's November 2020 recommendation is an under-the-radar, small-cap living technologies company at the very beginning of its growth trajectory. Nov 1, 2020 - By Maxx Chatsko Biotechnology Podcast Will the Cannabis Industry Give Way to Biotech? 7investing Lead Advisor Maxx Chatsko talks with Kevin Chen, co-founder and CEO of Hyasynth Bio, about the cannabis industry and how industrial biotech could transform the production of cannabinoid... Oct 22, 2020 - By Maxx Chatsko Biotechnology Article Not Another Political Discussion Maxx argues why investors today would do well to zoom out for a bigger-picture view of the world. Oct 22, 2020 - By Maxx Chatsko Premium Advisor Update “Cell Therapy’s First-Mover Disadvantage” Oct 15, 2020 - By Maxx Chatsko Biotechnology Premium Deep Dive Avita Therapeutics Deep Dive: October 2020 Oct 8, 2020 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for October 7investing lead advisor Maxx Chatsko's October 2020 recommendation is an under-the-radar, small-cap living technologies company at the very beginning of its growth trajectory. Oct 1, 2020 - By Maxx Chatsko Biotechnology Join Now! Why 7investing? Why Should I Invest? Why 7investing? Our Team Our 7 Principles Our Mission Testimonials How It Works What to Expect Our Report Format Membership Details Frequently Asked Questions Recommendations Research Articles Advisor Updates Company Updates Videos Special Reports Podcast Livestream Contact Us General Inquiries Submit a Testimonial Interested in Chatting With 7investing? My Account Log In
Premium Deep Dive Relay Therapeutics Deep Dive: July 2021 Jul 1, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for July 2021 7investing Lead Advisor Maxx Chatsko's Top Stock to buy in July 2021 is incorporating machine learning and artificial intelligence to enable true precision medicine. Jul 1, 2021 - By Maxx Chatsko Article RNAi is Setting a High Bar for Gene Editing In the second quarter, three different RNAi drug candidates or drug products demonstrated the ability to reverse three different diseases. Jun 23, 2021 - By Maxx Chatsko Biotechnology Article What Makes a Biotech 10-Bagger? You don't necessarily have to sift through microcaps. You do need to focus on the right metrics. Maxx Chatsko offers his perspective. Jun 21, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Can Better Antibodies Challenge Cell Therapy? Jun 14, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Invitae Deep Dive: June 2021 Jun 1, 2021 - By Maxx Chatsko Healthcare Technology Video Maxx’s Top Stock for June 2021 7investing Lead Advisor Maxx Chatsko's Top Stock for June 2021 is well positioned to build solutions for some of the biggest obstacles facing the genetic testing markets. Jun 1, 2021 - By Maxx Chatsko Healthcare Technology Article Thermodynamics and Long-Term Investing There is a game. You have to play the game. May 22, 2021 - By Maxx Chatsko General Premium Advisor Update Investing Success Isn’t Measured in Months May 15, 2021 - By Maxx Chatsko General Premium Deep Dive Xcel Energy Deep Dive: May 2021 May 1, 2021 - By Maxx Chatsko Energy Video Maxx’s Top Stock for May 2021 7investing Lead Advisor Maxx Chatsko's Top Stock for May 2021 is leading the energy transition to zero-carbon power sources and the electrification of transportation. May 1, 2021 - By Maxx Chatsko Energy Article Can the Bioeconomy Transform Argentina into a Regional Superpower? Maxx Chatsko notes that while all eyes are on Brazil, the geographic strengths of its southern neighbor cannot be overlooked. Apr 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Running with Scissors: Will CRISPR be Humbled in the Clinic? Apr 13, 2021 - By Maxx Chatsko Biotechnology Podcast AACR Annual Meeting 2021: What’s the Frontier of Cancer Research? The American Association for Cancer Research (AACR) Annual Meeting 2021 begins this weekend. 7investing Lead Advisors Maxx Chatsko and Dan Kline discuss why the scientific meeting matters to... Apr 8, 2021 - By Daniel Kline Biotechnology Video Maxx’s Top Stock for April 2021 7investing Lead Advisor Maxx Chatsko's Top Stock to buy in April 2021 is developing a genetic medicine platform with several key advantages over peers. Apr 1, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Dicerna Pharmaceuticals Deep Dive: April 2021 Apr 1, 2021 - By Maxx Chatsko Biotechnology Article The Many Paths to Portfolio Allocation Investing is personal, but Maxx Chatsko points out the many ways you can handle portfolio allocation. Mar 22, 2021 - By Maxx Chatsko Premium Advisor Update My Long-Term Strategy in a Volatile Market Mar 15, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Certara Deep Dive: March 2021 Mar 1, 2021 - By Maxx Chatsko Enterprise Software Video Maxx’s Top Stock for March 2021 Maxx's Top Stock for March 2021 is an enterprise software company driving the digital transformation of a massive global industry and saving customers billions of dollars. Mar 1, 2021 - By Maxx Chatsko Enterprise Software Podcast What FinTwit Isn’t Telling You About These Biotech Stocks When biotech stocks rise on stories alone, and those stories become detached from reality, then you might be subjecting your portfolio to unnecessary risk. 7investing Lead Advisors Manisha Samy and... Feb 23, 2021 - By Manisha Samy Biotechnology Article A Mission Statement is Easy. Execution is Difficult A mission statement is nice to have, but it too often becomes a marketing pitch. Progress, including within a company's mission, is more important for investors. Feb 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Most Investors Neglect One of Their Biggest Advantages Feb 14, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for February 2021 7investing Lead Advisor Maxx Chatsko's Top Stock for February is an early-stage biopharma attempting to fundamentally change drug discovery and drug development. Feb 1, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Relay Therapeutics Deep Dive: February 2021 Feb 1, 2021 - By Maxx Chatsko Biotechnology Article Genomics Isn’t the Only Omics Maxx discusses misconceptions surrounding one of the market's oft-used buzzwords. Jan 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Will Renewable Energy Soar During the Biden Administration? Jan 15, 2021 - By Maxx Chatsko Energy Podcast JPM 39th Annual Healthcare Conference: What We’re Watching The JPM 39th Annual Healthcare Conference is next week. 7investing Lead Advisors Simon Erickson, Manisha Samy, and Maxx Chatsko discuss what they're watching as investors (and science nerds) ahead of... Jan 7, 2021 - By Manisha Samy Biotechnology Premium Deep Dive Selecta Biosciences Deep Dive: January 2021 Jan 1, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for January 7investing Lead Advisor Maxx Chatsko's top stock to buy in January 2021 is a small-cap biopharma developing an important technology platform that could increase the value of gene therapies, genetic... Jan 1, 2021 - By Maxx Chatsko Biotechnology Article Does the “B” Word Apply? It’s Complicated Maxx Chatsko offers a glimpse into how he values development-stage biopharma stocks. Dec 22, 2020 - By Maxx Chatsko Biotechnology Premium Advisor Update The 7investing Recommendation That Wasn’t Dec 15, 2020 - By Maxx Chatsko Pharmaceuticals Podcast ASH Conference Preview: What We’re Watching 7investing lead advisors Manisha Samy and Maxx Chatsko share what they're watching at the upcoming American Society of Hematology annual conference. Dec 3, 2020 - By Manisha Samy Biotechnology Podcast Synthetic Biology’s “Window of Opportunity” with ConVergInce Advisers’ Joel Stone Can synthetic biology break the chemical industry's reliance on fossil fuels? Industry veteran Joel Stone shares how industrial biotech is changing consumer brands, energy, agriculture, and more. Dec 1, 2020 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for December 7investing lead advisor Maxx Chatsko's Top Stock for December is leading the energy transition, today and tomorrow. Dec 1, 2020 - By Maxx Chatsko Energy Premium Deep Dive Xcel Energy Deep Dive: December 2020 Dec 1, 2020 - By Maxx Chatsko Energy Article Lesson Learned: Great Technology Doesn’t Guarantee a Great Business Maxx explains the importance of separating promising technology from great business. Nov 22, 2020 - By Maxx Chatsko Premium Advisor Update Vaccines Are On the Way, but Winter is Coming Nov 15, 2020 - By Maxx Chatsko Healthcare Technology Premium Deep Dive Dicerna Pharmaceuticals Deep Dive: November 2020 Nov 1, 2020 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for November 7investing lead advisor Maxx Chatsko's November 2020 recommendation is an under-the-radar, small-cap living technologies company at the very beginning of its growth trajectory. Nov 1, 2020 - By Maxx Chatsko Biotechnology Podcast Will the Cannabis Industry Give Way to Biotech? 7investing Lead Advisor Maxx Chatsko talks with Kevin Chen, co-founder and CEO of Hyasynth Bio, about the cannabis industry and how industrial biotech could transform the production of cannabinoid... Oct 22, 2020 - By Maxx Chatsko Biotechnology Article Not Another Political Discussion Maxx argues why investors today would do well to zoom out for a bigger-picture view of the world. Oct 22, 2020 - By Maxx Chatsko Premium Advisor Update “Cell Therapy’s First-Mover Disadvantage” Oct 15, 2020 - By Maxx Chatsko Biotechnology Premium Deep Dive Avita Therapeutics Deep Dive: October 2020 Oct 8, 2020 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for October 7investing lead advisor Maxx Chatsko's October 2020 recommendation is an under-the-radar, small-cap living technologies company at the very beginning of its growth trajectory. Oct 1, 2020 - By Maxx Chatsko Biotechnology Join Now! Why 7investing? Why Should I Invest? Why 7investing? Our Team Our 7 Principles Our Mission Testimonials How It Works What to Expect Our Report Format Membership Details Frequently Asked Questions Recommendations Research Articles Advisor Updates Company Updates Videos Special Reports Podcast Livestream Contact Us General Inquiries Submit a Testimonial Interested in Chatting With 7investing? My Account Log In
Video Maxx’s Top Stock for July 2021 7investing Lead Advisor Maxx Chatsko's Top Stock to buy in July 2021 is incorporating machine learning and artificial intelligence to enable true precision medicine. Jul 1, 2021 - By Maxx Chatsko Article RNAi is Setting a High Bar for Gene Editing In the second quarter, three different RNAi drug candidates or drug products demonstrated the ability to reverse three different diseases. Jun 23, 2021 - By Maxx Chatsko Biotechnology Article What Makes a Biotech 10-Bagger? You don't necessarily have to sift through microcaps. You do need to focus on the right metrics. Maxx Chatsko offers his perspective. Jun 21, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Can Better Antibodies Challenge Cell Therapy? Jun 14, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Invitae Deep Dive: June 2021 Jun 1, 2021 - By Maxx Chatsko Healthcare Technology Video Maxx’s Top Stock for June 2021 7investing Lead Advisor Maxx Chatsko's Top Stock for June 2021 is well positioned to build solutions for some of the biggest obstacles facing the genetic testing markets. Jun 1, 2021 - By Maxx Chatsko Healthcare Technology Article Thermodynamics and Long-Term Investing There is a game. You have to play the game. May 22, 2021 - By Maxx Chatsko General Premium Advisor Update Investing Success Isn’t Measured in Months May 15, 2021 - By Maxx Chatsko General Premium Deep Dive Xcel Energy Deep Dive: May 2021 May 1, 2021 - By Maxx Chatsko Energy Video Maxx’s Top Stock for May 2021 7investing Lead Advisor Maxx Chatsko's Top Stock for May 2021 is leading the energy transition to zero-carbon power sources and the electrification of transportation. May 1, 2021 - By Maxx Chatsko Energy Article Can the Bioeconomy Transform Argentina into a Regional Superpower? Maxx Chatsko notes that while all eyes are on Brazil, the geographic strengths of its southern neighbor cannot be overlooked. Apr 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Running with Scissors: Will CRISPR be Humbled in the Clinic? Apr 13, 2021 - By Maxx Chatsko Biotechnology Podcast AACR Annual Meeting 2021: What’s the Frontier of Cancer Research? The American Association for Cancer Research (AACR) Annual Meeting 2021 begins this weekend. 7investing Lead Advisors Maxx Chatsko and Dan Kline discuss why the scientific meeting matters to... Apr 8, 2021 - By Daniel Kline Biotechnology Video Maxx’s Top Stock for April 2021 7investing Lead Advisor Maxx Chatsko's Top Stock to buy in April 2021 is developing a genetic medicine platform with several key advantages over peers. Apr 1, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Dicerna Pharmaceuticals Deep Dive: April 2021 Apr 1, 2021 - By Maxx Chatsko Biotechnology Article The Many Paths to Portfolio Allocation Investing is personal, but Maxx Chatsko points out the many ways you can handle portfolio allocation. Mar 22, 2021 - By Maxx Chatsko Premium Advisor Update My Long-Term Strategy in a Volatile Market Mar 15, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Certara Deep Dive: March 2021 Mar 1, 2021 - By Maxx Chatsko Enterprise Software Video Maxx’s Top Stock for March 2021 Maxx's Top Stock for March 2021 is an enterprise software company driving the digital transformation of a massive global industry and saving customers billions of dollars. Mar 1, 2021 - By Maxx Chatsko Enterprise Software Podcast What FinTwit Isn’t Telling You About These Biotech Stocks When biotech stocks rise on stories alone, and those stories become detached from reality, then you might be subjecting your portfolio to unnecessary risk. 7investing Lead Advisors Manisha Samy and... Feb 23, 2021 - By Manisha Samy Biotechnology Article A Mission Statement is Easy. Execution is Difficult A mission statement is nice to have, but it too often becomes a marketing pitch. Progress, including within a company's mission, is more important for investors. Feb 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Most Investors Neglect One of Their Biggest Advantages Feb 14, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for February 2021 7investing Lead Advisor Maxx Chatsko's Top Stock for February is an early-stage biopharma attempting to fundamentally change drug discovery and drug development. Feb 1, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Relay Therapeutics Deep Dive: February 2021 Feb 1, 2021 - By Maxx Chatsko Biotechnology Article Genomics Isn’t the Only Omics Maxx discusses misconceptions surrounding one of the market's oft-used buzzwords. Jan 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Will Renewable Energy Soar During the Biden Administration? Jan 15, 2021 - By Maxx Chatsko Energy Podcast JPM 39th Annual Healthcare Conference: What We’re Watching The JPM 39th Annual Healthcare Conference is next week. 7investing Lead Advisors Simon Erickson, Manisha Samy, and Maxx Chatsko discuss what they're watching as investors (and science nerds) ahead of... Jan 7, 2021 - By Manisha Samy Biotechnology Premium Deep Dive Selecta Biosciences Deep Dive: January 2021 Jan 1, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for January 7investing Lead Advisor Maxx Chatsko's top stock to buy in January 2021 is a small-cap biopharma developing an important technology platform that could increase the value of gene therapies, genetic... Jan 1, 2021 - By Maxx Chatsko Biotechnology Article Does the “B” Word Apply? It’s Complicated Maxx Chatsko offers a glimpse into how he values development-stage biopharma stocks. Dec 22, 2020 - By Maxx Chatsko Biotechnology Premium Advisor Update The 7investing Recommendation That Wasn’t Dec 15, 2020 - By Maxx Chatsko Pharmaceuticals Podcast ASH Conference Preview: What We’re Watching 7investing lead advisors Manisha Samy and Maxx Chatsko share what they're watching at the upcoming American Society of Hematology annual conference. Dec 3, 2020 - By Manisha Samy Biotechnology Podcast Synthetic Biology’s “Window of Opportunity” with ConVergInce Advisers’ Joel Stone Can synthetic biology break the chemical industry's reliance on fossil fuels? Industry veteran Joel Stone shares how industrial biotech is changing consumer brands, energy, agriculture, and more. Dec 1, 2020 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for December 7investing lead advisor Maxx Chatsko's Top Stock for December is leading the energy transition, today and tomorrow. Dec 1, 2020 - By Maxx Chatsko Energy Premium Deep Dive Xcel Energy Deep Dive: December 2020 Dec 1, 2020 - By Maxx Chatsko Energy Article Lesson Learned: Great Technology Doesn’t Guarantee a Great Business Maxx explains the importance of separating promising technology from great business. Nov 22, 2020 - By Maxx Chatsko Premium Advisor Update Vaccines Are On the Way, but Winter is Coming Nov 15, 2020 - By Maxx Chatsko Healthcare Technology Premium Deep Dive Dicerna Pharmaceuticals Deep Dive: November 2020 Nov 1, 2020 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for November 7investing lead advisor Maxx Chatsko's November 2020 recommendation is an under-the-radar, small-cap living technologies company at the very beginning of its growth trajectory. Nov 1, 2020 - By Maxx Chatsko Biotechnology Podcast Will the Cannabis Industry Give Way to Biotech? 7investing Lead Advisor Maxx Chatsko talks with Kevin Chen, co-founder and CEO of Hyasynth Bio, about the cannabis industry and how industrial biotech could transform the production of cannabinoid... Oct 22, 2020 - By Maxx Chatsko Biotechnology Article Not Another Political Discussion Maxx argues why investors today would do well to zoom out for a bigger-picture view of the world. Oct 22, 2020 - By Maxx Chatsko Premium Advisor Update “Cell Therapy’s First-Mover Disadvantage” Oct 15, 2020 - By Maxx Chatsko Biotechnology Premium Deep Dive Avita Therapeutics Deep Dive: October 2020 Oct 8, 2020 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for October 7investing lead advisor Maxx Chatsko's October 2020 recommendation is an under-the-radar, small-cap living technologies company at the very beginning of its growth trajectory. Oct 1, 2020 - By Maxx Chatsko Biotechnology Join Now! Why 7investing? Why Should I Invest? Why 7investing? Our Team Our 7 Principles Our Mission Testimonials How It Works What to Expect Our Report Format Membership Details Frequently Asked Questions Recommendations Research Articles Advisor Updates Company Updates Videos Special Reports Podcast Livestream Contact Us General Inquiries Submit a Testimonial Interested in Chatting With 7investing? My Account Log In
Article RNAi is Setting a High Bar for Gene Editing In the second quarter, three different RNAi drug candidates or drug products demonstrated the ability to reverse three different diseases. Jun 23, 2021 - By Maxx Chatsko Biotechnology Article What Makes a Biotech 10-Bagger? You don't necessarily have to sift through microcaps. You do need to focus on the right metrics. Maxx Chatsko offers his perspective. Jun 21, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Can Better Antibodies Challenge Cell Therapy? Jun 14, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Invitae Deep Dive: June 2021 Jun 1, 2021 - By Maxx Chatsko Healthcare Technology Video Maxx’s Top Stock for June 2021 7investing Lead Advisor Maxx Chatsko's Top Stock for June 2021 is well positioned to build solutions for some of the biggest obstacles facing the genetic testing markets. Jun 1, 2021 - By Maxx Chatsko Healthcare Technology Article Thermodynamics and Long-Term Investing There is a game. You have to play the game. May 22, 2021 - By Maxx Chatsko General Premium Advisor Update Investing Success Isn’t Measured in Months May 15, 2021 - By Maxx Chatsko General Premium Deep Dive Xcel Energy Deep Dive: May 2021 May 1, 2021 - By Maxx Chatsko Energy Video Maxx’s Top Stock for May 2021 7investing Lead Advisor Maxx Chatsko's Top Stock for May 2021 is leading the energy transition to zero-carbon power sources and the electrification of transportation. May 1, 2021 - By Maxx Chatsko Energy Article Can the Bioeconomy Transform Argentina into a Regional Superpower? Maxx Chatsko notes that while all eyes are on Brazil, the geographic strengths of its southern neighbor cannot be overlooked. Apr 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Running with Scissors: Will CRISPR be Humbled in the Clinic? Apr 13, 2021 - By Maxx Chatsko Biotechnology Podcast AACR Annual Meeting 2021: What’s the Frontier of Cancer Research? The American Association for Cancer Research (AACR) Annual Meeting 2021 begins this weekend. 7investing Lead Advisors Maxx Chatsko and Dan Kline discuss why the scientific meeting matters to... Apr 8, 2021 - By Daniel Kline Biotechnology Video Maxx’s Top Stock for April 2021 7investing Lead Advisor Maxx Chatsko's Top Stock to buy in April 2021 is developing a genetic medicine platform with several key advantages over peers. Apr 1, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Dicerna Pharmaceuticals Deep Dive: April 2021 Apr 1, 2021 - By Maxx Chatsko Biotechnology Article The Many Paths to Portfolio Allocation Investing is personal, but Maxx Chatsko points out the many ways you can handle portfolio allocation. Mar 22, 2021 - By Maxx Chatsko Premium Advisor Update My Long-Term Strategy in a Volatile Market Mar 15, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Certara Deep Dive: March 2021 Mar 1, 2021 - By Maxx Chatsko Enterprise Software Video Maxx’s Top Stock for March 2021 Maxx's Top Stock for March 2021 is an enterprise software company driving the digital transformation of a massive global industry and saving customers billions of dollars. Mar 1, 2021 - By Maxx Chatsko Enterprise Software Podcast What FinTwit Isn’t Telling You About These Biotech Stocks When biotech stocks rise on stories alone, and those stories become detached from reality, then you might be subjecting your portfolio to unnecessary risk. 7investing Lead Advisors Manisha Samy and... Feb 23, 2021 - By Manisha Samy Biotechnology Article A Mission Statement is Easy. Execution is Difficult A mission statement is nice to have, but it too often becomes a marketing pitch. Progress, including within a company's mission, is more important for investors. Feb 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Most Investors Neglect One of Their Biggest Advantages Feb 14, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for February 2021 7investing Lead Advisor Maxx Chatsko's Top Stock for February is an early-stage biopharma attempting to fundamentally change drug discovery and drug development. Feb 1, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Relay Therapeutics Deep Dive: February 2021 Feb 1, 2021 - By Maxx Chatsko Biotechnology Article Genomics Isn’t the Only Omics Maxx discusses misconceptions surrounding one of the market's oft-used buzzwords. Jan 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Will Renewable Energy Soar During the Biden Administration? Jan 15, 2021 - By Maxx Chatsko Energy Podcast JPM 39th Annual Healthcare Conference: What We’re Watching The JPM 39th Annual Healthcare Conference is next week. 7investing Lead Advisors Simon Erickson, Manisha Samy, and Maxx Chatsko discuss what they're watching as investors (and science nerds) ahead of... Jan 7, 2021 - By Manisha Samy Biotechnology Premium Deep Dive Selecta Biosciences Deep Dive: January 2021 Jan 1, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for January 7investing Lead Advisor Maxx Chatsko's top stock to buy in January 2021 is a small-cap biopharma developing an important technology platform that could increase the value of gene therapies, genetic... Jan 1, 2021 - By Maxx Chatsko Biotechnology Article Does the “B” Word Apply? It’s Complicated Maxx Chatsko offers a glimpse into how he values development-stage biopharma stocks. Dec 22, 2020 - By Maxx Chatsko Biotechnology Premium Advisor Update The 7investing Recommendation That Wasn’t Dec 15, 2020 - By Maxx Chatsko Pharmaceuticals Podcast ASH Conference Preview: What We’re Watching 7investing lead advisors Manisha Samy and Maxx Chatsko share what they're watching at the upcoming American Society of Hematology annual conference. Dec 3, 2020 - By Manisha Samy Biotechnology Podcast Synthetic Biology’s “Window of Opportunity” with ConVergInce Advisers’ Joel Stone Can synthetic biology break the chemical industry's reliance on fossil fuels? Industry veteran Joel Stone shares how industrial biotech is changing consumer brands, energy, agriculture, and more. Dec 1, 2020 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for December 7investing lead advisor Maxx Chatsko's Top Stock for December is leading the energy transition, today and tomorrow. Dec 1, 2020 - By Maxx Chatsko Energy Premium Deep Dive Xcel Energy Deep Dive: December 2020 Dec 1, 2020 - By Maxx Chatsko Energy Article Lesson Learned: Great Technology Doesn’t Guarantee a Great Business Maxx explains the importance of separating promising technology from great business. Nov 22, 2020 - By Maxx Chatsko Premium Advisor Update Vaccines Are On the Way, but Winter is Coming Nov 15, 2020 - By Maxx Chatsko Healthcare Technology Premium Deep Dive Dicerna Pharmaceuticals Deep Dive: November 2020 Nov 1, 2020 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for November 7investing lead advisor Maxx Chatsko's November 2020 recommendation is an under-the-radar, small-cap living technologies company at the very beginning of its growth trajectory. Nov 1, 2020 - By Maxx Chatsko Biotechnology Podcast Will the Cannabis Industry Give Way to Biotech? 7investing Lead Advisor Maxx Chatsko talks with Kevin Chen, co-founder and CEO of Hyasynth Bio, about the cannabis industry and how industrial biotech could transform the production of cannabinoid... Oct 22, 2020 - By Maxx Chatsko Biotechnology Article Not Another Political Discussion Maxx argues why investors today would do well to zoom out for a bigger-picture view of the world. Oct 22, 2020 - By Maxx Chatsko Premium Advisor Update “Cell Therapy’s First-Mover Disadvantage” Oct 15, 2020 - By Maxx Chatsko Biotechnology Premium Deep Dive Avita Therapeutics Deep Dive: October 2020 Oct 8, 2020 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for October 7investing lead advisor Maxx Chatsko's October 2020 recommendation is an under-the-radar, small-cap living technologies company at the very beginning of its growth trajectory. Oct 1, 2020 - By Maxx Chatsko Biotechnology Join Now! Why 7investing? Why Should I Invest? Why 7investing? Our Team Our 7 Principles Our Mission Testimonials How It Works What to Expect Our Report Format Membership Details Frequently Asked Questions Recommendations Research Articles Advisor Updates Company Updates Videos Special Reports Podcast Livestream Contact Us General Inquiries Submit a Testimonial Interested in Chatting With 7investing? My Account Log In
Article What Makes a Biotech 10-Bagger? You don't necessarily have to sift through microcaps. You do need to focus on the right metrics. Maxx Chatsko offers his perspective. Jun 21, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Can Better Antibodies Challenge Cell Therapy? Jun 14, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Invitae Deep Dive: June 2021 Jun 1, 2021 - By Maxx Chatsko Healthcare Technology Video Maxx’s Top Stock for June 2021 7investing Lead Advisor Maxx Chatsko's Top Stock for June 2021 is well positioned to build solutions for some of the biggest obstacles facing the genetic testing markets. Jun 1, 2021 - By Maxx Chatsko Healthcare Technology Article Thermodynamics and Long-Term Investing There is a game. You have to play the game. May 22, 2021 - By Maxx Chatsko General Premium Advisor Update Investing Success Isn’t Measured in Months May 15, 2021 - By Maxx Chatsko General Premium Deep Dive Xcel Energy Deep Dive: May 2021 May 1, 2021 - By Maxx Chatsko Energy Video Maxx’s Top Stock for May 2021 7investing Lead Advisor Maxx Chatsko's Top Stock for May 2021 is leading the energy transition to zero-carbon power sources and the electrification of transportation. May 1, 2021 - By Maxx Chatsko Energy Article Can the Bioeconomy Transform Argentina into a Regional Superpower? Maxx Chatsko notes that while all eyes are on Brazil, the geographic strengths of its southern neighbor cannot be overlooked. Apr 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Running with Scissors: Will CRISPR be Humbled in the Clinic? Apr 13, 2021 - By Maxx Chatsko Biotechnology Podcast AACR Annual Meeting 2021: What’s the Frontier of Cancer Research? The American Association for Cancer Research (AACR) Annual Meeting 2021 begins this weekend. 7investing Lead Advisors Maxx Chatsko and Dan Kline discuss why the scientific meeting matters to... Apr 8, 2021 - By Daniel Kline Biotechnology Video Maxx’s Top Stock for April 2021 7investing Lead Advisor Maxx Chatsko's Top Stock to buy in April 2021 is developing a genetic medicine platform with several key advantages over peers. Apr 1, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Dicerna Pharmaceuticals Deep Dive: April 2021 Apr 1, 2021 - By Maxx Chatsko Biotechnology Article The Many Paths to Portfolio Allocation Investing is personal, but Maxx Chatsko points out the many ways you can handle portfolio allocation. Mar 22, 2021 - By Maxx Chatsko Premium Advisor Update My Long-Term Strategy in a Volatile Market Mar 15, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Certara Deep Dive: March 2021 Mar 1, 2021 - By Maxx Chatsko Enterprise Software Video Maxx’s Top Stock for March 2021 Maxx's Top Stock for March 2021 is an enterprise software company driving the digital transformation of a massive global industry and saving customers billions of dollars. Mar 1, 2021 - By Maxx Chatsko Enterprise Software Podcast What FinTwit Isn’t Telling You About These Biotech Stocks When biotech stocks rise on stories alone, and those stories become detached from reality, then you might be subjecting your portfolio to unnecessary risk. 7investing Lead Advisors Manisha Samy and... Feb 23, 2021 - By Manisha Samy Biotechnology Article A Mission Statement is Easy. Execution is Difficult A mission statement is nice to have, but it too often becomes a marketing pitch. Progress, including within a company's mission, is more important for investors. Feb 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Most Investors Neglect One of Their Biggest Advantages Feb 14, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for February 2021 7investing Lead Advisor Maxx Chatsko's Top Stock for February is an early-stage biopharma attempting to fundamentally change drug discovery and drug development. Feb 1, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Relay Therapeutics Deep Dive: February 2021 Feb 1, 2021 - By Maxx Chatsko Biotechnology Article Genomics Isn’t the Only Omics Maxx discusses misconceptions surrounding one of the market's oft-used buzzwords. Jan 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Will Renewable Energy Soar During the Biden Administration? Jan 15, 2021 - By Maxx Chatsko Energy Podcast JPM 39th Annual Healthcare Conference: What We’re Watching The JPM 39th Annual Healthcare Conference is next week. 7investing Lead Advisors Simon Erickson, Manisha Samy, and Maxx Chatsko discuss what they're watching as investors (and science nerds) ahead of... Jan 7, 2021 - By Manisha Samy Biotechnology Premium Deep Dive Selecta Biosciences Deep Dive: January 2021 Jan 1, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for January 7investing Lead Advisor Maxx Chatsko's top stock to buy in January 2021 is a small-cap biopharma developing an important technology platform that could increase the value of gene therapies, genetic... Jan 1, 2021 - By Maxx Chatsko Biotechnology Article Does the “B” Word Apply? It’s Complicated Maxx Chatsko offers a glimpse into how he values development-stage biopharma stocks. Dec 22, 2020 - By Maxx Chatsko Biotechnology Premium Advisor Update The 7investing Recommendation That Wasn’t Dec 15, 2020 - By Maxx Chatsko Pharmaceuticals Podcast ASH Conference Preview: What We’re Watching 7investing lead advisors Manisha Samy and Maxx Chatsko share what they're watching at the upcoming American Society of Hematology annual conference. Dec 3, 2020 - By Manisha Samy Biotechnology Podcast Synthetic Biology’s “Window of Opportunity” with ConVergInce Advisers’ Joel Stone Can synthetic biology break the chemical industry's reliance on fossil fuels? Industry veteran Joel Stone shares how industrial biotech is changing consumer brands, energy, agriculture, and more. Dec 1, 2020 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for December 7investing lead advisor Maxx Chatsko's Top Stock for December is leading the energy transition, today and tomorrow. Dec 1, 2020 - By Maxx Chatsko Energy Premium Deep Dive Xcel Energy Deep Dive: December 2020 Dec 1, 2020 - By Maxx Chatsko Energy Article Lesson Learned: Great Technology Doesn’t Guarantee a Great Business Maxx explains the importance of separating promising technology from great business. Nov 22, 2020 - By Maxx Chatsko Premium Advisor Update Vaccines Are On the Way, but Winter is Coming Nov 15, 2020 - By Maxx Chatsko Healthcare Technology Premium Deep Dive Dicerna Pharmaceuticals Deep Dive: November 2020 Nov 1, 2020 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for November 7investing lead advisor Maxx Chatsko's November 2020 recommendation is an under-the-radar, small-cap living technologies company at the very beginning of its growth trajectory. Nov 1, 2020 - By Maxx Chatsko Biotechnology Podcast Will the Cannabis Industry Give Way to Biotech? 7investing Lead Advisor Maxx Chatsko talks with Kevin Chen, co-founder and CEO of Hyasynth Bio, about the cannabis industry and how industrial biotech could transform the production of cannabinoid... Oct 22, 2020 - By Maxx Chatsko Biotechnology Article Not Another Political Discussion Maxx argues why investors today would do well to zoom out for a bigger-picture view of the world. Oct 22, 2020 - By Maxx Chatsko Premium Advisor Update “Cell Therapy’s First-Mover Disadvantage” Oct 15, 2020 - By Maxx Chatsko Biotechnology Premium Deep Dive Avita Therapeutics Deep Dive: October 2020 Oct 8, 2020 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for October 7investing lead advisor Maxx Chatsko's October 2020 recommendation is an under-the-radar, small-cap living technologies company at the very beginning of its growth trajectory. Oct 1, 2020 - By Maxx Chatsko Biotechnology Join Now! Why 7investing? Why Should I Invest? Why 7investing? Our Team Our 7 Principles Our Mission Testimonials How It Works What to Expect Our Report Format Membership Details Frequently Asked Questions Recommendations Research Articles Advisor Updates Company Updates Videos Special Reports Podcast Livestream Contact Us General Inquiries Submit a Testimonial Interested in Chatting With 7investing? My Account Log In
Premium Advisor Update Can Better Antibodies Challenge Cell Therapy? Jun 14, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Invitae Deep Dive: June 2021 Jun 1, 2021 - By Maxx Chatsko Healthcare Technology Video Maxx’s Top Stock for June 2021 7investing Lead Advisor Maxx Chatsko's Top Stock for June 2021 is well positioned to build solutions for some of the biggest obstacles facing the genetic testing markets. Jun 1, 2021 - By Maxx Chatsko Healthcare Technology Article Thermodynamics and Long-Term Investing There is a game. You have to play the game. May 22, 2021 - By Maxx Chatsko General Premium Advisor Update Investing Success Isn’t Measured in Months May 15, 2021 - By Maxx Chatsko General Premium Deep Dive Xcel Energy Deep Dive: May 2021 May 1, 2021 - By Maxx Chatsko Energy Video Maxx’s Top Stock for May 2021 7investing Lead Advisor Maxx Chatsko's Top Stock for May 2021 is leading the energy transition to zero-carbon power sources and the electrification of transportation. May 1, 2021 - By Maxx Chatsko Energy Article Can the Bioeconomy Transform Argentina into a Regional Superpower? Maxx Chatsko notes that while all eyes are on Brazil, the geographic strengths of its southern neighbor cannot be overlooked. Apr 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Running with Scissors: Will CRISPR be Humbled in the Clinic? Apr 13, 2021 - By Maxx Chatsko Biotechnology Podcast AACR Annual Meeting 2021: What’s the Frontier of Cancer Research? The American Association for Cancer Research (AACR) Annual Meeting 2021 begins this weekend. 7investing Lead Advisors Maxx Chatsko and Dan Kline discuss why the scientific meeting matters to... Apr 8, 2021 - By Daniel Kline Biotechnology Video Maxx’s Top Stock for April 2021 7investing Lead Advisor Maxx Chatsko's Top Stock to buy in April 2021 is developing a genetic medicine platform with several key advantages over peers. Apr 1, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Dicerna Pharmaceuticals Deep Dive: April 2021 Apr 1, 2021 - By Maxx Chatsko Biotechnology Article The Many Paths to Portfolio Allocation Investing is personal, but Maxx Chatsko points out the many ways you can handle portfolio allocation. Mar 22, 2021 - By Maxx Chatsko Premium Advisor Update My Long-Term Strategy in a Volatile Market Mar 15, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Certara Deep Dive: March 2021 Mar 1, 2021 - By Maxx Chatsko Enterprise Software Video Maxx’s Top Stock for March 2021 Maxx's Top Stock for March 2021 is an enterprise software company driving the digital transformation of a massive global industry and saving customers billions of dollars. Mar 1, 2021 - By Maxx Chatsko Enterprise Software Podcast What FinTwit Isn’t Telling You About These Biotech Stocks When biotech stocks rise on stories alone, and those stories become detached from reality, then you might be subjecting your portfolio to unnecessary risk. 7investing Lead Advisors Manisha Samy and... Feb 23, 2021 - By Manisha Samy Biotechnology Article A Mission Statement is Easy. Execution is Difficult A mission statement is nice to have, but it too often becomes a marketing pitch. Progress, including within a company's mission, is more important for investors. Feb 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Most Investors Neglect One of Their Biggest Advantages Feb 14, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for February 2021 7investing Lead Advisor Maxx Chatsko's Top Stock for February is an early-stage biopharma attempting to fundamentally change drug discovery and drug development. Feb 1, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Relay Therapeutics Deep Dive: February 2021 Feb 1, 2021 - By Maxx Chatsko Biotechnology Article Genomics Isn’t the Only Omics Maxx discusses misconceptions surrounding one of the market's oft-used buzzwords. Jan 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Will Renewable Energy Soar During the Biden Administration? Jan 15, 2021 - By Maxx Chatsko Energy Podcast JPM 39th Annual Healthcare Conference: What We’re Watching The JPM 39th Annual Healthcare Conference is next week. 7investing Lead Advisors Simon Erickson, Manisha Samy, and Maxx Chatsko discuss what they're watching as investors (and science nerds) ahead of... Jan 7, 2021 - By Manisha Samy Biotechnology Premium Deep Dive Selecta Biosciences Deep Dive: January 2021 Jan 1, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for January 7investing Lead Advisor Maxx Chatsko's top stock to buy in January 2021 is a small-cap biopharma developing an important technology platform that could increase the value of gene therapies, genetic... Jan 1, 2021 - By Maxx Chatsko Biotechnology Article Does the “B” Word Apply? It’s Complicated Maxx Chatsko offers a glimpse into how he values development-stage biopharma stocks. Dec 22, 2020 - By Maxx Chatsko Biotechnology Premium Advisor Update The 7investing Recommendation That Wasn’t Dec 15, 2020 - By Maxx Chatsko Pharmaceuticals Podcast ASH Conference Preview: What We’re Watching 7investing lead advisors Manisha Samy and Maxx Chatsko share what they're watching at the upcoming American Society of Hematology annual conference. Dec 3, 2020 - By Manisha Samy Biotechnology Podcast Synthetic Biology’s “Window of Opportunity” with ConVergInce Advisers’ Joel Stone Can synthetic biology break the chemical industry's reliance on fossil fuels? Industry veteran Joel Stone shares how industrial biotech is changing consumer brands, energy, agriculture, and more. Dec 1, 2020 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for December 7investing lead advisor Maxx Chatsko's Top Stock for December is leading the energy transition, today and tomorrow. Dec 1, 2020 - By Maxx Chatsko Energy Premium Deep Dive Xcel Energy Deep Dive: December 2020 Dec 1, 2020 - By Maxx Chatsko Energy Article Lesson Learned: Great Technology Doesn’t Guarantee a Great Business Maxx explains the importance of separating promising technology from great business. Nov 22, 2020 - By Maxx Chatsko Premium Advisor Update Vaccines Are On the Way, but Winter is Coming Nov 15, 2020 - By Maxx Chatsko Healthcare Technology Premium Deep Dive Dicerna Pharmaceuticals Deep Dive: November 2020 Nov 1, 2020 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for November 7investing lead advisor Maxx Chatsko's November 2020 recommendation is an under-the-radar, small-cap living technologies company at the very beginning of its growth trajectory. Nov 1, 2020 - By Maxx Chatsko Biotechnology Podcast Will the Cannabis Industry Give Way to Biotech? 7investing Lead Advisor Maxx Chatsko talks with Kevin Chen, co-founder and CEO of Hyasynth Bio, about the cannabis industry and how industrial biotech could transform the production of cannabinoid... Oct 22, 2020 - By Maxx Chatsko Biotechnology Article Not Another Political Discussion Maxx argues why investors today would do well to zoom out for a bigger-picture view of the world. Oct 22, 2020 - By Maxx Chatsko Premium Advisor Update “Cell Therapy’s First-Mover Disadvantage” Oct 15, 2020 - By Maxx Chatsko Biotechnology Premium Deep Dive Avita Therapeutics Deep Dive: October 2020 Oct 8, 2020 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for October 7investing lead advisor Maxx Chatsko's October 2020 recommendation is an under-the-radar, small-cap living technologies company at the very beginning of its growth trajectory. Oct 1, 2020 - By Maxx Chatsko Biotechnology Join Now! Why 7investing? Why Should I Invest? Why 7investing? Our Team Our 7 Principles Our Mission Testimonials How It Works What to Expect Our Report Format Membership Details Frequently Asked Questions Recommendations Research Articles Advisor Updates Company Updates Videos Special Reports Podcast Livestream Contact Us General Inquiries Submit a Testimonial Interested in Chatting With 7investing? My Account Log In
Premium Deep Dive Invitae Deep Dive: June 2021 Jun 1, 2021 - By Maxx Chatsko Healthcare Technology Video Maxx’s Top Stock for June 2021 7investing Lead Advisor Maxx Chatsko's Top Stock for June 2021 is well positioned to build solutions for some of the biggest obstacles facing the genetic testing markets. Jun 1, 2021 - By Maxx Chatsko Healthcare Technology Article Thermodynamics and Long-Term Investing There is a game. You have to play the game. May 22, 2021 - By Maxx Chatsko General Premium Advisor Update Investing Success Isn’t Measured in Months May 15, 2021 - By Maxx Chatsko General Premium Deep Dive Xcel Energy Deep Dive: May 2021 May 1, 2021 - By Maxx Chatsko Energy Video Maxx’s Top Stock for May 2021 7investing Lead Advisor Maxx Chatsko's Top Stock for May 2021 is leading the energy transition to zero-carbon power sources and the electrification of transportation. May 1, 2021 - By Maxx Chatsko Energy Article Can the Bioeconomy Transform Argentina into a Regional Superpower? Maxx Chatsko notes that while all eyes are on Brazil, the geographic strengths of its southern neighbor cannot be overlooked. Apr 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Running with Scissors: Will CRISPR be Humbled in the Clinic? Apr 13, 2021 - By Maxx Chatsko Biotechnology Podcast AACR Annual Meeting 2021: What’s the Frontier of Cancer Research? The American Association for Cancer Research (AACR) Annual Meeting 2021 begins this weekend. 7investing Lead Advisors Maxx Chatsko and Dan Kline discuss why the scientific meeting matters to... Apr 8, 2021 - By Daniel Kline Biotechnology Video Maxx’s Top Stock for April 2021 7investing Lead Advisor Maxx Chatsko's Top Stock to buy in April 2021 is developing a genetic medicine platform with several key advantages over peers. Apr 1, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Dicerna Pharmaceuticals Deep Dive: April 2021 Apr 1, 2021 - By Maxx Chatsko Biotechnology Article The Many Paths to Portfolio Allocation Investing is personal, but Maxx Chatsko points out the many ways you can handle portfolio allocation. Mar 22, 2021 - By Maxx Chatsko Premium Advisor Update My Long-Term Strategy in a Volatile Market Mar 15, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Certara Deep Dive: March 2021 Mar 1, 2021 - By Maxx Chatsko Enterprise Software Video Maxx’s Top Stock for March 2021 Maxx's Top Stock for March 2021 is an enterprise software company driving the digital transformation of a massive global industry and saving customers billions of dollars. Mar 1, 2021 - By Maxx Chatsko Enterprise Software Podcast What FinTwit Isn’t Telling You About These Biotech Stocks When biotech stocks rise on stories alone, and those stories become detached from reality, then you might be subjecting your portfolio to unnecessary risk. 7investing Lead Advisors Manisha Samy and... Feb 23, 2021 - By Manisha Samy Biotechnology Article A Mission Statement is Easy. Execution is Difficult A mission statement is nice to have, but it too often becomes a marketing pitch. Progress, including within a company's mission, is more important for investors. Feb 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Most Investors Neglect One of Their Biggest Advantages Feb 14, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for February 2021 7investing Lead Advisor Maxx Chatsko's Top Stock for February is an early-stage biopharma attempting to fundamentally change drug discovery and drug development. Feb 1, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Relay Therapeutics Deep Dive: February 2021 Feb 1, 2021 - By Maxx Chatsko Biotechnology Article Genomics Isn’t the Only Omics Maxx discusses misconceptions surrounding one of the market's oft-used buzzwords. Jan 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Will Renewable Energy Soar During the Biden Administration? Jan 15, 2021 - By Maxx Chatsko Energy Podcast JPM 39th Annual Healthcare Conference: What We’re Watching The JPM 39th Annual Healthcare Conference is next week. 7investing Lead Advisors Simon Erickson, Manisha Samy, and Maxx Chatsko discuss what they're watching as investors (and science nerds) ahead of... Jan 7, 2021 - By Manisha Samy Biotechnology Premium Deep Dive Selecta Biosciences Deep Dive: January 2021 Jan 1, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for January 7investing Lead Advisor Maxx Chatsko's top stock to buy in January 2021 is a small-cap biopharma developing an important technology platform that could increase the value of gene therapies, genetic... Jan 1, 2021 - By Maxx Chatsko Biotechnology Article Does the “B” Word Apply? It’s Complicated Maxx Chatsko offers a glimpse into how he values development-stage biopharma stocks. Dec 22, 2020 - By Maxx Chatsko Biotechnology Premium Advisor Update The 7investing Recommendation That Wasn’t Dec 15, 2020 - By Maxx Chatsko Pharmaceuticals Podcast ASH Conference Preview: What We’re Watching 7investing lead advisors Manisha Samy and Maxx Chatsko share what they're watching at the upcoming American Society of Hematology annual conference. Dec 3, 2020 - By Manisha Samy Biotechnology Podcast Synthetic Biology’s “Window of Opportunity” with ConVergInce Advisers’ Joel Stone Can synthetic biology break the chemical industry's reliance on fossil fuels? Industry veteran Joel Stone shares how industrial biotech is changing consumer brands, energy, agriculture, and more. Dec 1, 2020 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for December 7investing lead advisor Maxx Chatsko's Top Stock for December is leading the energy transition, today and tomorrow. Dec 1, 2020 - By Maxx Chatsko Energy Premium Deep Dive Xcel Energy Deep Dive: December 2020 Dec 1, 2020 - By Maxx Chatsko Energy Article Lesson Learned: Great Technology Doesn’t Guarantee a Great Business Maxx explains the importance of separating promising technology from great business. Nov 22, 2020 - By Maxx Chatsko Premium Advisor Update Vaccines Are On the Way, but Winter is Coming Nov 15, 2020 - By Maxx Chatsko Healthcare Technology Premium Deep Dive Dicerna Pharmaceuticals Deep Dive: November 2020 Nov 1, 2020 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for November 7investing lead advisor Maxx Chatsko's November 2020 recommendation is an under-the-radar, small-cap living technologies company at the very beginning of its growth trajectory. Nov 1, 2020 - By Maxx Chatsko Biotechnology Podcast Will the Cannabis Industry Give Way to Biotech? 7investing Lead Advisor Maxx Chatsko talks with Kevin Chen, co-founder and CEO of Hyasynth Bio, about the cannabis industry and how industrial biotech could transform the production of cannabinoid... Oct 22, 2020 - By Maxx Chatsko Biotechnology Article Not Another Political Discussion Maxx argues why investors today would do well to zoom out for a bigger-picture view of the world. Oct 22, 2020 - By Maxx Chatsko Premium Advisor Update “Cell Therapy’s First-Mover Disadvantage” Oct 15, 2020 - By Maxx Chatsko Biotechnology Premium Deep Dive Avita Therapeutics Deep Dive: October 2020 Oct 8, 2020 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for October 7investing lead advisor Maxx Chatsko's October 2020 recommendation is an under-the-radar, small-cap living technologies company at the very beginning of its growth trajectory. Oct 1, 2020 - By Maxx Chatsko Biotechnology Join Now! Why 7investing? Why Should I Invest? Why 7investing? Our Team Our 7 Principles Our Mission Testimonials How It Works What to Expect Our Report Format Membership Details Frequently Asked Questions Recommendations Research Articles Advisor Updates Company Updates Videos Special Reports Podcast Livestream Contact Us General Inquiries Submit a Testimonial Interested in Chatting With 7investing? My Account Log In
Video Maxx’s Top Stock for June 2021 7investing Lead Advisor Maxx Chatsko's Top Stock for June 2021 is well positioned to build solutions for some of the biggest obstacles facing the genetic testing markets. Jun 1, 2021 - By Maxx Chatsko Healthcare Technology Article Thermodynamics and Long-Term Investing There is a game. You have to play the game. May 22, 2021 - By Maxx Chatsko General Premium Advisor Update Investing Success Isn’t Measured in Months May 15, 2021 - By Maxx Chatsko General Premium Deep Dive Xcel Energy Deep Dive: May 2021 May 1, 2021 - By Maxx Chatsko Energy Video Maxx’s Top Stock for May 2021 7investing Lead Advisor Maxx Chatsko's Top Stock for May 2021 is leading the energy transition to zero-carbon power sources and the electrification of transportation. May 1, 2021 - By Maxx Chatsko Energy Article Can the Bioeconomy Transform Argentina into a Regional Superpower? Maxx Chatsko notes that while all eyes are on Brazil, the geographic strengths of its southern neighbor cannot be overlooked. Apr 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Running with Scissors: Will CRISPR be Humbled in the Clinic? Apr 13, 2021 - By Maxx Chatsko Biotechnology Podcast AACR Annual Meeting 2021: What’s the Frontier of Cancer Research? The American Association for Cancer Research (AACR) Annual Meeting 2021 begins this weekend. 7investing Lead Advisors Maxx Chatsko and Dan Kline discuss why the scientific meeting matters to... Apr 8, 2021 - By Daniel Kline Biotechnology Video Maxx’s Top Stock for April 2021 7investing Lead Advisor Maxx Chatsko's Top Stock to buy in April 2021 is developing a genetic medicine platform with several key advantages over peers. Apr 1, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Dicerna Pharmaceuticals Deep Dive: April 2021 Apr 1, 2021 - By Maxx Chatsko Biotechnology Article The Many Paths to Portfolio Allocation Investing is personal, but Maxx Chatsko points out the many ways you can handle portfolio allocation. Mar 22, 2021 - By Maxx Chatsko Premium Advisor Update My Long-Term Strategy in a Volatile Market Mar 15, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Certara Deep Dive: March 2021 Mar 1, 2021 - By Maxx Chatsko Enterprise Software Video Maxx’s Top Stock for March 2021 Maxx's Top Stock for March 2021 is an enterprise software company driving the digital transformation of a massive global industry and saving customers billions of dollars. Mar 1, 2021 - By Maxx Chatsko Enterprise Software Podcast What FinTwit Isn’t Telling You About These Biotech Stocks When biotech stocks rise on stories alone, and those stories become detached from reality, then you might be subjecting your portfolio to unnecessary risk. 7investing Lead Advisors Manisha Samy and... Feb 23, 2021 - By Manisha Samy Biotechnology Article A Mission Statement is Easy. Execution is Difficult A mission statement is nice to have, but it too often becomes a marketing pitch. Progress, including within a company's mission, is more important for investors. Feb 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Most Investors Neglect One of Their Biggest Advantages Feb 14, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for February 2021 7investing Lead Advisor Maxx Chatsko's Top Stock for February is an early-stage biopharma attempting to fundamentally change drug discovery and drug development. Feb 1, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Relay Therapeutics Deep Dive: February 2021 Feb 1, 2021 - By Maxx Chatsko Biotechnology Article Genomics Isn’t the Only Omics Maxx discusses misconceptions surrounding one of the market's oft-used buzzwords. Jan 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Will Renewable Energy Soar During the Biden Administration? Jan 15, 2021 - By Maxx Chatsko Energy Podcast JPM 39th Annual Healthcare Conference: What We’re Watching The JPM 39th Annual Healthcare Conference is next week. 7investing Lead Advisors Simon Erickson, Manisha Samy, and Maxx Chatsko discuss what they're watching as investors (and science nerds) ahead of... Jan 7, 2021 - By Manisha Samy Biotechnology Premium Deep Dive Selecta Biosciences Deep Dive: January 2021 Jan 1, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for January 7investing Lead Advisor Maxx Chatsko's top stock to buy in January 2021 is a small-cap biopharma developing an important technology platform that could increase the value of gene therapies, genetic... Jan 1, 2021 - By Maxx Chatsko Biotechnology Article Does the “B” Word Apply? It’s Complicated Maxx Chatsko offers a glimpse into how he values development-stage biopharma stocks. Dec 22, 2020 - By Maxx Chatsko Biotechnology Premium Advisor Update The 7investing Recommendation That Wasn’t Dec 15, 2020 - By Maxx Chatsko Pharmaceuticals Podcast ASH Conference Preview: What We’re Watching 7investing lead advisors Manisha Samy and Maxx Chatsko share what they're watching at the upcoming American Society of Hematology annual conference. Dec 3, 2020 - By Manisha Samy Biotechnology Podcast Synthetic Biology’s “Window of Opportunity” with ConVergInce Advisers’ Joel Stone Can synthetic biology break the chemical industry's reliance on fossil fuels? Industry veteran Joel Stone shares how industrial biotech is changing consumer brands, energy, agriculture, and more. Dec 1, 2020 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for December 7investing lead advisor Maxx Chatsko's Top Stock for December is leading the energy transition, today and tomorrow. Dec 1, 2020 - By Maxx Chatsko Energy Premium Deep Dive Xcel Energy Deep Dive: December 2020 Dec 1, 2020 - By Maxx Chatsko Energy Article Lesson Learned: Great Technology Doesn’t Guarantee a Great Business Maxx explains the importance of separating promising technology from great business. Nov 22, 2020 - By Maxx Chatsko Premium Advisor Update Vaccines Are On the Way, but Winter is Coming Nov 15, 2020 - By Maxx Chatsko Healthcare Technology Premium Deep Dive Dicerna Pharmaceuticals Deep Dive: November 2020 Nov 1, 2020 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for November 7investing lead advisor Maxx Chatsko's November 2020 recommendation is an under-the-radar, small-cap living technologies company at the very beginning of its growth trajectory. Nov 1, 2020 - By Maxx Chatsko Biotechnology Podcast Will the Cannabis Industry Give Way to Biotech? 7investing Lead Advisor Maxx Chatsko talks with Kevin Chen, co-founder and CEO of Hyasynth Bio, about the cannabis industry and how industrial biotech could transform the production of cannabinoid... Oct 22, 2020 - By Maxx Chatsko Biotechnology Article Not Another Political Discussion Maxx argues why investors today would do well to zoom out for a bigger-picture view of the world. Oct 22, 2020 - By Maxx Chatsko Premium Advisor Update “Cell Therapy’s First-Mover Disadvantage” Oct 15, 2020 - By Maxx Chatsko Biotechnology Premium Deep Dive Avita Therapeutics Deep Dive: October 2020 Oct 8, 2020 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for October 7investing lead advisor Maxx Chatsko's October 2020 recommendation is an under-the-radar, small-cap living technologies company at the very beginning of its growth trajectory. Oct 1, 2020 - By Maxx Chatsko Biotechnology Join Now! Why 7investing? Why Should I Invest? Why 7investing? Our Team Our 7 Principles Our Mission Testimonials How It Works What to Expect Our Report Format Membership Details Frequently Asked Questions Recommendations Research Articles Advisor Updates Company Updates Videos Special Reports Podcast Livestream Contact Us General Inquiries Submit a Testimonial Interested in Chatting With 7investing? My Account Log In
Article Thermodynamics and Long-Term Investing There is a game. You have to play the game. May 22, 2021 - By Maxx Chatsko General Premium Advisor Update Investing Success Isn’t Measured in Months May 15, 2021 - By Maxx Chatsko General Premium Deep Dive Xcel Energy Deep Dive: May 2021 May 1, 2021 - By Maxx Chatsko Energy Video Maxx’s Top Stock for May 2021 7investing Lead Advisor Maxx Chatsko's Top Stock for May 2021 is leading the energy transition to zero-carbon power sources and the electrification of transportation. May 1, 2021 - By Maxx Chatsko Energy Article Can the Bioeconomy Transform Argentina into a Regional Superpower? Maxx Chatsko notes that while all eyes are on Brazil, the geographic strengths of its southern neighbor cannot be overlooked. Apr 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Running with Scissors: Will CRISPR be Humbled in the Clinic? Apr 13, 2021 - By Maxx Chatsko Biotechnology Podcast AACR Annual Meeting 2021: What’s the Frontier of Cancer Research? The American Association for Cancer Research (AACR) Annual Meeting 2021 begins this weekend. 7investing Lead Advisors Maxx Chatsko and Dan Kline discuss why the scientific meeting matters to... Apr 8, 2021 - By Daniel Kline Biotechnology Video Maxx’s Top Stock for April 2021 7investing Lead Advisor Maxx Chatsko's Top Stock to buy in April 2021 is developing a genetic medicine platform with several key advantages over peers. Apr 1, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Dicerna Pharmaceuticals Deep Dive: April 2021 Apr 1, 2021 - By Maxx Chatsko Biotechnology Article The Many Paths to Portfolio Allocation Investing is personal, but Maxx Chatsko points out the many ways you can handle portfolio allocation. Mar 22, 2021 - By Maxx Chatsko Premium Advisor Update My Long-Term Strategy in a Volatile Market Mar 15, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Certara Deep Dive: March 2021 Mar 1, 2021 - By Maxx Chatsko Enterprise Software Video Maxx’s Top Stock for March 2021 Maxx's Top Stock for March 2021 is an enterprise software company driving the digital transformation of a massive global industry and saving customers billions of dollars. Mar 1, 2021 - By Maxx Chatsko Enterprise Software Podcast What FinTwit Isn’t Telling You About These Biotech Stocks When biotech stocks rise on stories alone, and those stories become detached from reality, then you might be subjecting your portfolio to unnecessary risk. 7investing Lead Advisors Manisha Samy and... Feb 23, 2021 - By Manisha Samy Biotechnology Article A Mission Statement is Easy. Execution is Difficult A mission statement is nice to have, but it too often becomes a marketing pitch. Progress, including within a company's mission, is more important for investors. Feb 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Most Investors Neglect One of Their Biggest Advantages Feb 14, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for February 2021 7investing Lead Advisor Maxx Chatsko's Top Stock for February is an early-stage biopharma attempting to fundamentally change drug discovery and drug development. Feb 1, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Relay Therapeutics Deep Dive: February 2021 Feb 1, 2021 - By Maxx Chatsko Biotechnology Article Genomics Isn’t the Only Omics Maxx discusses misconceptions surrounding one of the market's oft-used buzzwords. Jan 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Will Renewable Energy Soar During the Biden Administration? Jan 15, 2021 - By Maxx Chatsko Energy Podcast JPM 39th Annual Healthcare Conference: What We’re Watching The JPM 39th Annual Healthcare Conference is next week. 7investing Lead Advisors Simon Erickson, Manisha Samy, and Maxx Chatsko discuss what they're watching as investors (and science nerds) ahead of... Jan 7, 2021 - By Manisha Samy Biotechnology Premium Deep Dive Selecta Biosciences Deep Dive: January 2021 Jan 1, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for January 7investing Lead Advisor Maxx Chatsko's top stock to buy in January 2021 is a small-cap biopharma developing an important technology platform that could increase the value of gene therapies, genetic... Jan 1, 2021 - By Maxx Chatsko Biotechnology Article Does the “B” Word Apply? It’s Complicated Maxx Chatsko offers a glimpse into how he values development-stage biopharma stocks. Dec 22, 2020 - By Maxx Chatsko Biotechnology Premium Advisor Update The 7investing Recommendation That Wasn’t Dec 15, 2020 - By Maxx Chatsko Pharmaceuticals Podcast ASH Conference Preview: What We’re Watching 7investing lead advisors Manisha Samy and Maxx Chatsko share what they're watching at the upcoming American Society of Hematology annual conference. Dec 3, 2020 - By Manisha Samy Biotechnology Podcast Synthetic Biology’s “Window of Opportunity” with ConVergInce Advisers’ Joel Stone Can synthetic biology break the chemical industry's reliance on fossil fuels? Industry veteran Joel Stone shares how industrial biotech is changing consumer brands, energy, agriculture, and more. Dec 1, 2020 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for December 7investing lead advisor Maxx Chatsko's Top Stock for December is leading the energy transition, today and tomorrow. Dec 1, 2020 - By Maxx Chatsko Energy Premium Deep Dive Xcel Energy Deep Dive: December 2020 Dec 1, 2020 - By Maxx Chatsko Energy Article Lesson Learned: Great Technology Doesn’t Guarantee a Great Business Maxx explains the importance of separating promising technology from great business. Nov 22, 2020 - By Maxx Chatsko Premium Advisor Update Vaccines Are On the Way, but Winter is Coming Nov 15, 2020 - By Maxx Chatsko Healthcare Technology Premium Deep Dive Dicerna Pharmaceuticals Deep Dive: November 2020 Nov 1, 2020 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for November 7investing lead advisor Maxx Chatsko's November 2020 recommendation is an under-the-radar, small-cap living technologies company at the very beginning of its growth trajectory. Nov 1, 2020 - By Maxx Chatsko Biotechnology Podcast Will the Cannabis Industry Give Way to Biotech? 7investing Lead Advisor Maxx Chatsko talks with Kevin Chen, co-founder and CEO of Hyasynth Bio, about the cannabis industry and how industrial biotech could transform the production of cannabinoid... Oct 22, 2020 - By Maxx Chatsko Biotechnology Article Not Another Political Discussion Maxx argues why investors today would do well to zoom out for a bigger-picture view of the world. Oct 22, 2020 - By Maxx Chatsko Premium Advisor Update “Cell Therapy’s First-Mover Disadvantage” Oct 15, 2020 - By Maxx Chatsko Biotechnology Premium Deep Dive Avita Therapeutics Deep Dive: October 2020 Oct 8, 2020 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for October 7investing lead advisor Maxx Chatsko's October 2020 recommendation is an under-the-radar, small-cap living technologies company at the very beginning of its growth trajectory. Oct 1, 2020 - By Maxx Chatsko Biotechnology Join Now! Why 7investing? Why Should I Invest? Why 7investing? Our Team Our 7 Principles Our Mission Testimonials How It Works What to Expect Our Report Format Membership Details Frequently Asked Questions Recommendations Research Articles Advisor Updates Company Updates Videos Special Reports Podcast Livestream Contact Us General Inquiries Submit a Testimonial Interested in Chatting With 7investing? My Account Log In
Premium Advisor Update Investing Success Isn’t Measured in Months May 15, 2021 - By Maxx Chatsko General Premium Deep Dive Xcel Energy Deep Dive: May 2021 May 1, 2021 - By Maxx Chatsko Energy Video Maxx’s Top Stock for May 2021 7investing Lead Advisor Maxx Chatsko's Top Stock for May 2021 is leading the energy transition to zero-carbon power sources and the electrification of transportation. May 1, 2021 - By Maxx Chatsko Energy Article Can the Bioeconomy Transform Argentina into a Regional Superpower? Maxx Chatsko notes that while all eyes are on Brazil, the geographic strengths of its southern neighbor cannot be overlooked. Apr 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Running with Scissors: Will CRISPR be Humbled in the Clinic? Apr 13, 2021 - By Maxx Chatsko Biotechnology Podcast AACR Annual Meeting 2021: What’s the Frontier of Cancer Research? The American Association for Cancer Research (AACR) Annual Meeting 2021 begins this weekend. 7investing Lead Advisors Maxx Chatsko and Dan Kline discuss why the scientific meeting matters to... Apr 8, 2021 - By Daniel Kline Biotechnology Video Maxx’s Top Stock for April 2021 7investing Lead Advisor Maxx Chatsko's Top Stock to buy in April 2021 is developing a genetic medicine platform with several key advantages over peers. Apr 1, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Dicerna Pharmaceuticals Deep Dive: April 2021 Apr 1, 2021 - By Maxx Chatsko Biotechnology Article The Many Paths to Portfolio Allocation Investing is personal, but Maxx Chatsko points out the many ways you can handle portfolio allocation. Mar 22, 2021 - By Maxx Chatsko Premium Advisor Update My Long-Term Strategy in a Volatile Market Mar 15, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Certara Deep Dive: March 2021 Mar 1, 2021 - By Maxx Chatsko Enterprise Software Video Maxx’s Top Stock for March 2021 Maxx's Top Stock for March 2021 is an enterprise software company driving the digital transformation of a massive global industry and saving customers billions of dollars. Mar 1, 2021 - By Maxx Chatsko Enterprise Software Podcast What FinTwit Isn’t Telling You About These Biotech Stocks When biotech stocks rise on stories alone, and those stories become detached from reality, then you might be subjecting your portfolio to unnecessary risk. 7investing Lead Advisors Manisha Samy and... Feb 23, 2021 - By Manisha Samy Biotechnology Article A Mission Statement is Easy. Execution is Difficult A mission statement is nice to have, but it too often becomes a marketing pitch. Progress, including within a company's mission, is more important for investors. Feb 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Most Investors Neglect One of Their Biggest Advantages Feb 14, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for February 2021 7investing Lead Advisor Maxx Chatsko's Top Stock for February is an early-stage biopharma attempting to fundamentally change drug discovery and drug development. Feb 1, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Relay Therapeutics Deep Dive: February 2021 Feb 1, 2021 - By Maxx Chatsko Biotechnology Article Genomics Isn’t the Only Omics Maxx discusses misconceptions surrounding one of the market's oft-used buzzwords. Jan 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Will Renewable Energy Soar During the Biden Administration? Jan 15, 2021 - By Maxx Chatsko Energy Podcast JPM 39th Annual Healthcare Conference: What We’re Watching The JPM 39th Annual Healthcare Conference is next week. 7investing Lead Advisors Simon Erickson, Manisha Samy, and Maxx Chatsko discuss what they're watching as investors (and science nerds) ahead of... Jan 7, 2021 - By Manisha Samy Biotechnology Premium Deep Dive Selecta Biosciences Deep Dive: January 2021 Jan 1, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for January 7investing Lead Advisor Maxx Chatsko's top stock to buy in January 2021 is a small-cap biopharma developing an important technology platform that could increase the value of gene therapies, genetic... Jan 1, 2021 - By Maxx Chatsko Biotechnology Article Does the “B” Word Apply? It’s Complicated Maxx Chatsko offers a glimpse into how he values development-stage biopharma stocks. Dec 22, 2020 - By Maxx Chatsko Biotechnology Premium Advisor Update The 7investing Recommendation That Wasn’t Dec 15, 2020 - By Maxx Chatsko Pharmaceuticals Podcast ASH Conference Preview: What We’re Watching 7investing lead advisors Manisha Samy and Maxx Chatsko share what they're watching at the upcoming American Society of Hematology annual conference. Dec 3, 2020 - By Manisha Samy Biotechnology Podcast Synthetic Biology’s “Window of Opportunity” with ConVergInce Advisers’ Joel Stone Can synthetic biology break the chemical industry's reliance on fossil fuels? Industry veteran Joel Stone shares how industrial biotech is changing consumer brands, energy, agriculture, and more. Dec 1, 2020 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for December 7investing lead advisor Maxx Chatsko's Top Stock for December is leading the energy transition, today and tomorrow. Dec 1, 2020 - By Maxx Chatsko Energy Premium Deep Dive Xcel Energy Deep Dive: December 2020 Dec 1, 2020 - By Maxx Chatsko Energy Article Lesson Learned: Great Technology Doesn’t Guarantee a Great Business Maxx explains the importance of separating promising technology from great business. Nov 22, 2020 - By Maxx Chatsko Premium Advisor Update Vaccines Are On the Way, but Winter is Coming Nov 15, 2020 - By Maxx Chatsko Healthcare Technology Premium Deep Dive Dicerna Pharmaceuticals Deep Dive: November 2020 Nov 1, 2020 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for November 7investing lead advisor Maxx Chatsko's November 2020 recommendation is an under-the-radar, small-cap living technologies company at the very beginning of its growth trajectory. Nov 1, 2020 - By Maxx Chatsko Biotechnology Podcast Will the Cannabis Industry Give Way to Biotech? 7investing Lead Advisor Maxx Chatsko talks with Kevin Chen, co-founder and CEO of Hyasynth Bio, about the cannabis industry and how industrial biotech could transform the production of cannabinoid... Oct 22, 2020 - By Maxx Chatsko Biotechnology Article Not Another Political Discussion Maxx argues why investors today would do well to zoom out for a bigger-picture view of the world. Oct 22, 2020 - By Maxx Chatsko Premium Advisor Update “Cell Therapy’s First-Mover Disadvantage” Oct 15, 2020 - By Maxx Chatsko Biotechnology Premium Deep Dive Avita Therapeutics Deep Dive: October 2020 Oct 8, 2020 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for October 7investing lead advisor Maxx Chatsko's October 2020 recommendation is an under-the-radar, small-cap living technologies company at the very beginning of its growth trajectory. Oct 1, 2020 - By Maxx Chatsko Biotechnology Join Now! Why 7investing? Why Should I Invest? Why 7investing? Our Team Our 7 Principles Our Mission Testimonials How It Works What to Expect Our Report Format Membership Details Frequently Asked Questions Recommendations Research Articles Advisor Updates Company Updates Videos Special Reports Podcast Livestream Contact Us General Inquiries Submit a Testimonial Interested in Chatting With 7investing? My Account Log In
Premium Deep Dive Xcel Energy Deep Dive: May 2021 May 1, 2021 - By Maxx Chatsko Energy Video Maxx’s Top Stock for May 2021 7investing Lead Advisor Maxx Chatsko's Top Stock for May 2021 is leading the energy transition to zero-carbon power sources and the electrification of transportation. May 1, 2021 - By Maxx Chatsko Energy Article Can the Bioeconomy Transform Argentina into a Regional Superpower? Maxx Chatsko notes that while all eyes are on Brazil, the geographic strengths of its southern neighbor cannot be overlooked. Apr 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Running with Scissors: Will CRISPR be Humbled in the Clinic? Apr 13, 2021 - By Maxx Chatsko Biotechnology Podcast AACR Annual Meeting 2021: What’s the Frontier of Cancer Research? The American Association for Cancer Research (AACR) Annual Meeting 2021 begins this weekend. 7investing Lead Advisors Maxx Chatsko and Dan Kline discuss why the scientific meeting matters to... Apr 8, 2021 - By Daniel Kline Biotechnology Video Maxx’s Top Stock for April 2021 7investing Lead Advisor Maxx Chatsko's Top Stock to buy in April 2021 is developing a genetic medicine platform with several key advantages over peers. Apr 1, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Dicerna Pharmaceuticals Deep Dive: April 2021 Apr 1, 2021 - By Maxx Chatsko Biotechnology Article The Many Paths to Portfolio Allocation Investing is personal, but Maxx Chatsko points out the many ways you can handle portfolio allocation. Mar 22, 2021 - By Maxx Chatsko Premium Advisor Update My Long-Term Strategy in a Volatile Market Mar 15, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Certara Deep Dive: March 2021 Mar 1, 2021 - By Maxx Chatsko Enterprise Software Video Maxx’s Top Stock for March 2021 Maxx's Top Stock for March 2021 is an enterprise software company driving the digital transformation of a massive global industry and saving customers billions of dollars. Mar 1, 2021 - By Maxx Chatsko Enterprise Software Podcast What FinTwit Isn’t Telling You About These Biotech Stocks When biotech stocks rise on stories alone, and those stories become detached from reality, then you might be subjecting your portfolio to unnecessary risk. 7investing Lead Advisors Manisha Samy and... Feb 23, 2021 - By Manisha Samy Biotechnology Article A Mission Statement is Easy. Execution is Difficult A mission statement is nice to have, but it too often becomes a marketing pitch. Progress, including within a company's mission, is more important for investors. Feb 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Most Investors Neglect One of Their Biggest Advantages Feb 14, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for February 2021 7investing Lead Advisor Maxx Chatsko's Top Stock for February is an early-stage biopharma attempting to fundamentally change drug discovery and drug development. Feb 1, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Relay Therapeutics Deep Dive: February 2021 Feb 1, 2021 - By Maxx Chatsko Biotechnology Article Genomics Isn’t the Only Omics Maxx discusses misconceptions surrounding one of the market's oft-used buzzwords. Jan 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Will Renewable Energy Soar During the Biden Administration? Jan 15, 2021 - By Maxx Chatsko Energy Podcast JPM 39th Annual Healthcare Conference: What We’re Watching The JPM 39th Annual Healthcare Conference is next week. 7investing Lead Advisors Simon Erickson, Manisha Samy, and Maxx Chatsko discuss what they're watching as investors (and science nerds) ahead of... Jan 7, 2021 - By Manisha Samy Biotechnology Premium Deep Dive Selecta Biosciences Deep Dive: January 2021 Jan 1, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for January 7investing Lead Advisor Maxx Chatsko's top stock to buy in January 2021 is a small-cap biopharma developing an important technology platform that could increase the value of gene therapies, genetic... Jan 1, 2021 - By Maxx Chatsko Biotechnology Article Does the “B” Word Apply? It’s Complicated Maxx Chatsko offers a glimpse into how he values development-stage biopharma stocks. Dec 22, 2020 - By Maxx Chatsko Biotechnology Premium Advisor Update The 7investing Recommendation That Wasn’t Dec 15, 2020 - By Maxx Chatsko Pharmaceuticals Podcast ASH Conference Preview: What We’re Watching 7investing lead advisors Manisha Samy and Maxx Chatsko share what they're watching at the upcoming American Society of Hematology annual conference. Dec 3, 2020 - By Manisha Samy Biotechnology Podcast Synthetic Biology’s “Window of Opportunity” with ConVergInce Advisers’ Joel Stone Can synthetic biology break the chemical industry's reliance on fossil fuels? Industry veteran Joel Stone shares how industrial biotech is changing consumer brands, energy, agriculture, and more. Dec 1, 2020 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for December 7investing lead advisor Maxx Chatsko's Top Stock for December is leading the energy transition, today and tomorrow. Dec 1, 2020 - By Maxx Chatsko Energy Premium Deep Dive Xcel Energy Deep Dive: December 2020 Dec 1, 2020 - By Maxx Chatsko Energy Article Lesson Learned: Great Technology Doesn’t Guarantee a Great Business Maxx explains the importance of separating promising technology from great business. Nov 22, 2020 - By Maxx Chatsko Premium Advisor Update Vaccines Are On the Way, but Winter is Coming Nov 15, 2020 - By Maxx Chatsko Healthcare Technology Premium Deep Dive Dicerna Pharmaceuticals Deep Dive: November 2020 Nov 1, 2020 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for November 7investing lead advisor Maxx Chatsko's November 2020 recommendation is an under-the-radar, small-cap living technologies company at the very beginning of its growth trajectory. Nov 1, 2020 - By Maxx Chatsko Biotechnology Podcast Will the Cannabis Industry Give Way to Biotech? 7investing Lead Advisor Maxx Chatsko talks with Kevin Chen, co-founder and CEO of Hyasynth Bio, about the cannabis industry and how industrial biotech could transform the production of cannabinoid... Oct 22, 2020 - By Maxx Chatsko Biotechnology Article Not Another Political Discussion Maxx argues why investors today would do well to zoom out for a bigger-picture view of the world. Oct 22, 2020 - By Maxx Chatsko Premium Advisor Update “Cell Therapy’s First-Mover Disadvantage” Oct 15, 2020 - By Maxx Chatsko Biotechnology Premium Deep Dive Avita Therapeutics Deep Dive: October 2020 Oct 8, 2020 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for October 7investing lead advisor Maxx Chatsko's October 2020 recommendation is an under-the-radar, small-cap living technologies company at the very beginning of its growth trajectory. Oct 1, 2020 - By Maxx Chatsko Biotechnology Join Now! Why 7investing? Why Should I Invest? Why 7investing? Our Team Our 7 Principles Our Mission Testimonials How It Works What to Expect Our Report Format Membership Details Frequently Asked Questions Recommendations Research Articles Advisor Updates Company Updates Videos Special Reports Podcast Livestream Contact Us General Inquiries Submit a Testimonial Interested in Chatting With 7investing? My Account Log In
Video Maxx’s Top Stock for May 2021 7investing Lead Advisor Maxx Chatsko's Top Stock for May 2021 is leading the energy transition to zero-carbon power sources and the electrification of transportation. May 1, 2021 - By Maxx Chatsko Energy Article Can the Bioeconomy Transform Argentina into a Regional Superpower? Maxx Chatsko notes that while all eyes are on Brazil, the geographic strengths of its southern neighbor cannot be overlooked. Apr 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Running with Scissors: Will CRISPR be Humbled in the Clinic? Apr 13, 2021 - By Maxx Chatsko Biotechnology Podcast AACR Annual Meeting 2021: What’s the Frontier of Cancer Research? The American Association for Cancer Research (AACR) Annual Meeting 2021 begins this weekend. 7investing Lead Advisors Maxx Chatsko and Dan Kline discuss why the scientific meeting matters to... Apr 8, 2021 - By Daniel Kline Biotechnology Video Maxx’s Top Stock for April 2021 7investing Lead Advisor Maxx Chatsko's Top Stock to buy in April 2021 is developing a genetic medicine platform with several key advantages over peers. Apr 1, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Dicerna Pharmaceuticals Deep Dive: April 2021 Apr 1, 2021 - By Maxx Chatsko Biotechnology Article The Many Paths to Portfolio Allocation Investing is personal, but Maxx Chatsko points out the many ways you can handle portfolio allocation. Mar 22, 2021 - By Maxx Chatsko Premium Advisor Update My Long-Term Strategy in a Volatile Market Mar 15, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Certara Deep Dive: March 2021 Mar 1, 2021 - By Maxx Chatsko Enterprise Software Video Maxx’s Top Stock for March 2021 Maxx's Top Stock for March 2021 is an enterprise software company driving the digital transformation of a massive global industry and saving customers billions of dollars. Mar 1, 2021 - By Maxx Chatsko Enterprise Software Podcast What FinTwit Isn’t Telling You About These Biotech Stocks When biotech stocks rise on stories alone, and those stories become detached from reality, then you might be subjecting your portfolio to unnecessary risk. 7investing Lead Advisors Manisha Samy and... Feb 23, 2021 - By Manisha Samy Biotechnology Article A Mission Statement is Easy. Execution is Difficult A mission statement is nice to have, but it too often becomes a marketing pitch. Progress, including within a company's mission, is more important for investors. Feb 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Most Investors Neglect One of Their Biggest Advantages Feb 14, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for February 2021 7investing Lead Advisor Maxx Chatsko's Top Stock for February is an early-stage biopharma attempting to fundamentally change drug discovery and drug development. Feb 1, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Relay Therapeutics Deep Dive: February 2021 Feb 1, 2021 - By Maxx Chatsko Biotechnology Article Genomics Isn’t the Only Omics Maxx discusses misconceptions surrounding one of the market's oft-used buzzwords. Jan 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Will Renewable Energy Soar During the Biden Administration? Jan 15, 2021 - By Maxx Chatsko Energy Podcast JPM 39th Annual Healthcare Conference: What We’re Watching The JPM 39th Annual Healthcare Conference is next week. 7investing Lead Advisors Simon Erickson, Manisha Samy, and Maxx Chatsko discuss what they're watching as investors (and science nerds) ahead of... Jan 7, 2021 - By Manisha Samy Biotechnology Premium Deep Dive Selecta Biosciences Deep Dive: January 2021 Jan 1, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for January 7investing Lead Advisor Maxx Chatsko's top stock to buy in January 2021 is a small-cap biopharma developing an important technology platform that could increase the value of gene therapies, genetic... Jan 1, 2021 - By Maxx Chatsko Biotechnology Article Does the “B” Word Apply? It’s Complicated Maxx Chatsko offers a glimpse into how he values development-stage biopharma stocks. Dec 22, 2020 - By Maxx Chatsko Biotechnology Premium Advisor Update The 7investing Recommendation That Wasn’t Dec 15, 2020 - By Maxx Chatsko Pharmaceuticals Podcast ASH Conference Preview: What We’re Watching 7investing lead advisors Manisha Samy and Maxx Chatsko share what they're watching at the upcoming American Society of Hematology annual conference. Dec 3, 2020 - By Manisha Samy Biotechnology Podcast Synthetic Biology’s “Window of Opportunity” with ConVergInce Advisers’ Joel Stone Can synthetic biology break the chemical industry's reliance on fossil fuels? Industry veteran Joel Stone shares how industrial biotech is changing consumer brands, energy, agriculture, and more. Dec 1, 2020 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for December 7investing lead advisor Maxx Chatsko's Top Stock for December is leading the energy transition, today and tomorrow. Dec 1, 2020 - By Maxx Chatsko Energy Premium Deep Dive Xcel Energy Deep Dive: December 2020 Dec 1, 2020 - By Maxx Chatsko Energy Article Lesson Learned: Great Technology Doesn’t Guarantee a Great Business Maxx explains the importance of separating promising technology from great business. Nov 22, 2020 - By Maxx Chatsko Premium Advisor Update Vaccines Are On the Way, but Winter is Coming Nov 15, 2020 - By Maxx Chatsko Healthcare Technology Premium Deep Dive Dicerna Pharmaceuticals Deep Dive: November 2020 Nov 1, 2020 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for November 7investing lead advisor Maxx Chatsko's November 2020 recommendation is an under-the-radar, small-cap living technologies company at the very beginning of its growth trajectory. Nov 1, 2020 - By Maxx Chatsko Biotechnology Podcast Will the Cannabis Industry Give Way to Biotech? 7investing Lead Advisor Maxx Chatsko talks with Kevin Chen, co-founder and CEO of Hyasynth Bio, about the cannabis industry and how industrial biotech could transform the production of cannabinoid... Oct 22, 2020 - By Maxx Chatsko Biotechnology Article Not Another Political Discussion Maxx argues why investors today would do well to zoom out for a bigger-picture view of the world. Oct 22, 2020 - By Maxx Chatsko Premium Advisor Update “Cell Therapy’s First-Mover Disadvantage” Oct 15, 2020 - By Maxx Chatsko Biotechnology Premium Deep Dive Avita Therapeutics Deep Dive: October 2020 Oct 8, 2020 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for October 7investing lead advisor Maxx Chatsko's October 2020 recommendation is an under-the-radar, small-cap living technologies company at the very beginning of its growth trajectory. Oct 1, 2020 - By Maxx Chatsko Biotechnology Join Now! Why 7investing? Why Should I Invest? Why 7investing? Our Team Our 7 Principles Our Mission Testimonials How It Works What to Expect Our Report Format Membership Details Frequently Asked Questions Recommendations Research Articles Advisor Updates Company Updates Videos Special Reports Podcast Livestream Contact Us General Inquiries Submit a Testimonial Interested in Chatting With 7investing? My Account Log In
Article Can the Bioeconomy Transform Argentina into a Regional Superpower? Maxx Chatsko notes that while all eyes are on Brazil, the geographic strengths of its southern neighbor cannot be overlooked. Apr 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Running with Scissors: Will CRISPR be Humbled in the Clinic? Apr 13, 2021 - By Maxx Chatsko Biotechnology Podcast AACR Annual Meeting 2021: What’s the Frontier of Cancer Research? The American Association for Cancer Research (AACR) Annual Meeting 2021 begins this weekend. 7investing Lead Advisors Maxx Chatsko and Dan Kline discuss why the scientific meeting matters to... Apr 8, 2021 - By Daniel Kline Biotechnology Video Maxx’s Top Stock for April 2021 7investing Lead Advisor Maxx Chatsko's Top Stock to buy in April 2021 is developing a genetic medicine platform with several key advantages over peers. Apr 1, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Dicerna Pharmaceuticals Deep Dive: April 2021 Apr 1, 2021 - By Maxx Chatsko Biotechnology Article The Many Paths to Portfolio Allocation Investing is personal, but Maxx Chatsko points out the many ways you can handle portfolio allocation. Mar 22, 2021 - By Maxx Chatsko Premium Advisor Update My Long-Term Strategy in a Volatile Market Mar 15, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Certara Deep Dive: March 2021 Mar 1, 2021 - By Maxx Chatsko Enterprise Software Video Maxx’s Top Stock for March 2021 Maxx's Top Stock for March 2021 is an enterprise software company driving the digital transformation of a massive global industry and saving customers billions of dollars. Mar 1, 2021 - By Maxx Chatsko Enterprise Software Podcast What FinTwit Isn’t Telling You About These Biotech Stocks When biotech stocks rise on stories alone, and those stories become detached from reality, then you might be subjecting your portfolio to unnecessary risk. 7investing Lead Advisors Manisha Samy and... Feb 23, 2021 - By Manisha Samy Biotechnology Article A Mission Statement is Easy. Execution is Difficult A mission statement is nice to have, but it too often becomes a marketing pitch. Progress, including within a company's mission, is more important for investors. Feb 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Most Investors Neglect One of Their Biggest Advantages Feb 14, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for February 2021 7investing Lead Advisor Maxx Chatsko's Top Stock for February is an early-stage biopharma attempting to fundamentally change drug discovery and drug development. Feb 1, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Relay Therapeutics Deep Dive: February 2021 Feb 1, 2021 - By Maxx Chatsko Biotechnology Article Genomics Isn’t the Only Omics Maxx discusses misconceptions surrounding one of the market's oft-used buzzwords. Jan 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Will Renewable Energy Soar During the Biden Administration? Jan 15, 2021 - By Maxx Chatsko Energy Podcast JPM 39th Annual Healthcare Conference: What We’re Watching The JPM 39th Annual Healthcare Conference is next week. 7investing Lead Advisors Simon Erickson, Manisha Samy, and Maxx Chatsko discuss what they're watching as investors (and science nerds) ahead of... Jan 7, 2021 - By Manisha Samy Biotechnology Premium Deep Dive Selecta Biosciences Deep Dive: January 2021 Jan 1, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for January 7investing Lead Advisor Maxx Chatsko's top stock to buy in January 2021 is a small-cap biopharma developing an important technology platform that could increase the value of gene therapies, genetic... Jan 1, 2021 - By Maxx Chatsko Biotechnology Article Does the “B” Word Apply? It’s Complicated Maxx Chatsko offers a glimpse into how he values development-stage biopharma stocks. Dec 22, 2020 - By Maxx Chatsko Biotechnology Premium Advisor Update The 7investing Recommendation That Wasn’t Dec 15, 2020 - By Maxx Chatsko Pharmaceuticals Podcast ASH Conference Preview: What We’re Watching 7investing lead advisors Manisha Samy and Maxx Chatsko share what they're watching at the upcoming American Society of Hematology annual conference. Dec 3, 2020 - By Manisha Samy Biotechnology Podcast Synthetic Biology’s “Window of Opportunity” with ConVergInce Advisers’ Joel Stone Can synthetic biology break the chemical industry's reliance on fossil fuels? Industry veteran Joel Stone shares how industrial biotech is changing consumer brands, energy, agriculture, and more. Dec 1, 2020 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for December 7investing lead advisor Maxx Chatsko's Top Stock for December is leading the energy transition, today and tomorrow. Dec 1, 2020 - By Maxx Chatsko Energy Premium Deep Dive Xcel Energy Deep Dive: December 2020 Dec 1, 2020 - By Maxx Chatsko Energy Article Lesson Learned: Great Technology Doesn’t Guarantee a Great Business Maxx explains the importance of separating promising technology from great business. Nov 22, 2020 - By Maxx Chatsko Premium Advisor Update Vaccines Are On the Way, but Winter is Coming Nov 15, 2020 - By Maxx Chatsko Healthcare Technology Premium Deep Dive Dicerna Pharmaceuticals Deep Dive: November 2020 Nov 1, 2020 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for November 7investing lead advisor Maxx Chatsko's November 2020 recommendation is an under-the-radar, small-cap living technologies company at the very beginning of its growth trajectory. Nov 1, 2020 - By Maxx Chatsko Biotechnology Podcast Will the Cannabis Industry Give Way to Biotech? 7investing Lead Advisor Maxx Chatsko talks with Kevin Chen, co-founder and CEO of Hyasynth Bio, about the cannabis industry and how industrial biotech could transform the production of cannabinoid... Oct 22, 2020 - By Maxx Chatsko Biotechnology Article Not Another Political Discussion Maxx argues why investors today would do well to zoom out for a bigger-picture view of the world. Oct 22, 2020 - By Maxx Chatsko Premium Advisor Update “Cell Therapy’s First-Mover Disadvantage” Oct 15, 2020 - By Maxx Chatsko Biotechnology Premium Deep Dive Avita Therapeutics Deep Dive: October 2020 Oct 8, 2020 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for October 7investing lead advisor Maxx Chatsko's October 2020 recommendation is an under-the-radar, small-cap living technologies company at the very beginning of its growth trajectory. Oct 1, 2020 - By Maxx Chatsko Biotechnology Join Now! Why 7investing? Why Should I Invest? Why 7investing? Our Team Our 7 Principles Our Mission Testimonials How It Works What to Expect Our Report Format Membership Details Frequently Asked Questions Recommendations Research Articles Advisor Updates Company Updates Videos Special Reports Podcast Livestream Contact Us General Inquiries Submit a Testimonial Interested in Chatting With 7investing? My Account Log In
Premium Advisor Update Running with Scissors: Will CRISPR be Humbled in the Clinic? Apr 13, 2021 - By Maxx Chatsko Biotechnology Podcast AACR Annual Meeting 2021: What’s the Frontier of Cancer Research? The American Association for Cancer Research (AACR) Annual Meeting 2021 begins this weekend. 7investing Lead Advisors Maxx Chatsko and Dan Kline discuss why the scientific meeting matters to... Apr 8, 2021 - By Daniel Kline Biotechnology Video Maxx’s Top Stock for April 2021 7investing Lead Advisor Maxx Chatsko's Top Stock to buy in April 2021 is developing a genetic medicine platform with several key advantages over peers. Apr 1, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Dicerna Pharmaceuticals Deep Dive: April 2021 Apr 1, 2021 - By Maxx Chatsko Biotechnology Article The Many Paths to Portfolio Allocation Investing is personal, but Maxx Chatsko points out the many ways you can handle portfolio allocation. Mar 22, 2021 - By Maxx Chatsko Premium Advisor Update My Long-Term Strategy in a Volatile Market Mar 15, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Certara Deep Dive: March 2021 Mar 1, 2021 - By Maxx Chatsko Enterprise Software Video Maxx’s Top Stock for March 2021 Maxx's Top Stock for March 2021 is an enterprise software company driving the digital transformation of a massive global industry and saving customers billions of dollars. Mar 1, 2021 - By Maxx Chatsko Enterprise Software Podcast What FinTwit Isn’t Telling You About These Biotech Stocks When biotech stocks rise on stories alone, and those stories become detached from reality, then you might be subjecting your portfolio to unnecessary risk. 7investing Lead Advisors Manisha Samy and... Feb 23, 2021 - By Manisha Samy Biotechnology Article A Mission Statement is Easy. Execution is Difficult A mission statement is nice to have, but it too often becomes a marketing pitch. Progress, including within a company's mission, is more important for investors. Feb 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Most Investors Neglect One of Their Biggest Advantages Feb 14, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for February 2021 7investing Lead Advisor Maxx Chatsko's Top Stock for February is an early-stage biopharma attempting to fundamentally change drug discovery and drug development. Feb 1, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Relay Therapeutics Deep Dive: February 2021 Feb 1, 2021 - By Maxx Chatsko Biotechnology Article Genomics Isn’t the Only Omics Maxx discusses misconceptions surrounding one of the market's oft-used buzzwords. Jan 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Will Renewable Energy Soar During the Biden Administration? Jan 15, 2021 - By Maxx Chatsko Energy Podcast JPM 39th Annual Healthcare Conference: What We’re Watching The JPM 39th Annual Healthcare Conference is next week. 7investing Lead Advisors Simon Erickson, Manisha Samy, and Maxx Chatsko discuss what they're watching as investors (and science nerds) ahead of... Jan 7, 2021 - By Manisha Samy Biotechnology Premium Deep Dive Selecta Biosciences Deep Dive: January 2021 Jan 1, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for January 7investing Lead Advisor Maxx Chatsko's top stock to buy in January 2021 is a small-cap biopharma developing an important technology platform that could increase the value of gene therapies, genetic... Jan 1, 2021 - By Maxx Chatsko Biotechnology Article Does the “B” Word Apply? It’s Complicated Maxx Chatsko offers a glimpse into how he values development-stage biopharma stocks. Dec 22, 2020 - By Maxx Chatsko Biotechnology Premium Advisor Update The 7investing Recommendation That Wasn’t Dec 15, 2020 - By Maxx Chatsko Pharmaceuticals Podcast ASH Conference Preview: What We’re Watching 7investing lead advisors Manisha Samy and Maxx Chatsko share what they're watching at the upcoming American Society of Hematology annual conference. Dec 3, 2020 - By Manisha Samy Biotechnology Podcast Synthetic Biology’s “Window of Opportunity” with ConVergInce Advisers’ Joel Stone Can synthetic biology break the chemical industry's reliance on fossil fuels? Industry veteran Joel Stone shares how industrial biotech is changing consumer brands, energy, agriculture, and more. Dec 1, 2020 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for December 7investing lead advisor Maxx Chatsko's Top Stock for December is leading the energy transition, today and tomorrow. Dec 1, 2020 - By Maxx Chatsko Energy Premium Deep Dive Xcel Energy Deep Dive: December 2020 Dec 1, 2020 - By Maxx Chatsko Energy Article Lesson Learned: Great Technology Doesn’t Guarantee a Great Business Maxx explains the importance of separating promising technology from great business. Nov 22, 2020 - By Maxx Chatsko Premium Advisor Update Vaccines Are On the Way, but Winter is Coming Nov 15, 2020 - By Maxx Chatsko Healthcare Technology Premium Deep Dive Dicerna Pharmaceuticals Deep Dive: November 2020 Nov 1, 2020 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for November 7investing lead advisor Maxx Chatsko's November 2020 recommendation is an under-the-radar, small-cap living technologies company at the very beginning of its growth trajectory. Nov 1, 2020 - By Maxx Chatsko Biotechnology Podcast Will the Cannabis Industry Give Way to Biotech? 7investing Lead Advisor Maxx Chatsko talks with Kevin Chen, co-founder and CEO of Hyasynth Bio, about the cannabis industry and how industrial biotech could transform the production of cannabinoid... Oct 22, 2020 - By Maxx Chatsko Biotechnology Article Not Another Political Discussion Maxx argues why investors today would do well to zoom out for a bigger-picture view of the world. Oct 22, 2020 - By Maxx Chatsko Premium Advisor Update “Cell Therapy’s First-Mover Disadvantage” Oct 15, 2020 - By Maxx Chatsko Biotechnology Premium Deep Dive Avita Therapeutics Deep Dive: October 2020 Oct 8, 2020 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for October 7investing lead advisor Maxx Chatsko's October 2020 recommendation is an under-the-radar, small-cap living technologies company at the very beginning of its growth trajectory. Oct 1, 2020 - By Maxx Chatsko Biotechnology Join Now! Why 7investing? Why Should I Invest? Why 7investing? Our Team Our 7 Principles Our Mission Testimonials How It Works What to Expect Our Report Format Membership Details Frequently Asked Questions Recommendations Research Articles Advisor Updates Company Updates Videos Special Reports Podcast Livestream Contact Us General Inquiries Submit a Testimonial Interested in Chatting With 7investing? My Account Log In
Podcast AACR Annual Meeting 2021: What’s the Frontier of Cancer Research? The American Association for Cancer Research (AACR) Annual Meeting 2021 begins this weekend. 7investing Lead Advisors Maxx Chatsko and Dan Kline discuss why the scientific meeting matters to... Apr 8, 2021 - By Daniel Kline Biotechnology Video Maxx’s Top Stock for April 2021 7investing Lead Advisor Maxx Chatsko's Top Stock to buy in April 2021 is developing a genetic medicine platform with several key advantages over peers. Apr 1, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Dicerna Pharmaceuticals Deep Dive: April 2021 Apr 1, 2021 - By Maxx Chatsko Biotechnology Article The Many Paths to Portfolio Allocation Investing is personal, but Maxx Chatsko points out the many ways you can handle portfolio allocation. Mar 22, 2021 - By Maxx Chatsko Premium Advisor Update My Long-Term Strategy in a Volatile Market Mar 15, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Certara Deep Dive: March 2021 Mar 1, 2021 - By Maxx Chatsko Enterprise Software Video Maxx’s Top Stock for March 2021 Maxx's Top Stock for March 2021 is an enterprise software company driving the digital transformation of a massive global industry and saving customers billions of dollars. Mar 1, 2021 - By Maxx Chatsko Enterprise Software Podcast What FinTwit Isn’t Telling You About These Biotech Stocks When biotech stocks rise on stories alone, and those stories become detached from reality, then you might be subjecting your portfolio to unnecessary risk. 7investing Lead Advisors Manisha Samy and... Feb 23, 2021 - By Manisha Samy Biotechnology Article A Mission Statement is Easy. Execution is Difficult A mission statement is nice to have, but it too often becomes a marketing pitch. Progress, including within a company's mission, is more important for investors. Feb 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Most Investors Neglect One of Their Biggest Advantages Feb 14, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for February 2021 7investing Lead Advisor Maxx Chatsko's Top Stock for February is an early-stage biopharma attempting to fundamentally change drug discovery and drug development. Feb 1, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Relay Therapeutics Deep Dive: February 2021 Feb 1, 2021 - By Maxx Chatsko Biotechnology Article Genomics Isn’t the Only Omics Maxx discusses misconceptions surrounding one of the market's oft-used buzzwords. Jan 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Will Renewable Energy Soar During the Biden Administration? Jan 15, 2021 - By Maxx Chatsko Energy Podcast JPM 39th Annual Healthcare Conference: What We’re Watching The JPM 39th Annual Healthcare Conference is next week. 7investing Lead Advisors Simon Erickson, Manisha Samy, and Maxx Chatsko discuss what they're watching as investors (and science nerds) ahead of... Jan 7, 2021 - By Manisha Samy Biotechnology Premium Deep Dive Selecta Biosciences Deep Dive: January 2021 Jan 1, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for January 7investing Lead Advisor Maxx Chatsko's top stock to buy in January 2021 is a small-cap biopharma developing an important technology platform that could increase the value of gene therapies, genetic... Jan 1, 2021 - By Maxx Chatsko Biotechnology Article Does the “B” Word Apply? It’s Complicated Maxx Chatsko offers a glimpse into how he values development-stage biopharma stocks. Dec 22, 2020 - By Maxx Chatsko Biotechnology Premium Advisor Update The 7investing Recommendation That Wasn’t Dec 15, 2020 - By Maxx Chatsko Pharmaceuticals Podcast ASH Conference Preview: What We’re Watching 7investing lead advisors Manisha Samy and Maxx Chatsko share what they're watching at the upcoming American Society of Hematology annual conference. Dec 3, 2020 - By Manisha Samy Biotechnology Podcast Synthetic Biology’s “Window of Opportunity” with ConVergInce Advisers’ Joel Stone Can synthetic biology break the chemical industry's reliance on fossil fuels? Industry veteran Joel Stone shares how industrial biotech is changing consumer brands, energy, agriculture, and more. Dec 1, 2020 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for December 7investing lead advisor Maxx Chatsko's Top Stock for December is leading the energy transition, today and tomorrow. Dec 1, 2020 - By Maxx Chatsko Energy Premium Deep Dive Xcel Energy Deep Dive: December 2020 Dec 1, 2020 - By Maxx Chatsko Energy Article Lesson Learned: Great Technology Doesn’t Guarantee a Great Business Maxx explains the importance of separating promising technology from great business. Nov 22, 2020 - By Maxx Chatsko Premium Advisor Update Vaccines Are On the Way, but Winter is Coming Nov 15, 2020 - By Maxx Chatsko Healthcare Technology Premium Deep Dive Dicerna Pharmaceuticals Deep Dive: November 2020 Nov 1, 2020 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for November 7investing lead advisor Maxx Chatsko's November 2020 recommendation is an under-the-radar, small-cap living technologies company at the very beginning of its growth trajectory. Nov 1, 2020 - By Maxx Chatsko Biotechnology Podcast Will the Cannabis Industry Give Way to Biotech? 7investing Lead Advisor Maxx Chatsko talks with Kevin Chen, co-founder and CEO of Hyasynth Bio, about the cannabis industry and how industrial biotech could transform the production of cannabinoid... Oct 22, 2020 - By Maxx Chatsko Biotechnology Article Not Another Political Discussion Maxx argues why investors today would do well to zoom out for a bigger-picture view of the world. Oct 22, 2020 - By Maxx Chatsko Premium Advisor Update “Cell Therapy’s First-Mover Disadvantage” Oct 15, 2020 - By Maxx Chatsko Biotechnology Premium Deep Dive Avita Therapeutics Deep Dive: October 2020 Oct 8, 2020 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for October 7investing lead advisor Maxx Chatsko's October 2020 recommendation is an under-the-radar, small-cap living technologies company at the very beginning of its growth trajectory. Oct 1, 2020 - By Maxx Chatsko Biotechnology Join Now! Why 7investing? Why Should I Invest? Why 7investing? Our Team Our 7 Principles Our Mission Testimonials How It Works What to Expect Our Report Format Membership Details Frequently Asked Questions Recommendations Research Articles Advisor Updates Company Updates Videos Special Reports Podcast Livestream Contact Us General Inquiries Submit a Testimonial Interested in Chatting With 7investing? My Account Log In
Video Maxx’s Top Stock for April 2021 7investing Lead Advisor Maxx Chatsko's Top Stock to buy in April 2021 is developing a genetic medicine platform with several key advantages over peers. Apr 1, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Dicerna Pharmaceuticals Deep Dive: April 2021 Apr 1, 2021 - By Maxx Chatsko Biotechnology Article The Many Paths to Portfolio Allocation Investing is personal, but Maxx Chatsko points out the many ways you can handle portfolio allocation. Mar 22, 2021 - By Maxx Chatsko Premium Advisor Update My Long-Term Strategy in a Volatile Market Mar 15, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Certara Deep Dive: March 2021 Mar 1, 2021 - By Maxx Chatsko Enterprise Software Video Maxx’s Top Stock for March 2021 Maxx's Top Stock for March 2021 is an enterprise software company driving the digital transformation of a massive global industry and saving customers billions of dollars. Mar 1, 2021 - By Maxx Chatsko Enterprise Software Podcast What FinTwit Isn’t Telling You About These Biotech Stocks When biotech stocks rise on stories alone, and those stories become detached from reality, then you might be subjecting your portfolio to unnecessary risk. 7investing Lead Advisors Manisha Samy and... Feb 23, 2021 - By Manisha Samy Biotechnology Article A Mission Statement is Easy. Execution is Difficult A mission statement is nice to have, but it too often becomes a marketing pitch. Progress, including within a company's mission, is more important for investors. Feb 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Most Investors Neglect One of Their Biggest Advantages Feb 14, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for February 2021 7investing Lead Advisor Maxx Chatsko's Top Stock for February is an early-stage biopharma attempting to fundamentally change drug discovery and drug development. Feb 1, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Relay Therapeutics Deep Dive: February 2021 Feb 1, 2021 - By Maxx Chatsko Biotechnology Article Genomics Isn’t the Only Omics Maxx discusses misconceptions surrounding one of the market's oft-used buzzwords. Jan 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Will Renewable Energy Soar During the Biden Administration? Jan 15, 2021 - By Maxx Chatsko Energy Podcast JPM 39th Annual Healthcare Conference: What We’re Watching The JPM 39th Annual Healthcare Conference is next week. 7investing Lead Advisors Simon Erickson, Manisha Samy, and Maxx Chatsko discuss what they're watching as investors (and science nerds) ahead of... Jan 7, 2021 - By Manisha Samy Biotechnology Premium Deep Dive Selecta Biosciences Deep Dive: January 2021 Jan 1, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for January 7investing Lead Advisor Maxx Chatsko's top stock to buy in January 2021 is a small-cap biopharma developing an important technology platform that could increase the value of gene therapies, genetic... Jan 1, 2021 - By Maxx Chatsko Biotechnology Article Does the “B” Word Apply? It’s Complicated Maxx Chatsko offers a glimpse into how he values development-stage biopharma stocks. Dec 22, 2020 - By Maxx Chatsko Biotechnology Premium Advisor Update The 7investing Recommendation That Wasn’t Dec 15, 2020 - By Maxx Chatsko Pharmaceuticals Podcast ASH Conference Preview: What We’re Watching 7investing lead advisors Manisha Samy and Maxx Chatsko share what they're watching at the upcoming American Society of Hematology annual conference. Dec 3, 2020 - By Manisha Samy Biotechnology Podcast Synthetic Biology’s “Window of Opportunity” with ConVergInce Advisers’ Joel Stone Can synthetic biology break the chemical industry's reliance on fossil fuels? Industry veteran Joel Stone shares how industrial biotech is changing consumer brands, energy, agriculture, and more. Dec 1, 2020 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for December 7investing lead advisor Maxx Chatsko's Top Stock for December is leading the energy transition, today and tomorrow. Dec 1, 2020 - By Maxx Chatsko Energy Premium Deep Dive Xcel Energy Deep Dive: December 2020 Dec 1, 2020 - By Maxx Chatsko Energy Article Lesson Learned: Great Technology Doesn’t Guarantee a Great Business Maxx explains the importance of separating promising technology from great business. Nov 22, 2020 - By Maxx Chatsko Premium Advisor Update Vaccines Are On the Way, but Winter is Coming Nov 15, 2020 - By Maxx Chatsko Healthcare Technology Premium Deep Dive Dicerna Pharmaceuticals Deep Dive: November 2020 Nov 1, 2020 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for November 7investing lead advisor Maxx Chatsko's November 2020 recommendation is an under-the-radar, small-cap living technologies company at the very beginning of its growth trajectory. Nov 1, 2020 - By Maxx Chatsko Biotechnology Podcast Will the Cannabis Industry Give Way to Biotech? 7investing Lead Advisor Maxx Chatsko talks with Kevin Chen, co-founder and CEO of Hyasynth Bio, about the cannabis industry and how industrial biotech could transform the production of cannabinoid... Oct 22, 2020 - By Maxx Chatsko Biotechnology Article Not Another Political Discussion Maxx argues why investors today would do well to zoom out for a bigger-picture view of the world. Oct 22, 2020 - By Maxx Chatsko Premium Advisor Update “Cell Therapy’s First-Mover Disadvantage” Oct 15, 2020 - By Maxx Chatsko Biotechnology Premium Deep Dive Avita Therapeutics Deep Dive: October 2020 Oct 8, 2020 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for October 7investing lead advisor Maxx Chatsko's October 2020 recommendation is an under-the-radar, small-cap living technologies company at the very beginning of its growth trajectory. Oct 1, 2020 - By Maxx Chatsko Biotechnology Join Now! Why 7investing? Why Should I Invest? Why 7investing? Our Team Our 7 Principles Our Mission Testimonials How It Works What to Expect Our Report Format Membership Details Frequently Asked Questions Recommendations Research Articles Advisor Updates Company Updates Videos Special Reports Podcast Livestream Contact Us General Inquiries Submit a Testimonial Interested in Chatting With 7investing? My Account Log In
Premium Deep Dive Dicerna Pharmaceuticals Deep Dive: April 2021 Apr 1, 2021 - By Maxx Chatsko Biotechnology Article The Many Paths to Portfolio Allocation Investing is personal, but Maxx Chatsko points out the many ways you can handle portfolio allocation. Mar 22, 2021 - By Maxx Chatsko Premium Advisor Update My Long-Term Strategy in a Volatile Market Mar 15, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Certara Deep Dive: March 2021 Mar 1, 2021 - By Maxx Chatsko Enterprise Software Video Maxx’s Top Stock for March 2021 Maxx's Top Stock for March 2021 is an enterprise software company driving the digital transformation of a massive global industry and saving customers billions of dollars. Mar 1, 2021 - By Maxx Chatsko Enterprise Software Podcast What FinTwit Isn’t Telling You About These Biotech Stocks When biotech stocks rise on stories alone, and those stories become detached from reality, then you might be subjecting your portfolio to unnecessary risk. 7investing Lead Advisors Manisha Samy and... Feb 23, 2021 - By Manisha Samy Biotechnology Article A Mission Statement is Easy. Execution is Difficult A mission statement is nice to have, but it too often becomes a marketing pitch. Progress, including within a company's mission, is more important for investors. Feb 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Most Investors Neglect One of Their Biggest Advantages Feb 14, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for February 2021 7investing Lead Advisor Maxx Chatsko's Top Stock for February is an early-stage biopharma attempting to fundamentally change drug discovery and drug development. Feb 1, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Relay Therapeutics Deep Dive: February 2021 Feb 1, 2021 - By Maxx Chatsko Biotechnology Article Genomics Isn’t the Only Omics Maxx discusses misconceptions surrounding one of the market's oft-used buzzwords. Jan 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Will Renewable Energy Soar During the Biden Administration? Jan 15, 2021 - By Maxx Chatsko Energy Podcast JPM 39th Annual Healthcare Conference: What We’re Watching The JPM 39th Annual Healthcare Conference is next week. 7investing Lead Advisors Simon Erickson, Manisha Samy, and Maxx Chatsko discuss what they're watching as investors (and science nerds) ahead of... Jan 7, 2021 - By Manisha Samy Biotechnology Premium Deep Dive Selecta Biosciences Deep Dive: January 2021 Jan 1, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for January 7investing Lead Advisor Maxx Chatsko's top stock to buy in January 2021 is a small-cap biopharma developing an important technology platform that could increase the value of gene therapies, genetic... Jan 1, 2021 - By Maxx Chatsko Biotechnology Article Does the “B” Word Apply? It’s Complicated Maxx Chatsko offers a glimpse into how he values development-stage biopharma stocks. Dec 22, 2020 - By Maxx Chatsko Biotechnology Premium Advisor Update The 7investing Recommendation That Wasn’t Dec 15, 2020 - By Maxx Chatsko Pharmaceuticals Podcast ASH Conference Preview: What We’re Watching 7investing lead advisors Manisha Samy and Maxx Chatsko share what they're watching at the upcoming American Society of Hematology annual conference. Dec 3, 2020 - By Manisha Samy Biotechnology Podcast Synthetic Biology’s “Window of Opportunity” with ConVergInce Advisers’ Joel Stone Can synthetic biology break the chemical industry's reliance on fossil fuels? Industry veteran Joel Stone shares how industrial biotech is changing consumer brands, energy, agriculture, and more. Dec 1, 2020 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for December 7investing lead advisor Maxx Chatsko's Top Stock for December is leading the energy transition, today and tomorrow. Dec 1, 2020 - By Maxx Chatsko Energy Premium Deep Dive Xcel Energy Deep Dive: December 2020 Dec 1, 2020 - By Maxx Chatsko Energy Article Lesson Learned: Great Technology Doesn’t Guarantee a Great Business Maxx explains the importance of separating promising technology from great business. Nov 22, 2020 - By Maxx Chatsko Premium Advisor Update Vaccines Are On the Way, but Winter is Coming Nov 15, 2020 - By Maxx Chatsko Healthcare Technology Premium Deep Dive Dicerna Pharmaceuticals Deep Dive: November 2020 Nov 1, 2020 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for November 7investing lead advisor Maxx Chatsko's November 2020 recommendation is an under-the-radar, small-cap living technologies company at the very beginning of its growth trajectory. Nov 1, 2020 - By Maxx Chatsko Biotechnology Podcast Will the Cannabis Industry Give Way to Biotech? 7investing Lead Advisor Maxx Chatsko talks with Kevin Chen, co-founder and CEO of Hyasynth Bio, about the cannabis industry and how industrial biotech could transform the production of cannabinoid... Oct 22, 2020 - By Maxx Chatsko Biotechnology Article Not Another Political Discussion Maxx argues why investors today would do well to zoom out for a bigger-picture view of the world. Oct 22, 2020 - By Maxx Chatsko Premium Advisor Update “Cell Therapy’s First-Mover Disadvantage” Oct 15, 2020 - By Maxx Chatsko Biotechnology Premium Deep Dive Avita Therapeutics Deep Dive: October 2020 Oct 8, 2020 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for October 7investing lead advisor Maxx Chatsko's October 2020 recommendation is an under-the-radar, small-cap living technologies company at the very beginning of its growth trajectory. Oct 1, 2020 - By Maxx Chatsko Biotechnology Join Now! Why 7investing? Why Should I Invest? Why 7investing? Our Team Our 7 Principles Our Mission Testimonials How It Works What to Expect Our Report Format Membership Details Frequently Asked Questions Recommendations Research Articles Advisor Updates Company Updates Videos Special Reports Podcast Livestream Contact Us General Inquiries Submit a Testimonial Interested in Chatting With 7investing? My Account Log In
Article The Many Paths to Portfolio Allocation Investing is personal, but Maxx Chatsko points out the many ways you can handle portfolio allocation. Mar 22, 2021 - By Maxx Chatsko Premium Advisor Update My Long-Term Strategy in a Volatile Market Mar 15, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Certara Deep Dive: March 2021 Mar 1, 2021 - By Maxx Chatsko Enterprise Software Video Maxx’s Top Stock for March 2021 Maxx's Top Stock for March 2021 is an enterprise software company driving the digital transformation of a massive global industry and saving customers billions of dollars. Mar 1, 2021 - By Maxx Chatsko Enterprise Software Podcast What FinTwit Isn’t Telling You About These Biotech Stocks When biotech stocks rise on stories alone, and those stories become detached from reality, then you might be subjecting your portfolio to unnecessary risk. 7investing Lead Advisors Manisha Samy and... Feb 23, 2021 - By Manisha Samy Biotechnology Article A Mission Statement is Easy. Execution is Difficult A mission statement is nice to have, but it too often becomes a marketing pitch. Progress, including within a company's mission, is more important for investors. Feb 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Most Investors Neglect One of Their Biggest Advantages Feb 14, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for February 2021 7investing Lead Advisor Maxx Chatsko's Top Stock for February is an early-stage biopharma attempting to fundamentally change drug discovery and drug development. Feb 1, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Relay Therapeutics Deep Dive: February 2021 Feb 1, 2021 - By Maxx Chatsko Biotechnology Article Genomics Isn’t the Only Omics Maxx discusses misconceptions surrounding one of the market's oft-used buzzwords. Jan 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Will Renewable Energy Soar During the Biden Administration? Jan 15, 2021 - By Maxx Chatsko Energy Podcast JPM 39th Annual Healthcare Conference: What We’re Watching The JPM 39th Annual Healthcare Conference is next week. 7investing Lead Advisors Simon Erickson, Manisha Samy, and Maxx Chatsko discuss what they're watching as investors (and science nerds) ahead of... Jan 7, 2021 - By Manisha Samy Biotechnology Premium Deep Dive Selecta Biosciences Deep Dive: January 2021 Jan 1, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for January 7investing Lead Advisor Maxx Chatsko's top stock to buy in January 2021 is a small-cap biopharma developing an important technology platform that could increase the value of gene therapies, genetic... Jan 1, 2021 - By Maxx Chatsko Biotechnology Article Does the “B” Word Apply? It’s Complicated Maxx Chatsko offers a glimpse into how he values development-stage biopharma stocks. Dec 22, 2020 - By Maxx Chatsko Biotechnology Premium Advisor Update The 7investing Recommendation That Wasn’t Dec 15, 2020 - By Maxx Chatsko Pharmaceuticals Podcast ASH Conference Preview: What We’re Watching 7investing lead advisors Manisha Samy and Maxx Chatsko share what they're watching at the upcoming American Society of Hematology annual conference. Dec 3, 2020 - By Manisha Samy Biotechnology Podcast Synthetic Biology’s “Window of Opportunity” with ConVergInce Advisers’ Joel Stone Can synthetic biology break the chemical industry's reliance on fossil fuels? Industry veteran Joel Stone shares how industrial biotech is changing consumer brands, energy, agriculture, and more. Dec 1, 2020 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for December 7investing lead advisor Maxx Chatsko's Top Stock for December is leading the energy transition, today and tomorrow. Dec 1, 2020 - By Maxx Chatsko Energy Premium Deep Dive Xcel Energy Deep Dive: December 2020 Dec 1, 2020 - By Maxx Chatsko Energy Article Lesson Learned: Great Technology Doesn’t Guarantee a Great Business Maxx explains the importance of separating promising technology from great business. Nov 22, 2020 - By Maxx Chatsko Premium Advisor Update Vaccines Are On the Way, but Winter is Coming Nov 15, 2020 - By Maxx Chatsko Healthcare Technology Premium Deep Dive Dicerna Pharmaceuticals Deep Dive: November 2020 Nov 1, 2020 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for November 7investing lead advisor Maxx Chatsko's November 2020 recommendation is an under-the-radar, small-cap living technologies company at the very beginning of its growth trajectory. Nov 1, 2020 - By Maxx Chatsko Biotechnology Podcast Will the Cannabis Industry Give Way to Biotech? 7investing Lead Advisor Maxx Chatsko talks with Kevin Chen, co-founder and CEO of Hyasynth Bio, about the cannabis industry and how industrial biotech could transform the production of cannabinoid... Oct 22, 2020 - By Maxx Chatsko Biotechnology Article Not Another Political Discussion Maxx argues why investors today would do well to zoom out for a bigger-picture view of the world. Oct 22, 2020 - By Maxx Chatsko Premium Advisor Update “Cell Therapy’s First-Mover Disadvantage” Oct 15, 2020 - By Maxx Chatsko Biotechnology Premium Deep Dive Avita Therapeutics Deep Dive: October 2020 Oct 8, 2020 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for October 7investing lead advisor Maxx Chatsko's October 2020 recommendation is an under-the-radar, small-cap living technologies company at the very beginning of its growth trajectory. Oct 1, 2020 - By Maxx Chatsko Biotechnology Join Now! Why 7investing? Why Should I Invest? Why 7investing? Our Team Our 7 Principles Our Mission Testimonials How It Works What to Expect Our Report Format Membership Details Frequently Asked Questions Recommendations Research Articles Advisor Updates Company Updates Videos Special Reports Podcast Livestream Contact Us General Inquiries Submit a Testimonial Interested in Chatting With 7investing? My Account Log In
Premium Advisor Update My Long-Term Strategy in a Volatile Market Mar 15, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Certara Deep Dive: March 2021 Mar 1, 2021 - By Maxx Chatsko Enterprise Software Video Maxx’s Top Stock for March 2021 Maxx's Top Stock for March 2021 is an enterprise software company driving the digital transformation of a massive global industry and saving customers billions of dollars. Mar 1, 2021 - By Maxx Chatsko Enterprise Software Podcast What FinTwit Isn’t Telling You About These Biotech Stocks When biotech stocks rise on stories alone, and those stories become detached from reality, then you might be subjecting your portfolio to unnecessary risk. 7investing Lead Advisors Manisha Samy and... Feb 23, 2021 - By Manisha Samy Biotechnology Article A Mission Statement is Easy. Execution is Difficult A mission statement is nice to have, but it too often becomes a marketing pitch. Progress, including within a company's mission, is more important for investors. Feb 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Most Investors Neglect One of Their Biggest Advantages Feb 14, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for February 2021 7investing Lead Advisor Maxx Chatsko's Top Stock for February is an early-stage biopharma attempting to fundamentally change drug discovery and drug development. Feb 1, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Relay Therapeutics Deep Dive: February 2021 Feb 1, 2021 - By Maxx Chatsko Biotechnology Article Genomics Isn’t the Only Omics Maxx discusses misconceptions surrounding one of the market's oft-used buzzwords. Jan 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Will Renewable Energy Soar During the Biden Administration? Jan 15, 2021 - By Maxx Chatsko Energy Podcast JPM 39th Annual Healthcare Conference: What We’re Watching The JPM 39th Annual Healthcare Conference is next week. 7investing Lead Advisors Simon Erickson, Manisha Samy, and Maxx Chatsko discuss what they're watching as investors (and science nerds) ahead of... Jan 7, 2021 - By Manisha Samy Biotechnology Premium Deep Dive Selecta Biosciences Deep Dive: January 2021 Jan 1, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for January 7investing Lead Advisor Maxx Chatsko's top stock to buy in January 2021 is a small-cap biopharma developing an important technology platform that could increase the value of gene therapies, genetic... Jan 1, 2021 - By Maxx Chatsko Biotechnology Article Does the “B” Word Apply? It’s Complicated Maxx Chatsko offers a glimpse into how he values development-stage biopharma stocks. Dec 22, 2020 - By Maxx Chatsko Biotechnology Premium Advisor Update The 7investing Recommendation That Wasn’t Dec 15, 2020 - By Maxx Chatsko Pharmaceuticals Podcast ASH Conference Preview: What We’re Watching 7investing lead advisors Manisha Samy and Maxx Chatsko share what they're watching at the upcoming American Society of Hematology annual conference. Dec 3, 2020 - By Manisha Samy Biotechnology Podcast Synthetic Biology’s “Window of Opportunity” with ConVergInce Advisers’ Joel Stone Can synthetic biology break the chemical industry's reliance on fossil fuels? Industry veteran Joel Stone shares how industrial biotech is changing consumer brands, energy, agriculture, and more. Dec 1, 2020 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for December 7investing lead advisor Maxx Chatsko's Top Stock for December is leading the energy transition, today and tomorrow. Dec 1, 2020 - By Maxx Chatsko Energy Premium Deep Dive Xcel Energy Deep Dive: December 2020 Dec 1, 2020 - By Maxx Chatsko Energy Article Lesson Learned: Great Technology Doesn’t Guarantee a Great Business Maxx explains the importance of separating promising technology from great business. Nov 22, 2020 - By Maxx Chatsko Premium Advisor Update Vaccines Are On the Way, but Winter is Coming Nov 15, 2020 - By Maxx Chatsko Healthcare Technology Premium Deep Dive Dicerna Pharmaceuticals Deep Dive: November 2020 Nov 1, 2020 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for November 7investing lead advisor Maxx Chatsko's November 2020 recommendation is an under-the-radar, small-cap living technologies company at the very beginning of its growth trajectory. Nov 1, 2020 - By Maxx Chatsko Biotechnology Podcast Will the Cannabis Industry Give Way to Biotech? 7investing Lead Advisor Maxx Chatsko talks with Kevin Chen, co-founder and CEO of Hyasynth Bio, about the cannabis industry and how industrial biotech could transform the production of cannabinoid... Oct 22, 2020 - By Maxx Chatsko Biotechnology Article Not Another Political Discussion Maxx argues why investors today would do well to zoom out for a bigger-picture view of the world. Oct 22, 2020 - By Maxx Chatsko Premium Advisor Update “Cell Therapy’s First-Mover Disadvantage” Oct 15, 2020 - By Maxx Chatsko Biotechnology Premium Deep Dive Avita Therapeutics Deep Dive: October 2020 Oct 8, 2020 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for October 7investing lead advisor Maxx Chatsko's October 2020 recommendation is an under-the-radar, small-cap living technologies company at the very beginning of its growth trajectory. Oct 1, 2020 - By Maxx Chatsko Biotechnology Join Now! Why 7investing? Why Should I Invest? Why 7investing? Our Team Our 7 Principles Our Mission Testimonials How It Works What to Expect Our Report Format Membership Details Frequently Asked Questions Recommendations Research Articles Advisor Updates Company Updates Videos Special Reports Podcast Livestream Contact Us General Inquiries Submit a Testimonial Interested in Chatting With 7investing? My Account Log In
Premium Deep Dive Certara Deep Dive: March 2021 Mar 1, 2021 - By Maxx Chatsko Enterprise Software Video Maxx’s Top Stock for March 2021 Maxx's Top Stock for March 2021 is an enterprise software company driving the digital transformation of a massive global industry and saving customers billions of dollars. Mar 1, 2021 - By Maxx Chatsko Enterprise Software Podcast What FinTwit Isn’t Telling You About These Biotech Stocks When biotech stocks rise on stories alone, and those stories become detached from reality, then you might be subjecting your portfolio to unnecessary risk. 7investing Lead Advisors Manisha Samy and... Feb 23, 2021 - By Manisha Samy Biotechnology Article A Mission Statement is Easy. Execution is Difficult A mission statement is nice to have, but it too often becomes a marketing pitch. Progress, including within a company's mission, is more important for investors. Feb 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Most Investors Neglect One of Their Biggest Advantages Feb 14, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for February 2021 7investing Lead Advisor Maxx Chatsko's Top Stock for February is an early-stage biopharma attempting to fundamentally change drug discovery and drug development. Feb 1, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Relay Therapeutics Deep Dive: February 2021 Feb 1, 2021 - By Maxx Chatsko Biotechnology Article Genomics Isn’t the Only Omics Maxx discusses misconceptions surrounding one of the market's oft-used buzzwords. Jan 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Will Renewable Energy Soar During the Biden Administration? Jan 15, 2021 - By Maxx Chatsko Energy Podcast JPM 39th Annual Healthcare Conference: What We’re Watching The JPM 39th Annual Healthcare Conference is next week. 7investing Lead Advisors Simon Erickson, Manisha Samy, and Maxx Chatsko discuss what they're watching as investors (and science nerds) ahead of... Jan 7, 2021 - By Manisha Samy Biotechnology Premium Deep Dive Selecta Biosciences Deep Dive: January 2021 Jan 1, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for January 7investing Lead Advisor Maxx Chatsko's top stock to buy in January 2021 is a small-cap biopharma developing an important technology platform that could increase the value of gene therapies, genetic... Jan 1, 2021 - By Maxx Chatsko Biotechnology Article Does the “B” Word Apply? It’s Complicated Maxx Chatsko offers a glimpse into how he values development-stage biopharma stocks. Dec 22, 2020 - By Maxx Chatsko Biotechnology Premium Advisor Update The 7investing Recommendation That Wasn’t Dec 15, 2020 - By Maxx Chatsko Pharmaceuticals Podcast ASH Conference Preview: What We’re Watching 7investing lead advisors Manisha Samy and Maxx Chatsko share what they're watching at the upcoming American Society of Hematology annual conference. Dec 3, 2020 - By Manisha Samy Biotechnology Podcast Synthetic Biology’s “Window of Opportunity” with ConVergInce Advisers’ Joel Stone Can synthetic biology break the chemical industry's reliance on fossil fuels? Industry veteran Joel Stone shares how industrial biotech is changing consumer brands, energy, agriculture, and more. Dec 1, 2020 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for December 7investing lead advisor Maxx Chatsko's Top Stock for December is leading the energy transition, today and tomorrow. Dec 1, 2020 - By Maxx Chatsko Energy Premium Deep Dive Xcel Energy Deep Dive: December 2020 Dec 1, 2020 - By Maxx Chatsko Energy Article Lesson Learned: Great Technology Doesn’t Guarantee a Great Business Maxx explains the importance of separating promising technology from great business. Nov 22, 2020 - By Maxx Chatsko Premium Advisor Update Vaccines Are On the Way, but Winter is Coming Nov 15, 2020 - By Maxx Chatsko Healthcare Technology Premium Deep Dive Dicerna Pharmaceuticals Deep Dive: November 2020 Nov 1, 2020 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for November 7investing lead advisor Maxx Chatsko's November 2020 recommendation is an under-the-radar, small-cap living technologies company at the very beginning of its growth trajectory. Nov 1, 2020 - By Maxx Chatsko Biotechnology Podcast Will the Cannabis Industry Give Way to Biotech? 7investing Lead Advisor Maxx Chatsko talks with Kevin Chen, co-founder and CEO of Hyasynth Bio, about the cannabis industry and how industrial biotech could transform the production of cannabinoid... Oct 22, 2020 - By Maxx Chatsko Biotechnology Article Not Another Political Discussion Maxx argues why investors today would do well to zoom out for a bigger-picture view of the world. Oct 22, 2020 - By Maxx Chatsko Premium Advisor Update “Cell Therapy’s First-Mover Disadvantage” Oct 15, 2020 - By Maxx Chatsko Biotechnology Premium Deep Dive Avita Therapeutics Deep Dive: October 2020 Oct 8, 2020 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for October 7investing lead advisor Maxx Chatsko's October 2020 recommendation is an under-the-radar, small-cap living technologies company at the very beginning of its growth trajectory. Oct 1, 2020 - By Maxx Chatsko Biotechnology Join Now! Why 7investing? Why Should I Invest? Why 7investing? Our Team Our 7 Principles Our Mission Testimonials How It Works What to Expect Our Report Format Membership Details Frequently Asked Questions Recommendations Research Articles Advisor Updates Company Updates Videos Special Reports Podcast Livestream Contact Us General Inquiries Submit a Testimonial Interested in Chatting With 7investing? My Account Log In
Video Maxx’s Top Stock for March 2021 Maxx's Top Stock for March 2021 is an enterprise software company driving the digital transformation of a massive global industry and saving customers billions of dollars. Mar 1, 2021 - By Maxx Chatsko Enterprise Software Podcast What FinTwit Isn’t Telling You About These Biotech Stocks When biotech stocks rise on stories alone, and those stories become detached from reality, then you might be subjecting your portfolio to unnecessary risk. 7investing Lead Advisors Manisha Samy and... Feb 23, 2021 - By Manisha Samy Biotechnology Article A Mission Statement is Easy. Execution is Difficult A mission statement is nice to have, but it too often becomes a marketing pitch. Progress, including within a company's mission, is more important for investors. Feb 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Most Investors Neglect One of Their Biggest Advantages Feb 14, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for February 2021 7investing Lead Advisor Maxx Chatsko's Top Stock for February is an early-stage biopharma attempting to fundamentally change drug discovery and drug development. Feb 1, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Relay Therapeutics Deep Dive: February 2021 Feb 1, 2021 - By Maxx Chatsko Biotechnology Article Genomics Isn’t the Only Omics Maxx discusses misconceptions surrounding one of the market's oft-used buzzwords. Jan 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Will Renewable Energy Soar During the Biden Administration? Jan 15, 2021 - By Maxx Chatsko Energy Podcast JPM 39th Annual Healthcare Conference: What We’re Watching The JPM 39th Annual Healthcare Conference is next week. 7investing Lead Advisors Simon Erickson, Manisha Samy, and Maxx Chatsko discuss what they're watching as investors (and science nerds) ahead of... Jan 7, 2021 - By Manisha Samy Biotechnology Premium Deep Dive Selecta Biosciences Deep Dive: January 2021 Jan 1, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for January 7investing Lead Advisor Maxx Chatsko's top stock to buy in January 2021 is a small-cap biopharma developing an important technology platform that could increase the value of gene therapies, genetic... Jan 1, 2021 - By Maxx Chatsko Biotechnology Article Does the “B” Word Apply? It’s Complicated Maxx Chatsko offers a glimpse into how he values development-stage biopharma stocks. Dec 22, 2020 - By Maxx Chatsko Biotechnology Premium Advisor Update The 7investing Recommendation That Wasn’t Dec 15, 2020 - By Maxx Chatsko Pharmaceuticals Podcast ASH Conference Preview: What We’re Watching 7investing lead advisors Manisha Samy and Maxx Chatsko share what they're watching at the upcoming American Society of Hematology annual conference. Dec 3, 2020 - By Manisha Samy Biotechnology Podcast Synthetic Biology’s “Window of Opportunity” with ConVergInce Advisers’ Joel Stone Can synthetic biology break the chemical industry's reliance on fossil fuels? Industry veteran Joel Stone shares how industrial biotech is changing consumer brands, energy, agriculture, and more. Dec 1, 2020 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for December 7investing lead advisor Maxx Chatsko's Top Stock for December is leading the energy transition, today and tomorrow. Dec 1, 2020 - By Maxx Chatsko Energy Premium Deep Dive Xcel Energy Deep Dive: December 2020 Dec 1, 2020 - By Maxx Chatsko Energy Article Lesson Learned: Great Technology Doesn’t Guarantee a Great Business Maxx explains the importance of separating promising technology from great business. Nov 22, 2020 - By Maxx Chatsko Premium Advisor Update Vaccines Are On the Way, but Winter is Coming Nov 15, 2020 - By Maxx Chatsko Healthcare Technology Premium Deep Dive Dicerna Pharmaceuticals Deep Dive: November 2020 Nov 1, 2020 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for November 7investing lead advisor Maxx Chatsko's November 2020 recommendation is an under-the-radar, small-cap living technologies company at the very beginning of its growth trajectory. Nov 1, 2020 - By Maxx Chatsko Biotechnology Podcast Will the Cannabis Industry Give Way to Biotech? 7investing Lead Advisor Maxx Chatsko talks with Kevin Chen, co-founder and CEO of Hyasynth Bio, about the cannabis industry and how industrial biotech could transform the production of cannabinoid... Oct 22, 2020 - By Maxx Chatsko Biotechnology Article Not Another Political Discussion Maxx argues why investors today would do well to zoom out for a bigger-picture view of the world. Oct 22, 2020 - By Maxx Chatsko Premium Advisor Update “Cell Therapy’s First-Mover Disadvantage” Oct 15, 2020 - By Maxx Chatsko Biotechnology Premium Deep Dive Avita Therapeutics Deep Dive: October 2020 Oct 8, 2020 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for October 7investing lead advisor Maxx Chatsko's October 2020 recommendation is an under-the-radar, small-cap living technologies company at the very beginning of its growth trajectory. Oct 1, 2020 - By Maxx Chatsko Biotechnology Join Now! Why 7investing? Why Should I Invest? Why 7investing? Our Team Our 7 Principles Our Mission Testimonials How It Works What to Expect Our Report Format Membership Details Frequently Asked Questions Recommendations Research Articles Advisor Updates Company Updates Videos Special Reports Podcast Livestream Contact Us General Inquiries Submit a Testimonial Interested in Chatting With 7investing? My Account Log In
Podcast What FinTwit Isn’t Telling You About These Biotech Stocks When biotech stocks rise on stories alone, and those stories become detached from reality, then you might be subjecting your portfolio to unnecessary risk. 7investing Lead Advisors Manisha Samy and... Feb 23, 2021 - By Manisha Samy Biotechnology Article A Mission Statement is Easy. Execution is Difficult A mission statement is nice to have, but it too often becomes a marketing pitch. Progress, including within a company's mission, is more important for investors. Feb 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Most Investors Neglect One of Their Biggest Advantages Feb 14, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for February 2021 7investing Lead Advisor Maxx Chatsko's Top Stock for February is an early-stage biopharma attempting to fundamentally change drug discovery and drug development. Feb 1, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Relay Therapeutics Deep Dive: February 2021 Feb 1, 2021 - By Maxx Chatsko Biotechnology Article Genomics Isn’t the Only Omics Maxx discusses misconceptions surrounding one of the market's oft-used buzzwords. Jan 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Will Renewable Energy Soar During the Biden Administration? Jan 15, 2021 - By Maxx Chatsko Energy Podcast JPM 39th Annual Healthcare Conference: What We’re Watching The JPM 39th Annual Healthcare Conference is next week. 7investing Lead Advisors Simon Erickson, Manisha Samy, and Maxx Chatsko discuss what they're watching as investors (and science nerds) ahead of... Jan 7, 2021 - By Manisha Samy Biotechnology Premium Deep Dive Selecta Biosciences Deep Dive: January 2021 Jan 1, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for January 7investing Lead Advisor Maxx Chatsko's top stock to buy in January 2021 is a small-cap biopharma developing an important technology platform that could increase the value of gene therapies, genetic... Jan 1, 2021 - By Maxx Chatsko Biotechnology Article Does the “B” Word Apply? It’s Complicated Maxx Chatsko offers a glimpse into how he values development-stage biopharma stocks. Dec 22, 2020 - By Maxx Chatsko Biotechnology Premium Advisor Update The 7investing Recommendation That Wasn’t Dec 15, 2020 - By Maxx Chatsko Pharmaceuticals Podcast ASH Conference Preview: What We’re Watching 7investing lead advisors Manisha Samy and Maxx Chatsko share what they're watching at the upcoming American Society of Hematology annual conference. Dec 3, 2020 - By Manisha Samy Biotechnology Podcast Synthetic Biology’s “Window of Opportunity” with ConVergInce Advisers’ Joel Stone Can synthetic biology break the chemical industry's reliance on fossil fuels? Industry veteran Joel Stone shares how industrial biotech is changing consumer brands, energy, agriculture, and more. Dec 1, 2020 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for December 7investing lead advisor Maxx Chatsko's Top Stock for December is leading the energy transition, today and tomorrow. Dec 1, 2020 - By Maxx Chatsko Energy Premium Deep Dive Xcel Energy Deep Dive: December 2020 Dec 1, 2020 - By Maxx Chatsko Energy Article Lesson Learned: Great Technology Doesn’t Guarantee a Great Business Maxx explains the importance of separating promising technology from great business. Nov 22, 2020 - By Maxx Chatsko Premium Advisor Update Vaccines Are On the Way, but Winter is Coming Nov 15, 2020 - By Maxx Chatsko Healthcare Technology Premium Deep Dive Dicerna Pharmaceuticals Deep Dive: November 2020 Nov 1, 2020 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for November 7investing lead advisor Maxx Chatsko's November 2020 recommendation is an under-the-radar, small-cap living technologies company at the very beginning of its growth trajectory. Nov 1, 2020 - By Maxx Chatsko Biotechnology Podcast Will the Cannabis Industry Give Way to Biotech? 7investing Lead Advisor Maxx Chatsko talks with Kevin Chen, co-founder and CEO of Hyasynth Bio, about the cannabis industry and how industrial biotech could transform the production of cannabinoid... Oct 22, 2020 - By Maxx Chatsko Biotechnology Article Not Another Political Discussion Maxx argues why investors today would do well to zoom out for a bigger-picture view of the world. Oct 22, 2020 - By Maxx Chatsko Premium Advisor Update “Cell Therapy’s First-Mover Disadvantage” Oct 15, 2020 - By Maxx Chatsko Biotechnology Premium Deep Dive Avita Therapeutics Deep Dive: October 2020 Oct 8, 2020 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for October 7investing lead advisor Maxx Chatsko's October 2020 recommendation is an under-the-radar, small-cap living technologies company at the very beginning of its growth trajectory. Oct 1, 2020 - By Maxx Chatsko Biotechnology Join Now! Why 7investing? Why Should I Invest? Why 7investing? Our Team Our 7 Principles Our Mission Testimonials How It Works What to Expect Our Report Format Membership Details Frequently Asked Questions Recommendations Research Articles Advisor Updates Company Updates Videos Special Reports Podcast Livestream Contact Us General Inquiries Submit a Testimonial Interested in Chatting With 7investing? My Account Log In
Article A Mission Statement is Easy. Execution is Difficult A mission statement is nice to have, but it too often becomes a marketing pitch. Progress, including within a company's mission, is more important for investors. Feb 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Most Investors Neglect One of Their Biggest Advantages Feb 14, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for February 2021 7investing Lead Advisor Maxx Chatsko's Top Stock for February is an early-stage biopharma attempting to fundamentally change drug discovery and drug development. Feb 1, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Relay Therapeutics Deep Dive: February 2021 Feb 1, 2021 - By Maxx Chatsko Biotechnology Article Genomics Isn’t the Only Omics Maxx discusses misconceptions surrounding one of the market's oft-used buzzwords. Jan 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Will Renewable Energy Soar During the Biden Administration? Jan 15, 2021 - By Maxx Chatsko Energy Podcast JPM 39th Annual Healthcare Conference: What We’re Watching The JPM 39th Annual Healthcare Conference is next week. 7investing Lead Advisors Simon Erickson, Manisha Samy, and Maxx Chatsko discuss what they're watching as investors (and science nerds) ahead of... Jan 7, 2021 - By Manisha Samy Biotechnology Premium Deep Dive Selecta Biosciences Deep Dive: January 2021 Jan 1, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for January 7investing Lead Advisor Maxx Chatsko's top stock to buy in January 2021 is a small-cap biopharma developing an important technology platform that could increase the value of gene therapies, genetic... Jan 1, 2021 - By Maxx Chatsko Biotechnology Article Does the “B” Word Apply? It’s Complicated Maxx Chatsko offers a glimpse into how he values development-stage biopharma stocks. Dec 22, 2020 - By Maxx Chatsko Biotechnology Premium Advisor Update The 7investing Recommendation That Wasn’t Dec 15, 2020 - By Maxx Chatsko Pharmaceuticals Podcast ASH Conference Preview: What We’re Watching 7investing lead advisors Manisha Samy and Maxx Chatsko share what they're watching at the upcoming American Society of Hematology annual conference. Dec 3, 2020 - By Manisha Samy Biotechnology Podcast Synthetic Biology’s “Window of Opportunity” with ConVergInce Advisers’ Joel Stone Can synthetic biology break the chemical industry's reliance on fossil fuels? Industry veteran Joel Stone shares how industrial biotech is changing consumer brands, energy, agriculture, and more. Dec 1, 2020 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for December 7investing lead advisor Maxx Chatsko's Top Stock for December is leading the energy transition, today and tomorrow. Dec 1, 2020 - By Maxx Chatsko Energy Premium Deep Dive Xcel Energy Deep Dive: December 2020 Dec 1, 2020 - By Maxx Chatsko Energy Article Lesson Learned: Great Technology Doesn’t Guarantee a Great Business Maxx explains the importance of separating promising technology from great business. Nov 22, 2020 - By Maxx Chatsko Premium Advisor Update Vaccines Are On the Way, but Winter is Coming Nov 15, 2020 - By Maxx Chatsko Healthcare Technology Premium Deep Dive Dicerna Pharmaceuticals Deep Dive: November 2020 Nov 1, 2020 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for November 7investing lead advisor Maxx Chatsko's November 2020 recommendation is an under-the-radar, small-cap living technologies company at the very beginning of its growth trajectory. Nov 1, 2020 - By Maxx Chatsko Biotechnology Podcast Will the Cannabis Industry Give Way to Biotech? 7investing Lead Advisor Maxx Chatsko talks with Kevin Chen, co-founder and CEO of Hyasynth Bio, about the cannabis industry and how industrial biotech could transform the production of cannabinoid... Oct 22, 2020 - By Maxx Chatsko Biotechnology Article Not Another Political Discussion Maxx argues why investors today would do well to zoom out for a bigger-picture view of the world. Oct 22, 2020 - By Maxx Chatsko Premium Advisor Update “Cell Therapy’s First-Mover Disadvantage” Oct 15, 2020 - By Maxx Chatsko Biotechnology Premium Deep Dive Avita Therapeutics Deep Dive: October 2020 Oct 8, 2020 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for October 7investing lead advisor Maxx Chatsko's October 2020 recommendation is an under-the-radar, small-cap living technologies company at the very beginning of its growth trajectory. Oct 1, 2020 - By Maxx Chatsko Biotechnology Join Now! Why 7investing? Why Should I Invest? Why 7investing? Our Team Our 7 Principles Our Mission Testimonials How It Works What to Expect Our Report Format Membership Details Frequently Asked Questions Recommendations Research Articles Advisor Updates Company Updates Videos Special Reports Podcast Livestream Contact Us General Inquiries Submit a Testimonial Interested in Chatting With 7investing? My Account Log In
Premium Advisor Update Most Investors Neglect One of Their Biggest Advantages Feb 14, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for February 2021 7investing Lead Advisor Maxx Chatsko's Top Stock for February is an early-stage biopharma attempting to fundamentally change drug discovery and drug development. Feb 1, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Relay Therapeutics Deep Dive: February 2021 Feb 1, 2021 - By Maxx Chatsko Biotechnology Article Genomics Isn’t the Only Omics Maxx discusses misconceptions surrounding one of the market's oft-used buzzwords. Jan 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Will Renewable Energy Soar During the Biden Administration? Jan 15, 2021 - By Maxx Chatsko Energy Podcast JPM 39th Annual Healthcare Conference: What We’re Watching The JPM 39th Annual Healthcare Conference is next week. 7investing Lead Advisors Simon Erickson, Manisha Samy, and Maxx Chatsko discuss what they're watching as investors (and science nerds) ahead of... Jan 7, 2021 - By Manisha Samy Biotechnology Premium Deep Dive Selecta Biosciences Deep Dive: January 2021 Jan 1, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for January 7investing Lead Advisor Maxx Chatsko's top stock to buy in January 2021 is a small-cap biopharma developing an important technology platform that could increase the value of gene therapies, genetic... Jan 1, 2021 - By Maxx Chatsko Biotechnology Article Does the “B” Word Apply? It’s Complicated Maxx Chatsko offers a glimpse into how he values development-stage biopharma stocks. Dec 22, 2020 - By Maxx Chatsko Biotechnology Premium Advisor Update The 7investing Recommendation That Wasn’t Dec 15, 2020 - By Maxx Chatsko Pharmaceuticals Podcast ASH Conference Preview: What We’re Watching 7investing lead advisors Manisha Samy and Maxx Chatsko share what they're watching at the upcoming American Society of Hematology annual conference. Dec 3, 2020 - By Manisha Samy Biotechnology Podcast Synthetic Biology’s “Window of Opportunity” with ConVergInce Advisers’ Joel Stone Can synthetic biology break the chemical industry's reliance on fossil fuels? Industry veteran Joel Stone shares how industrial biotech is changing consumer brands, energy, agriculture, and more. Dec 1, 2020 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for December 7investing lead advisor Maxx Chatsko's Top Stock for December is leading the energy transition, today and tomorrow. Dec 1, 2020 - By Maxx Chatsko Energy Premium Deep Dive Xcel Energy Deep Dive: December 2020 Dec 1, 2020 - By Maxx Chatsko Energy Article Lesson Learned: Great Technology Doesn’t Guarantee a Great Business Maxx explains the importance of separating promising technology from great business. Nov 22, 2020 - By Maxx Chatsko Premium Advisor Update Vaccines Are On the Way, but Winter is Coming Nov 15, 2020 - By Maxx Chatsko Healthcare Technology Premium Deep Dive Dicerna Pharmaceuticals Deep Dive: November 2020 Nov 1, 2020 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for November 7investing lead advisor Maxx Chatsko's November 2020 recommendation is an under-the-radar, small-cap living technologies company at the very beginning of its growth trajectory. Nov 1, 2020 - By Maxx Chatsko Biotechnology Podcast Will the Cannabis Industry Give Way to Biotech? 7investing Lead Advisor Maxx Chatsko talks with Kevin Chen, co-founder and CEO of Hyasynth Bio, about the cannabis industry and how industrial biotech could transform the production of cannabinoid... Oct 22, 2020 - By Maxx Chatsko Biotechnology Article Not Another Political Discussion Maxx argues why investors today would do well to zoom out for a bigger-picture view of the world. Oct 22, 2020 - By Maxx Chatsko Premium Advisor Update “Cell Therapy’s First-Mover Disadvantage” Oct 15, 2020 - By Maxx Chatsko Biotechnology Premium Deep Dive Avita Therapeutics Deep Dive: October 2020 Oct 8, 2020 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for October 7investing lead advisor Maxx Chatsko's October 2020 recommendation is an under-the-radar, small-cap living technologies company at the very beginning of its growth trajectory. Oct 1, 2020 - By Maxx Chatsko Biotechnology Join Now! Why 7investing? Why Should I Invest? Why 7investing? Our Team Our 7 Principles Our Mission Testimonials How It Works What to Expect Our Report Format Membership Details Frequently Asked Questions Recommendations Research Articles Advisor Updates Company Updates Videos Special Reports Podcast Livestream Contact Us General Inquiries Submit a Testimonial Interested in Chatting With 7investing? My Account Log In
Video Maxx’s Top Stock for February 2021 7investing Lead Advisor Maxx Chatsko's Top Stock for February is an early-stage biopharma attempting to fundamentally change drug discovery and drug development. Feb 1, 2021 - By Maxx Chatsko Biotechnology Premium Deep Dive Relay Therapeutics Deep Dive: February 2021 Feb 1, 2021 - By Maxx Chatsko Biotechnology Article Genomics Isn’t the Only Omics Maxx discusses misconceptions surrounding one of the market's oft-used buzzwords. Jan 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Will Renewable Energy Soar During the Biden Administration? Jan 15, 2021 - By Maxx Chatsko Energy Podcast JPM 39th Annual Healthcare Conference: What We’re Watching The JPM 39th Annual Healthcare Conference is next week. 7investing Lead Advisors Simon Erickson, Manisha Samy, and Maxx Chatsko discuss what they're watching as investors (and science nerds) ahead of... Jan 7, 2021 - By Manisha Samy Biotechnology Premium Deep Dive Selecta Biosciences Deep Dive: January 2021 Jan 1, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for January 7investing Lead Advisor Maxx Chatsko's top stock to buy in January 2021 is a small-cap biopharma developing an important technology platform that could increase the value of gene therapies, genetic... Jan 1, 2021 - By Maxx Chatsko Biotechnology Article Does the “B” Word Apply? It’s Complicated Maxx Chatsko offers a glimpse into how he values development-stage biopharma stocks. Dec 22, 2020 - By Maxx Chatsko Biotechnology Premium Advisor Update The 7investing Recommendation That Wasn’t Dec 15, 2020 - By Maxx Chatsko Pharmaceuticals Podcast ASH Conference Preview: What We’re Watching 7investing lead advisors Manisha Samy and Maxx Chatsko share what they're watching at the upcoming American Society of Hematology annual conference. Dec 3, 2020 - By Manisha Samy Biotechnology Podcast Synthetic Biology’s “Window of Opportunity” with ConVergInce Advisers’ Joel Stone Can synthetic biology break the chemical industry's reliance on fossil fuels? Industry veteran Joel Stone shares how industrial biotech is changing consumer brands, energy, agriculture, and more. Dec 1, 2020 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for December 7investing lead advisor Maxx Chatsko's Top Stock for December is leading the energy transition, today and tomorrow. Dec 1, 2020 - By Maxx Chatsko Energy Premium Deep Dive Xcel Energy Deep Dive: December 2020 Dec 1, 2020 - By Maxx Chatsko Energy Article Lesson Learned: Great Technology Doesn’t Guarantee a Great Business Maxx explains the importance of separating promising technology from great business. Nov 22, 2020 - By Maxx Chatsko Premium Advisor Update Vaccines Are On the Way, but Winter is Coming Nov 15, 2020 - By Maxx Chatsko Healthcare Technology Premium Deep Dive Dicerna Pharmaceuticals Deep Dive: November 2020 Nov 1, 2020 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for November 7investing lead advisor Maxx Chatsko's November 2020 recommendation is an under-the-radar, small-cap living technologies company at the very beginning of its growth trajectory. Nov 1, 2020 - By Maxx Chatsko Biotechnology Podcast Will the Cannabis Industry Give Way to Biotech? 7investing Lead Advisor Maxx Chatsko talks with Kevin Chen, co-founder and CEO of Hyasynth Bio, about the cannabis industry and how industrial biotech could transform the production of cannabinoid... Oct 22, 2020 - By Maxx Chatsko Biotechnology Article Not Another Political Discussion Maxx argues why investors today would do well to zoom out for a bigger-picture view of the world. Oct 22, 2020 - By Maxx Chatsko Premium Advisor Update “Cell Therapy’s First-Mover Disadvantage” Oct 15, 2020 - By Maxx Chatsko Biotechnology Premium Deep Dive Avita Therapeutics Deep Dive: October 2020 Oct 8, 2020 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for October 7investing lead advisor Maxx Chatsko's October 2020 recommendation is an under-the-radar, small-cap living technologies company at the very beginning of its growth trajectory. Oct 1, 2020 - By Maxx Chatsko Biotechnology Join Now! Why 7investing? Why Should I Invest? Why 7investing? Our Team Our 7 Principles Our Mission Testimonials How It Works What to Expect Our Report Format Membership Details Frequently Asked Questions Recommendations Research Articles Advisor Updates Company Updates Videos Special Reports Podcast Livestream Contact Us General Inquiries Submit a Testimonial Interested in Chatting With 7investing? My Account Log In
Premium Deep Dive Relay Therapeutics Deep Dive: February 2021 Feb 1, 2021 - By Maxx Chatsko Biotechnology Article Genomics Isn’t the Only Omics Maxx discusses misconceptions surrounding one of the market's oft-used buzzwords. Jan 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Will Renewable Energy Soar During the Biden Administration? Jan 15, 2021 - By Maxx Chatsko Energy Podcast JPM 39th Annual Healthcare Conference: What We’re Watching The JPM 39th Annual Healthcare Conference is next week. 7investing Lead Advisors Simon Erickson, Manisha Samy, and Maxx Chatsko discuss what they're watching as investors (and science nerds) ahead of... Jan 7, 2021 - By Manisha Samy Biotechnology Premium Deep Dive Selecta Biosciences Deep Dive: January 2021 Jan 1, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for January 7investing Lead Advisor Maxx Chatsko's top stock to buy in January 2021 is a small-cap biopharma developing an important technology platform that could increase the value of gene therapies, genetic... Jan 1, 2021 - By Maxx Chatsko Biotechnology Article Does the “B” Word Apply? It’s Complicated Maxx Chatsko offers a glimpse into how he values development-stage biopharma stocks. Dec 22, 2020 - By Maxx Chatsko Biotechnology Premium Advisor Update The 7investing Recommendation That Wasn’t Dec 15, 2020 - By Maxx Chatsko Pharmaceuticals Podcast ASH Conference Preview: What We’re Watching 7investing lead advisors Manisha Samy and Maxx Chatsko share what they're watching at the upcoming American Society of Hematology annual conference. Dec 3, 2020 - By Manisha Samy Biotechnology Podcast Synthetic Biology’s “Window of Opportunity” with ConVergInce Advisers’ Joel Stone Can synthetic biology break the chemical industry's reliance on fossil fuels? Industry veteran Joel Stone shares how industrial biotech is changing consumer brands, energy, agriculture, and more. Dec 1, 2020 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for December 7investing lead advisor Maxx Chatsko's Top Stock for December is leading the energy transition, today and tomorrow. Dec 1, 2020 - By Maxx Chatsko Energy Premium Deep Dive Xcel Energy Deep Dive: December 2020 Dec 1, 2020 - By Maxx Chatsko Energy Article Lesson Learned: Great Technology Doesn’t Guarantee a Great Business Maxx explains the importance of separating promising technology from great business. Nov 22, 2020 - By Maxx Chatsko Premium Advisor Update Vaccines Are On the Way, but Winter is Coming Nov 15, 2020 - By Maxx Chatsko Healthcare Technology Premium Deep Dive Dicerna Pharmaceuticals Deep Dive: November 2020 Nov 1, 2020 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for November 7investing lead advisor Maxx Chatsko's November 2020 recommendation is an under-the-radar, small-cap living technologies company at the very beginning of its growth trajectory. Nov 1, 2020 - By Maxx Chatsko Biotechnology Podcast Will the Cannabis Industry Give Way to Biotech? 7investing Lead Advisor Maxx Chatsko talks with Kevin Chen, co-founder and CEO of Hyasynth Bio, about the cannabis industry and how industrial biotech could transform the production of cannabinoid... Oct 22, 2020 - By Maxx Chatsko Biotechnology Article Not Another Political Discussion Maxx argues why investors today would do well to zoom out for a bigger-picture view of the world. Oct 22, 2020 - By Maxx Chatsko Premium Advisor Update “Cell Therapy’s First-Mover Disadvantage” Oct 15, 2020 - By Maxx Chatsko Biotechnology Premium Deep Dive Avita Therapeutics Deep Dive: October 2020 Oct 8, 2020 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for October 7investing lead advisor Maxx Chatsko's October 2020 recommendation is an under-the-radar, small-cap living technologies company at the very beginning of its growth trajectory. Oct 1, 2020 - By Maxx Chatsko Biotechnology Join Now! Why 7investing? Why Should I Invest? Why 7investing? Our Team Our 7 Principles Our Mission Testimonials How It Works What to Expect Our Report Format Membership Details Frequently Asked Questions Recommendations Research Articles Advisor Updates Company Updates Videos Special Reports Podcast Livestream Contact Us General Inquiries Submit a Testimonial Interested in Chatting With 7investing? My Account Log In
Article Genomics Isn’t the Only Omics Maxx discusses misconceptions surrounding one of the market's oft-used buzzwords. Jan 22, 2021 - By Maxx Chatsko Biotechnology Premium Advisor Update Will Renewable Energy Soar During the Biden Administration? Jan 15, 2021 - By Maxx Chatsko Energy Podcast JPM 39th Annual Healthcare Conference: What We’re Watching The JPM 39th Annual Healthcare Conference is next week. 7investing Lead Advisors Simon Erickson, Manisha Samy, and Maxx Chatsko discuss what they're watching as investors (and science nerds) ahead of... Jan 7, 2021 - By Manisha Samy Biotechnology Premium Deep Dive Selecta Biosciences Deep Dive: January 2021 Jan 1, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for January 7investing Lead Advisor Maxx Chatsko's top stock to buy in January 2021 is a small-cap biopharma developing an important technology platform that could increase the value of gene therapies, genetic... Jan 1, 2021 - By Maxx Chatsko Biotechnology Article Does the “B” Word Apply? It’s Complicated Maxx Chatsko offers a glimpse into how he values development-stage biopharma stocks. Dec 22, 2020 - By Maxx Chatsko Biotechnology Premium Advisor Update The 7investing Recommendation That Wasn’t Dec 15, 2020 - By Maxx Chatsko Pharmaceuticals Podcast ASH Conference Preview: What We’re Watching 7investing lead advisors Manisha Samy and Maxx Chatsko share what they're watching at the upcoming American Society of Hematology annual conference. Dec 3, 2020 - By Manisha Samy Biotechnology Podcast Synthetic Biology’s “Window of Opportunity” with ConVergInce Advisers’ Joel Stone Can synthetic biology break the chemical industry's reliance on fossil fuels? Industry veteran Joel Stone shares how industrial biotech is changing consumer brands, energy, agriculture, and more. Dec 1, 2020 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for December 7investing lead advisor Maxx Chatsko's Top Stock for December is leading the energy transition, today and tomorrow. Dec 1, 2020 - By Maxx Chatsko Energy Premium Deep Dive Xcel Energy Deep Dive: December 2020 Dec 1, 2020 - By Maxx Chatsko Energy Article Lesson Learned: Great Technology Doesn’t Guarantee a Great Business Maxx explains the importance of separating promising technology from great business. Nov 22, 2020 - By Maxx Chatsko Premium Advisor Update Vaccines Are On the Way, but Winter is Coming Nov 15, 2020 - By Maxx Chatsko Healthcare Technology Premium Deep Dive Dicerna Pharmaceuticals Deep Dive: November 2020 Nov 1, 2020 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for November 7investing lead advisor Maxx Chatsko's November 2020 recommendation is an under-the-radar, small-cap living technologies company at the very beginning of its growth trajectory. Nov 1, 2020 - By Maxx Chatsko Biotechnology Podcast Will the Cannabis Industry Give Way to Biotech? 7investing Lead Advisor Maxx Chatsko talks with Kevin Chen, co-founder and CEO of Hyasynth Bio, about the cannabis industry and how industrial biotech could transform the production of cannabinoid... Oct 22, 2020 - By Maxx Chatsko Biotechnology Article Not Another Political Discussion Maxx argues why investors today would do well to zoom out for a bigger-picture view of the world. Oct 22, 2020 - By Maxx Chatsko Premium Advisor Update “Cell Therapy’s First-Mover Disadvantage” Oct 15, 2020 - By Maxx Chatsko Biotechnology Premium Deep Dive Avita Therapeutics Deep Dive: October 2020 Oct 8, 2020 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for October 7investing lead advisor Maxx Chatsko's October 2020 recommendation is an under-the-radar, small-cap living technologies company at the very beginning of its growth trajectory. Oct 1, 2020 - By Maxx Chatsko Biotechnology Join Now! Why 7investing? Why Should I Invest? Why 7investing? Our Team Our 7 Principles Our Mission Testimonials How It Works What to Expect Our Report Format Membership Details Frequently Asked Questions Recommendations Research Articles Advisor Updates Company Updates Videos Special Reports Podcast Livestream Contact Us General Inquiries Submit a Testimonial Interested in Chatting With 7investing? My Account Log In
Premium Advisor Update Will Renewable Energy Soar During the Biden Administration? Jan 15, 2021 - By Maxx Chatsko Energy Podcast JPM 39th Annual Healthcare Conference: What We’re Watching The JPM 39th Annual Healthcare Conference is next week. 7investing Lead Advisors Simon Erickson, Manisha Samy, and Maxx Chatsko discuss what they're watching as investors (and science nerds) ahead of... Jan 7, 2021 - By Manisha Samy Biotechnology Premium Deep Dive Selecta Biosciences Deep Dive: January 2021 Jan 1, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for January 7investing Lead Advisor Maxx Chatsko's top stock to buy in January 2021 is a small-cap biopharma developing an important technology platform that could increase the value of gene therapies, genetic... Jan 1, 2021 - By Maxx Chatsko Biotechnology Article Does the “B” Word Apply? It’s Complicated Maxx Chatsko offers a glimpse into how he values development-stage biopharma stocks. Dec 22, 2020 - By Maxx Chatsko Biotechnology Premium Advisor Update The 7investing Recommendation That Wasn’t Dec 15, 2020 - By Maxx Chatsko Pharmaceuticals Podcast ASH Conference Preview: What We’re Watching 7investing lead advisors Manisha Samy and Maxx Chatsko share what they're watching at the upcoming American Society of Hematology annual conference. Dec 3, 2020 - By Manisha Samy Biotechnology Podcast Synthetic Biology’s “Window of Opportunity” with ConVergInce Advisers’ Joel Stone Can synthetic biology break the chemical industry's reliance on fossil fuels? Industry veteran Joel Stone shares how industrial biotech is changing consumer brands, energy, agriculture, and more. Dec 1, 2020 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for December 7investing lead advisor Maxx Chatsko's Top Stock for December is leading the energy transition, today and tomorrow. Dec 1, 2020 - By Maxx Chatsko Energy Premium Deep Dive Xcel Energy Deep Dive: December 2020 Dec 1, 2020 - By Maxx Chatsko Energy Article Lesson Learned: Great Technology Doesn’t Guarantee a Great Business Maxx explains the importance of separating promising technology from great business. Nov 22, 2020 - By Maxx Chatsko Premium Advisor Update Vaccines Are On the Way, but Winter is Coming Nov 15, 2020 - By Maxx Chatsko Healthcare Technology Premium Deep Dive Dicerna Pharmaceuticals Deep Dive: November 2020 Nov 1, 2020 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for November 7investing lead advisor Maxx Chatsko's November 2020 recommendation is an under-the-radar, small-cap living technologies company at the very beginning of its growth trajectory. Nov 1, 2020 - By Maxx Chatsko Biotechnology Podcast Will the Cannabis Industry Give Way to Biotech? 7investing Lead Advisor Maxx Chatsko talks with Kevin Chen, co-founder and CEO of Hyasynth Bio, about the cannabis industry and how industrial biotech could transform the production of cannabinoid... Oct 22, 2020 - By Maxx Chatsko Biotechnology Article Not Another Political Discussion Maxx argues why investors today would do well to zoom out for a bigger-picture view of the world. Oct 22, 2020 - By Maxx Chatsko Premium Advisor Update “Cell Therapy’s First-Mover Disadvantage” Oct 15, 2020 - By Maxx Chatsko Biotechnology Premium Deep Dive Avita Therapeutics Deep Dive: October 2020 Oct 8, 2020 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for October 7investing lead advisor Maxx Chatsko's October 2020 recommendation is an under-the-radar, small-cap living technologies company at the very beginning of its growth trajectory. Oct 1, 2020 - By Maxx Chatsko Biotechnology Join Now! Why 7investing? Why Should I Invest? Why 7investing? Our Team Our 7 Principles Our Mission Testimonials How It Works What to Expect Our Report Format Membership Details Frequently Asked Questions Recommendations Research Articles Advisor Updates Company Updates Videos Special Reports Podcast Livestream Contact Us General Inquiries Submit a Testimonial Interested in Chatting With 7investing? My Account Log In
Podcast JPM 39th Annual Healthcare Conference: What We’re Watching The JPM 39th Annual Healthcare Conference is next week. 7investing Lead Advisors Simon Erickson, Manisha Samy, and Maxx Chatsko discuss what they're watching as investors (and science nerds) ahead of... Jan 7, 2021 - By Manisha Samy Biotechnology Premium Deep Dive Selecta Biosciences Deep Dive: January 2021 Jan 1, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for January 7investing Lead Advisor Maxx Chatsko's top stock to buy in January 2021 is a small-cap biopharma developing an important technology platform that could increase the value of gene therapies, genetic... Jan 1, 2021 - By Maxx Chatsko Biotechnology Article Does the “B” Word Apply? It’s Complicated Maxx Chatsko offers a glimpse into how he values development-stage biopharma stocks. Dec 22, 2020 - By Maxx Chatsko Biotechnology Premium Advisor Update The 7investing Recommendation That Wasn’t Dec 15, 2020 - By Maxx Chatsko Pharmaceuticals Podcast ASH Conference Preview: What We’re Watching 7investing lead advisors Manisha Samy and Maxx Chatsko share what they're watching at the upcoming American Society of Hematology annual conference. Dec 3, 2020 - By Manisha Samy Biotechnology Podcast Synthetic Biology’s “Window of Opportunity” with ConVergInce Advisers’ Joel Stone Can synthetic biology break the chemical industry's reliance on fossil fuels? Industry veteran Joel Stone shares how industrial biotech is changing consumer brands, energy, agriculture, and more. Dec 1, 2020 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for December 7investing lead advisor Maxx Chatsko's Top Stock for December is leading the energy transition, today and tomorrow. Dec 1, 2020 - By Maxx Chatsko Energy Premium Deep Dive Xcel Energy Deep Dive: December 2020 Dec 1, 2020 - By Maxx Chatsko Energy Article Lesson Learned: Great Technology Doesn’t Guarantee a Great Business Maxx explains the importance of separating promising technology from great business. Nov 22, 2020 - By Maxx Chatsko Premium Advisor Update Vaccines Are On the Way, but Winter is Coming Nov 15, 2020 - By Maxx Chatsko Healthcare Technology Premium Deep Dive Dicerna Pharmaceuticals Deep Dive: November 2020 Nov 1, 2020 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for November 7investing lead advisor Maxx Chatsko's November 2020 recommendation is an under-the-radar, small-cap living technologies company at the very beginning of its growth trajectory. Nov 1, 2020 - By Maxx Chatsko Biotechnology Podcast Will the Cannabis Industry Give Way to Biotech? 7investing Lead Advisor Maxx Chatsko talks with Kevin Chen, co-founder and CEO of Hyasynth Bio, about the cannabis industry and how industrial biotech could transform the production of cannabinoid... Oct 22, 2020 - By Maxx Chatsko Biotechnology Article Not Another Political Discussion Maxx argues why investors today would do well to zoom out for a bigger-picture view of the world. Oct 22, 2020 - By Maxx Chatsko Premium Advisor Update “Cell Therapy’s First-Mover Disadvantage” Oct 15, 2020 - By Maxx Chatsko Biotechnology Premium Deep Dive Avita Therapeutics Deep Dive: October 2020 Oct 8, 2020 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for October 7investing lead advisor Maxx Chatsko's October 2020 recommendation is an under-the-radar, small-cap living technologies company at the very beginning of its growth trajectory. Oct 1, 2020 - By Maxx Chatsko Biotechnology Join Now! Why 7investing? Why Should I Invest? Why 7investing? Our Team Our 7 Principles Our Mission Testimonials How It Works What to Expect Our Report Format Membership Details Frequently Asked Questions Recommendations Research Articles Advisor Updates Company Updates Videos Special Reports Podcast Livestream Contact Us General Inquiries Submit a Testimonial Interested in Chatting With 7investing? My Account Log In
Premium Deep Dive Selecta Biosciences Deep Dive: January 2021 Jan 1, 2021 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for January 7investing Lead Advisor Maxx Chatsko's top stock to buy in January 2021 is a small-cap biopharma developing an important technology platform that could increase the value of gene therapies, genetic... Jan 1, 2021 - By Maxx Chatsko Biotechnology Article Does the “B” Word Apply? It’s Complicated Maxx Chatsko offers a glimpse into how he values development-stage biopharma stocks. Dec 22, 2020 - By Maxx Chatsko Biotechnology Premium Advisor Update The 7investing Recommendation That Wasn’t Dec 15, 2020 - By Maxx Chatsko Pharmaceuticals Podcast ASH Conference Preview: What We’re Watching 7investing lead advisors Manisha Samy and Maxx Chatsko share what they're watching at the upcoming American Society of Hematology annual conference. Dec 3, 2020 - By Manisha Samy Biotechnology Podcast Synthetic Biology’s “Window of Opportunity” with ConVergInce Advisers’ Joel Stone Can synthetic biology break the chemical industry's reliance on fossil fuels? Industry veteran Joel Stone shares how industrial biotech is changing consumer brands, energy, agriculture, and more. Dec 1, 2020 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for December 7investing lead advisor Maxx Chatsko's Top Stock for December is leading the energy transition, today and tomorrow. Dec 1, 2020 - By Maxx Chatsko Energy Premium Deep Dive Xcel Energy Deep Dive: December 2020 Dec 1, 2020 - By Maxx Chatsko Energy Article Lesson Learned: Great Technology Doesn’t Guarantee a Great Business Maxx explains the importance of separating promising technology from great business. Nov 22, 2020 - By Maxx Chatsko Premium Advisor Update Vaccines Are On the Way, but Winter is Coming Nov 15, 2020 - By Maxx Chatsko Healthcare Technology Premium Deep Dive Dicerna Pharmaceuticals Deep Dive: November 2020 Nov 1, 2020 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for November 7investing lead advisor Maxx Chatsko's November 2020 recommendation is an under-the-radar, small-cap living technologies company at the very beginning of its growth trajectory. Nov 1, 2020 - By Maxx Chatsko Biotechnology Podcast Will the Cannabis Industry Give Way to Biotech? 7investing Lead Advisor Maxx Chatsko talks with Kevin Chen, co-founder and CEO of Hyasynth Bio, about the cannabis industry and how industrial biotech could transform the production of cannabinoid... Oct 22, 2020 - By Maxx Chatsko Biotechnology Article Not Another Political Discussion Maxx argues why investors today would do well to zoom out for a bigger-picture view of the world. Oct 22, 2020 - By Maxx Chatsko Premium Advisor Update “Cell Therapy’s First-Mover Disadvantage” Oct 15, 2020 - By Maxx Chatsko Biotechnology Premium Deep Dive Avita Therapeutics Deep Dive: October 2020 Oct 8, 2020 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for October 7investing lead advisor Maxx Chatsko's October 2020 recommendation is an under-the-radar, small-cap living technologies company at the very beginning of its growth trajectory. Oct 1, 2020 - By Maxx Chatsko Biotechnology Join Now! Why 7investing? Why Should I Invest? Why 7investing? Our Team Our 7 Principles Our Mission Testimonials How It Works What to Expect Our Report Format Membership Details Frequently Asked Questions Recommendations Research Articles Advisor Updates Company Updates Videos Special Reports Podcast Livestream Contact Us General Inquiries Submit a Testimonial Interested in Chatting With 7investing? My Account Log In
Video Maxx’s Top Stock for January 7investing Lead Advisor Maxx Chatsko's top stock to buy in January 2021 is a small-cap biopharma developing an important technology platform that could increase the value of gene therapies, genetic... Jan 1, 2021 - By Maxx Chatsko Biotechnology Article Does the “B” Word Apply? It’s Complicated Maxx Chatsko offers a glimpse into how he values development-stage biopharma stocks. Dec 22, 2020 - By Maxx Chatsko Biotechnology Premium Advisor Update The 7investing Recommendation That Wasn’t Dec 15, 2020 - By Maxx Chatsko Pharmaceuticals Podcast ASH Conference Preview: What We’re Watching 7investing lead advisors Manisha Samy and Maxx Chatsko share what they're watching at the upcoming American Society of Hematology annual conference. Dec 3, 2020 - By Manisha Samy Biotechnology Podcast Synthetic Biology’s “Window of Opportunity” with ConVergInce Advisers’ Joel Stone Can synthetic biology break the chemical industry's reliance on fossil fuels? Industry veteran Joel Stone shares how industrial biotech is changing consumer brands, energy, agriculture, and more. Dec 1, 2020 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for December 7investing lead advisor Maxx Chatsko's Top Stock for December is leading the energy transition, today and tomorrow. Dec 1, 2020 - By Maxx Chatsko Energy Premium Deep Dive Xcel Energy Deep Dive: December 2020 Dec 1, 2020 - By Maxx Chatsko Energy Article Lesson Learned: Great Technology Doesn’t Guarantee a Great Business Maxx explains the importance of separating promising technology from great business. Nov 22, 2020 - By Maxx Chatsko Premium Advisor Update Vaccines Are On the Way, but Winter is Coming Nov 15, 2020 - By Maxx Chatsko Healthcare Technology Premium Deep Dive Dicerna Pharmaceuticals Deep Dive: November 2020 Nov 1, 2020 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for November 7investing lead advisor Maxx Chatsko's November 2020 recommendation is an under-the-radar, small-cap living technologies company at the very beginning of its growth trajectory. Nov 1, 2020 - By Maxx Chatsko Biotechnology Podcast Will the Cannabis Industry Give Way to Biotech? 7investing Lead Advisor Maxx Chatsko talks with Kevin Chen, co-founder and CEO of Hyasynth Bio, about the cannabis industry and how industrial biotech could transform the production of cannabinoid... Oct 22, 2020 - By Maxx Chatsko Biotechnology Article Not Another Political Discussion Maxx argues why investors today would do well to zoom out for a bigger-picture view of the world. Oct 22, 2020 - By Maxx Chatsko Premium Advisor Update “Cell Therapy’s First-Mover Disadvantage” Oct 15, 2020 - By Maxx Chatsko Biotechnology Premium Deep Dive Avita Therapeutics Deep Dive: October 2020 Oct 8, 2020 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for October 7investing lead advisor Maxx Chatsko's October 2020 recommendation is an under-the-radar, small-cap living technologies company at the very beginning of its growth trajectory. Oct 1, 2020 - By Maxx Chatsko Biotechnology Join Now! Why 7investing? Why Should I Invest? Why 7investing? Our Team Our 7 Principles Our Mission Testimonials How It Works What to Expect Our Report Format Membership Details Frequently Asked Questions Recommendations Research Articles Advisor Updates Company Updates Videos Special Reports Podcast Livestream Contact Us General Inquiries Submit a Testimonial Interested in Chatting With 7investing? My Account Log In
Article Does the “B” Word Apply? It’s Complicated Maxx Chatsko offers a glimpse into how he values development-stage biopharma stocks. Dec 22, 2020 - By Maxx Chatsko Biotechnology Premium Advisor Update The 7investing Recommendation That Wasn’t Dec 15, 2020 - By Maxx Chatsko Pharmaceuticals Podcast ASH Conference Preview: What We’re Watching 7investing lead advisors Manisha Samy and Maxx Chatsko share what they're watching at the upcoming American Society of Hematology annual conference. Dec 3, 2020 - By Manisha Samy Biotechnology Podcast Synthetic Biology’s “Window of Opportunity” with ConVergInce Advisers’ Joel Stone Can synthetic biology break the chemical industry's reliance on fossil fuels? Industry veteran Joel Stone shares how industrial biotech is changing consumer brands, energy, agriculture, and more. Dec 1, 2020 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for December 7investing lead advisor Maxx Chatsko's Top Stock for December is leading the energy transition, today and tomorrow. Dec 1, 2020 - By Maxx Chatsko Energy Premium Deep Dive Xcel Energy Deep Dive: December 2020 Dec 1, 2020 - By Maxx Chatsko Energy Article Lesson Learned: Great Technology Doesn’t Guarantee a Great Business Maxx explains the importance of separating promising technology from great business. Nov 22, 2020 - By Maxx Chatsko Premium Advisor Update Vaccines Are On the Way, but Winter is Coming Nov 15, 2020 - By Maxx Chatsko Healthcare Technology Premium Deep Dive Dicerna Pharmaceuticals Deep Dive: November 2020 Nov 1, 2020 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for November 7investing lead advisor Maxx Chatsko's November 2020 recommendation is an under-the-radar, small-cap living technologies company at the very beginning of its growth trajectory. Nov 1, 2020 - By Maxx Chatsko Biotechnology Podcast Will the Cannabis Industry Give Way to Biotech? 7investing Lead Advisor Maxx Chatsko talks with Kevin Chen, co-founder and CEO of Hyasynth Bio, about the cannabis industry and how industrial biotech could transform the production of cannabinoid... Oct 22, 2020 - By Maxx Chatsko Biotechnology Article Not Another Political Discussion Maxx argues why investors today would do well to zoom out for a bigger-picture view of the world. Oct 22, 2020 - By Maxx Chatsko Premium Advisor Update “Cell Therapy’s First-Mover Disadvantage” Oct 15, 2020 - By Maxx Chatsko Biotechnology Premium Deep Dive Avita Therapeutics Deep Dive: October 2020 Oct 8, 2020 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for October 7investing lead advisor Maxx Chatsko's October 2020 recommendation is an under-the-radar, small-cap living technologies company at the very beginning of its growth trajectory. Oct 1, 2020 - By Maxx Chatsko Biotechnology Join Now! Why 7investing? Why Should I Invest? Why 7investing? Our Team Our 7 Principles Our Mission Testimonials How It Works What to Expect Our Report Format Membership Details Frequently Asked Questions Recommendations Research Articles Advisor Updates Company Updates Videos Special Reports Podcast Livestream Contact Us General Inquiries Submit a Testimonial Interested in Chatting With 7investing? My Account Log In
Premium Advisor Update The 7investing Recommendation That Wasn’t Dec 15, 2020 - By Maxx Chatsko Pharmaceuticals Podcast ASH Conference Preview: What We’re Watching 7investing lead advisors Manisha Samy and Maxx Chatsko share what they're watching at the upcoming American Society of Hematology annual conference. Dec 3, 2020 - By Manisha Samy Biotechnology Podcast Synthetic Biology’s “Window of Opportunity” with ConVergInce Advisers’ Joel Stone Can synthetic biology break the chemical industry's reliance on fossil fuels? Industry veteran Joel Stone shares how industrial biotech is changing consumer brands, energy, agriculture, and more. Dec 1, 2020 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for December 7investing lead advisor Maxx Chatsko's Top Stock for December is leading the energy transition, today and tomorrow. Dec 1, 2020 - By Maxx Chatsko Energy Premium Deep Dive Xcel Energy Deep Dive: December 2020 Dec 1, 2020 - By Maxx Chatsko Energy Article Lesson Learned: Great Technology Doesn’t Guarantee a Great Business Maxx explains the importance of separating promising technology from great business. Nov 22, 2020 - By Maxx Chatsko Premium Advisor Update Vaccines Are On the Way, but Winter is Coming Nov 15, 2020 - By Maxx Chatsko Healthcare Technology Premium Deep Dive Dicerna Pharmaceuticals Deep Dive: November 2020 Nov 1, 2020 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for November 7investing lead advisor Maxx Chatsko's November 2020 recommendation is an under-the-radar, small-cap living technologies company at the very beginning of its growth trajectory. Nov 1, 2020 - By Maxx Chatsko Biotechnology Podcast Will the Cannabis Industry Give Way to Biotech? 7investing Lead Advisor Maxx Chatsko talks with Kevin Chen, co-founder and CEO of Hyasynth Bio, about the cannabis industry and how industrial biotech could transform the production of cannabinoid... Oct 22, 2020 - By Maxx Chatsko Biotechnology Article Not Another Political Discussion Maxx argues why investors today would do well to zoom out for a bigger-picture view of the world. Oct 22, 2020 - By Maxx Chatsko Premium Advisor Update “Cell Therapy’s First-Mover Disadvantage” Oct 15, 2020 - By Maxx Chatsko Biotechnology Premium Deep Dive Avita Therapeutics Deep Dive: October 2020 Oct 8, 2020 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for October 7investing lead advisor Maxx Chatsko's October 2020 recommendation is an under-the-radar, small-cap living technologies company at the very beginning of its growth trajectory. Oct 1, 2020 - By Maxx Chatsko Biotechnology Join Now! Why 7investing? Why Should I Invest? Why 7investing? Our Team Our 7 Principles Our Mission Testimonials How It Works What to Expect Our Report Format Membership Details Frequently Asked Questions Recommendations Research Articles Advisor Updates Company Updates Videos Special Reports Podcast Livestream Contact Us General Inquiries Submit a Testimonial Interested in Chatting With 7investing? My Account Log In
Podcast ASH Conference Preview: What We’re Watching 7investing lead advisors Manisha Samy and Maxx Chatsko share what they're watching at the upcoming American Society of Hematology annual conference. Dec 3, 2020 - By Manisha Samy Biotechnology Podcast Synthetic Biology’s “Window of Opportunity” with ConVergInce Advisers’ Joel Stone Can synthetic biology break the chemical industry's reliance on fossil fuels? Industry veteran Joel Stone shares how industrial biotech is changing consumer brands, energy, agriculture, and more. Dec 1, 2020 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for December 7investing lead advisor Maxx Chatsko's Top Stock for December is leading the energy transition, today and tomorrow. Dec 1, 2020 - By Maxx Chatsko Energy Premium Deep Dive Xcel Energy Deep Dive: December 2020 Dec 1, 2020 - By Maxx Chatsko Energy Article Lesson Learned: Great Technology Doesn’t Guarantee a Great Business Maxx explains the importance of separating promising technology from great business. Nov 22, 2020 - By Maxx Chatsko Premium Advisor Update Vaccines Are On the Way, but Winter is Coming Nov 15, 2020 - By Maxx Chatsko Healthcare Technology Premium Deep Dive Dicerna Pharmaceuticals Deep Dive: November 2020 Nov 1, 2020 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for November 7investing lead advisor Maxx Chatsko's November 2020 recommendation is an under-the-radar, small-cap living technologies company at the very beginning of its growth trajectory. Nov 1, 2020 - By Maxx Chatsko Biotechnology Podcast Will the Cannabis Industry Give Way to Biotech? 7investing Lead Advisor Maxx Chatsko talks with Kevin Chen, co-founder and CEO of Hyasynth Bio, about the cannabis industry and how industrial biotech could transform the production of cannabinoid... Oct 22, 2020 - By Maxx Chatsko Biotechnology Article Not Another Political Discussion Maxx argues why investors today would do well to zoom out for a bigger-picture view of the world. Oct 22, 2020 - By Maxx Chatsko Premium Advisor Update “Cell Therapy’s First-Mover Disadvantage” Oct 15, 2020 - By Maxx Chatsko Biotechnology Premium Deep Dive Avita Therapeutics Deep Dive: October 2020 Oct 8, 2020 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for October 7investing lead advisor Maxx Chatsko's October 2020 recommendation is an under-the-radar, small-cap living technologies company at the very beginning of its growth trajectory. Oct 1, 2020 - By Maxx Chatsko Biotechnology Join Now! Why 7investing? Why Should I Invest? Why 7investing? Our Team Our 7 Principles Our Mission Testimonials How It Works What to Expect Our Report Format Membership Details Frequently Asked Questions Recommendations Research Articles Advisor Updates Company Updates Videos Special Reports Podcast Livestream Contact Us General Inquiries Submit a Testimonial Interested in Chatting With 7investing? My Account Log In
Podcast Synthetic Biology’s “Window of Opportunity” with ConVergInce Advisers’ Joel Stone Can synthetic biology break the chemical industry's reliance on fossil fuels? Industry veteran Joel Stone shares how industrial biotech is changing consumer brands, energy, agriculture, and more. Dec 1, 2020 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for December 7investing lead advisor Maxx Chatsko's Top Stock for December is leading the energy transition, today and tomorrow. Dec 1, 2020 - By Maxx Chatsko Energy Premium Deep Dive Xcel Energy Deep Dive: December 2020 Dec 1, 2020 - By Maxx Chatsko Energy Article Lesson Learned: Great Technology Doesn’t Guarantee a Great Business Maxx explains the importance of separating promising technology from great business. Nov 22, 2020 - By Maxx Chatsko Premium Advisor Update Vaccines Are On the Way, but Winter is Coming Nov 15, 2020 - By Maxx Chatsko Healthcare Technology Premium Deep Dive Dicerna Pharmaceuticals Deep Dive: November 2020 Nov 1, 2020 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for November 7investing lead advisor Maxx Chatsko's November 2020 recommendation is an under-the-radar, small-cap living technologies company at the very beginning of its growth trajectory. Nov 1, 2020 - By Maxx Chatsko Biotechnology Podcast Will the Cannabis Industry Give Way to Biotech? 7investing Lead Advisor Maxx Chatsko talks with Kevin Chen, co-founder and CEO of Hyasynth Bio, about the cannabis industry and how industrial biotech could transform the production of cannabinoid... Oct 22, 2020 - By Maxx Chatsko Biotechnology Article Not Another Political Discussion Maxx argues why investors today would do well to zoom out for a bigger-picture view of the world. Oct 22, 2020 - By Maxx Chatsko Premium Advisor Update “Cell Therapy’s First-Mover Disadvantage” Oct 15, 2020 - By Maxx Chatsko Biotechnology Premium Deep Dive Avita Therapeutics Deep Dive: October 2020 Oct 8, 2020 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for October 7investing lead advisor Maxx Chatsko's October 2020 recommendation is an under-the-radar, small-cap living technologies company at the very beginning of its growth trajectory. Oct 1, 2020 - By Maxx Chatsko Biotechnology Join Now! Why 7investing? Why Should I Invest? Why 7investing? Our Team Our 7 Principles Our Mission Testimonials How It Works What to Expect Our Report Format Membership Details Frequently Asked Questions Recommendations Research Articles Advisor Updates Company Updates Videos Special Reports Podcast Livestream Contact Us General Inquiries Submit a Testimonial Interested in Chatting With 7investing? My Account Log In
Video Maxx’s Top Stock for December 7investing lead advisor Maxx Chatsko's Top Stock for December is leading the energy transition, today and tomorrow. Dec 1, 2020 - By Maxx Chatsko Energy Premium Deep Dive Xcel Energy Deep Dive: December 2020 Dec 1, 2020 - By Maxx Chatsko Energy Article Lesson Learned: Great Technology Doesn’t Guarantee a Great Business Maxx explains the importance of separating promising technology from great business. Nov 22, 2020 - By Maxx Chatsko Premium Advisor Update Vaccines Are On the Way, but Winter is Coming Nov 15, 2020 - By Maxx Chatsko Healthcare Technology Premium Deep Dive Dicerna Pharmaceuticals Deep Dive: November 2020 Nov 1, 2020 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for November 7investing lead advisor Maxx Chatsko's November 2020 recommendation is an under-the-radar, small-cap living technologies company at the very beginning of its growth trajectory. Nov 1, 2020 - By Maxx Chatsko Biotechnology Podcast Will the Cannabis Industry Give Way to Biotech? 7investing Lead Advisor Maxx Chatsko talks with Kevin Chen, co-founder and CEO of Hyasynth Bio, about the cannabis industry and how industrial biotech could transform the production of cannabinoid... Oct 22, 2020 - By Maxx Chatsko Biotechnology Article Not Another Political Discussion Maxx argues why investors today would do well to zoom out for a bigger-picture view of the world. Oct 22, 2020 - By Maxx Chatsko Premium Advisor Update “Cell Therapy’s First-Mover Disadvantage” Oct 15, 2020 - By Maxx Chatsko Biotechnology Premium Deep Dive Avita Therapeutics Deep Dive: October 2020 Oct 8, 2020 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for October 7investing lead advisor Maxx Chatsko's October 2020 recommendation is an under-the-radar, small-cap living technologies company at the very beginning of its growth trajectory. Oct 1, 2020 - By Maxx Chatsko Biotechnology Join Now! Why 7investing? Why Should I Invest? Why 7investing? Our Team Our 7 Principles Our Mission Testimonials How It Works What to Expect Our Report Format Membership Details Frequently Asked Questions Recommendations Research Articles Advisor Updates Company Updates Videos Special Reports Podcast Livestream Contact Us General Inquiries Submit a Testimonial Interested in Chatting With 7investing? My Account Log In
Premium Deep Dive Xcel Energy Deep Dive: December 2020 Dec 1, 2020 - By Maxx Chatsko Energy Article Lesson Learned: Great Technology Doesn’t Guarantee a Great Business Maxx explains the importance of separating promising technology from great business. Nov 22, 2020 - By Maxx Chatsko Premium Advisor Update Vaccines Are On the Way, but Winter is Coming Nov 15, 2020 - By Maxx Chatsko Healthcare Technology Premium Deep Dive Dicerna Pharmaceuticals Deep Dive: November 2020 Nov 1, 2020 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for November 7investing lead advisor Maxx Chatsko's November 2020 recommendation is an under-the-radar, small-cap living technologies company at the very beginning of its growth trajectory. Nov 1, 2020 - By Maxx Chatsko Biotechnology Podcast Will the Cannabis Industry Give Way to Biotech? 7investing Lead Advisor Maxx Chatsko talks with Kevin Chen, co-founder and CEO of Hyasynth Bio, about the cannabis industry and how industrial biotech could transform the production of cannabinoid... Oct 22, 2020 - By Maxx Chatsko Biotechnology Article Not Another Political Discussion Maxx argues why investors today would do well to zoom out for a bigger-picture view of the world. Oct 22, 2020 - By Maxx Chatsko Premium Advisor Update “Cell Therapy’s First-Mover Disadvantage” Oct 15, 2020 - By Maxx Chatsko Biotechnology Premium Deep Dive Avita Therapeutics Deep Dive: October 2020 Oct 8, 2020 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for October 7investing lead advisor Maxx Chatsko's October 2020 recommendation is an under-the-radar, small-cap living technologies company at the very beginning of its growth trajectory. Oct 1, 2020 - By Maxx Chatsko Biotechnology Join Now! Why 7investing? Why Should I Invest? Why 7investing? Our Team Our 7 Principles Our Mission Testimonials How It Works What to Expect Our Report Format Membership Details Frequently Asked Questions Recommendations Research Articles Advisor Updates Company Updates Videos Special Reports Podcast Livestream Contact Us General Inquiries Submit a Testimonial Interested in Chatting With 7investing? My Account Log In
Article Lesson Learned: Great Technology Doesn’t Guarantee a Great Business Maxx explains the importance of separating promising technology from great business. Nov 22, 2020 - By Maxx Chatsko Premium Advisor Update Vaccines Are On the Way, but Winter is Coming Nov 15, 2020 - By Maxx Chatsko Healthcare Technology Premium Deep Dive Dicerna Pharmaceuticals Deep Dive: November 2020 Nov 1, 2020 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for November 7investing lead advisor Maxx Chatsko's November 2020 recommendation is an under-the-radar, small-cap living technologies company at the very beginning of its growth trajectory. Nov 1, 2020 - By Maxx Chatsko Biotechnology Podcast Will the Cannabis Industry Give Way to Biotech? 7investing Lead Advisor Maxx Chatsko talks with Kevin Chen, co-founder and CEO of Hyasynth Bio, about the cannabis industry and how industrial biotech could transform the production of cannabinoid... Oct 22, 2020 - By Maxx Chatsko Biotechnology Article Not Another Political Discussion Maxx argues why investors today would do well to zoom out for a bigger-picture view of the world. Oct 22, 2020 - By Maxx Chatsko Premium Advisor Update “Cell Therapy’s First-Mover Disadvantage” Oct 15, 2020 - By Maxx Chatsko Biotechnology Premium Deep Dive Avita Therapeutics Deep Dive: October 2020 Oct 8, 2020 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for October 7investing lead advisor Maxx Chatsko's October 2020 recommendation is an under-the-radar, small-cap living technologies company at the very beginning of its growth trajectory. Oct 1, 2020 - By Maxx Chatsko Biotechnology Join Now! Why 7investing? Why Should I Invest? Why 7investing? Our Team Our 7 Principles Our Mission Testimonials How It Works What to Expect Our Report Format Membership Details Frequently Asked Questions Recommendations Research Articles Advisor Updates Company Updates Videos Special Reports Podcast Livestream Contact Us General Inquiries Submit a Testimonial Interested in Chatting With 7investing? My Account Log In
Premium Advisor Update Vaccines Are On the Way, but Winter is Coming Nov 15, 2020 - By Maxx Chatsko Healthcare Technology Premium Deep Dive Dicerna Pharmaceuticals Deep Dive: November 2020 Nov 1, 2020 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for November 7investing lead advisor Maxx Chatsko's November 2020 recommendation is an under-the-radar, small-cap living technologies company at the very beginning of its growth trajectory. Nov 1, 2020 - By Maxx Chatsko Biotechnology Podcast Will the Cannabis Industry Give Way to Biotech? 7investing Lead Advisor Maxx Chatsko talks with Kevin Chen, co-founder and CEO of Hyasynth Bio, about the cannabis industry and how industrial biotech could transform the production of cannabinoid... Oct 22, 2020 - By Maxx Chatsko Biotechnology Article Not Another Political Discussion Maxx argues why investors today would do well to zoom out for a bigger-picture view of the world. Oct 22, 2020 - By Maxx Chatsko Premium Advisor Update “Cell Therapy’s First-Mover Disadvantage” Oct 15, 2020 - By Maxx Chatsko Biotechnology Premium Deep Dive Avita Therapeutics Deep Dive: October 2020 Oct 8, 2020 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for October 7investing lead advisor Maxx Chatsko's October 2020 recommendation is an under-the-radar, small-cap living technologies company at the very beginning of its growth trajectory. Oct 1, 2020 - By Maxx Chatsko Biotechnology Join Now! Why 7investing? Why Should I Invest? Why 7investing? Our Team Our 7 Principles Our Mission Testimonials How It Works What to Expect Our Report Format Membership Details Frequently Asked Questions Recommendations Research Articles Advisor Updates Company Updates Videos Special Reports Podcast Livestream Contact Us General Inquiries Submit a Testimonial Interested in Chatting With 7investing? My Account Log In
Premium Deep Dive Dicerna Pharmaceuticals Deep Dive: November 2020 Nov 1, 2020 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for November 7investing lead advisor Maxx Chatsko's November 2020 recommendation is an under-the-radar, small-cap living technologies company at the very beginning of its growth trajectory. Nov 1, 2020 - By Maxx Chatsko Biotechnology Podcast Will the Cannabis Industry Give Way to Biotech? 7investing Lead Advisor Maxx Chatsko talks with Kevin Chen, co-founder and CEO of Hyasynth Bio, about the cannabis industry and how industrial biotech could transform the production of cannabinoid... Oct 22, 2020 - By Maxx Chatsko Biotechnology Article Not Another Political Discussion Maxx argues why investors today would do well to zoom out for a bigger-picture view of the world. Oct 22, 2020 - By Maxx Chatsko Premium Advisor Update “Cell Therapy’s First-Mover Disadvantage” Oct 15, 2020 - By Maxx Chatsko Biotechnology Premium Deep Dive Avita Therapeutics Deep Dive: October 2020 Oct 8, 2020 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for October 7investing lead advisor Maxx Chatsko's October 2020 recommendation is an under-the-radar, small-cap living technologies company at the very beginning of its growth trajectory. Oct 1, 2020 - By Maxx Chatsko Biotechnology Join Now! Why 7investing? Why Should I Invest? Why 7investing? Our Team Our 7 Principles Our Mission Testimonials How It Works What to Expect Our Report Format Membership Details Frequently Asked Questions Recommendations Research Articles Advisor Updates Company Updates Videos Special Reports Podcast Livestream Contact Us General Inquiries Submit a Testimonial Interested in Chatting With 7investing? My Account Log In
Video Maxx’s Top Stock for November 7investing lead advisor Maxx Chatsko's November 2020 recommendation is an under-the-radar, small-cap living technologies company at the very beginning of its growth trajectory. Nov 1, 2020 - By Maxx Chatsko Biotechnology Podcast Will the Cannabis Industry Give Way to Biotech? 7investing Lead Advisor Maxx Chatsko talks with Kevin Chen, co-founder and CEO of Hyasynth Bio, about the cannabis industry and how industrial biotech could transform the production of cannabinoid... Oct 22, 2020 - By Maxx Chatsko Biotechnology Article Not Another Political Discussion Maxx argues why investors today would do well to zoom out for a bigger-picture view of the world. Oct 22, 2020 - By Maxx Chatsko Premium Advisor Update “Cell Therapy’s First-Mover Disadvantage” Oct 15, 2020 - By Maxx Chatsko Biotechnology Premium Deep Dive Avita Therapeutics Deep Dive: October 2020 Oct 8, 2020 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for October 7investing lead advisor Maxx Chatsko's October 2020 recommendation is an under-the-radar, small-cap living technologies company at the very beginning of its growth trajectory. Oct 1, 2020 - By Maxx Chatsko Biotechnology Join Now! Why 7investing? Why Should I Invest? Why 7investing? Our Team Our 7 Principles Our Mission Testimonials How It Works What to Expect Our Report Format Membership Details Frequently Asked Questions Recommendations Research Articles Advisor Updates Company Updates Videos Special Reports Podcast Livestream Contact Us General Inquiries Submit a Testimonial Interested in Chatting With 7investing? My Account Log In
Podcast Will the Cannabis Industry Give Way to Biotech? 7investing Lead Advisor Maxx Chatsko talks with Kevin Chen, co-founder and CEO of Hyasynth Bio, about the cannabis industry and how industrial biotech could transform the production of cannabinoid... Oct 22, 2020 - By Maxx Chatsko Biotechnology Article Not Another Political Discussion Maxx argues why investors today would do well to zoom out for a bigger-picture view of the world. Oct 22, 2020 - By Maxx Chatsko Premium Advisor Update “Cell Therapy’s First-Mover Disadvantage” Oct 15, 2020 - By Maxx Chatsko Biotechnology Premium Deep Dive Avita Therapeutics Deep Dive: October 2020 Oct 8, 2020 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for October 7investing lead advisor Maxx Chatsko's October 2020 recommendation is an under-the-radar, small-cap living technologies company at the very beginning of its growth trajectory. Oct 1, 2020 - By Maxx Chatsko Biotechnology Join Now! Why 7investing? Why Should I Invest? Why 7investing? Our Team Our 7 Principles Our Mission Testimonials How It Works What to Expect Our Report Format Membership Details Frequently Asked Questions Recommendations Research Articles Advisor Updates Company Updates Videos Special Reports Podcast Livestream Contact Us General Inquiries Submit a Testimonial Interested in Chatting With 7investing? My Account Log In
Article Not Another Political Discussion Maxx argues why investors today would do well to zoom out for a bigger-picture view of the world. Oct 22, 2020 - By Maxx Chatsko Premium Advisor Update “Cell Therapy’s First-Mover Disadvantage” Oct 15, 2020 - By Maxx Chatsko Biotechnology Premium Deep Dive Avita Therapeutics Deep Dive: October 2020 Oct 8, 2020 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for October 7investing lead advisor Maxx Chatsko's October 2020 recommendation is an under-the-radar, small-cap living technologies company at the very beginning of its growth trajectory. Oct 1, 2020 - By Maxx Chatsko Biotechnology Join Now! Why 7investing? Why Should I Invest? Why 7investing? Our Team Our 7 Principles Our Mission Testimonials How It Works What to Expect Our Report Format Membership Details Frequently Asked Questions Recommendations Research Articles Advisor Updates Company Updates Videos Special Reports Podcast Livestream Contact Us General Inquiries Submit a Testimonial Interested in Chatting With 7investing? My Account Log In
Premium Advisor Update “Cell Therapy’s First-Mover Disadvantage” Oct 15, 2020 - By Maxx Chatsko Biotechnology Premium Deep Dive Avita Therapeutics Deep Dive: October 2020 Oct 8, 2020 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for October 7investing lead advisor Maxx Chatsko's October 2020 recommendation is an under-the-radar, small-cap living technologies company at the very beginning of its growth trajectory. Oct 1, 2020 - By Maxx Chatsko Biotechnology
Premium Deep Dive Avita Therapeutics Deep Dive: October 2020 Oct 8, 2020 - By Maxx Chatsko Biotechnology Video Maxx’s Top Stock for October 7investing lead advisor Maxx Chatsko's October 2020 recommendation is an under-the-radar, small-cap living technologies company at the very beginning of its growth trajectory. Oct 1, 2020 - By Maxx Chatsko Biotechnology
Video Maxx’s Top Stock for October 7investing lead advisor Maxx Chatsko's October 2020 recommendation is an under-the-radar, small-cap living technologies company at the very beginning of its growth trajectory. Oct 1, 2020 - By Maxx Chatsko Biotechnology
